Purdue University

Purdue e-Pubs
Open Access Dissertations

Theses and Dissertations

Fall 2013

Fluorous- Phase Synthesis of Heparan Sulfate
Disaccharides & Low-Molecular Weight Additives
for Enhancing the Performance of Lithium-Ion
Batteries.
Matthew Daniel Casselman
Purdue University

Follow this and additional works at: https://docs.lib.purdue.edu/open_access_dissertations
Part of the Organic Chemistry Commons
Recommended Citation
Casselman, Matthew Daniel, "Fluorous- Phase Synthesis of Heparan Sulfate Disaccharides & Low-Molecular Weight Additives for
Enhancing the Performance of Lithium-Ion Batteries." (2013). Open Access Dissertations. 173.
https://docs.lib.purdue.edu/open_access_dissertations/173

This document has been made available through Purdue e-Pubs, a service of the Purdue University Libraries. Please contact epubs@purdue.edu for
additional information.

Graduate School ETD Form 9
(Revised 12/07)

PURDUE UNIVERSITY
GRADUATE SCHOOL
Thesis/Dissertation Acceptance
This is to certify that the thesis/dissertation prepared
By Matthew D. Casselman
Entitled FLUOROUS-PHASE SYNTHESIS OF HEPARAN SULFATE DISACCHARIDES &

LOW-MOLECULAR WEIGHT ADDITIVES FOR ENHANCING THE PERFORMANCE
OF LITHIUM-ION BATTERIES

For the degree of Doctor of Philosophy
Is approved by the final examining committee:
Alexander Wei
Chair

David H. Thompson

Yu Xia

Mingji Dai

To the best of my knowledge and as understood by the student in the Research Integrity and
Copyright Disclaimer (Graduate School Form 20), this thesis/dissertation adheres to the provisions of
Purdue University’s “Policy on Integrity in Research” and the use of copyrighted material.

Alexander Wei
Approved by Major Professor(s): ____________________________________

____________________________________
Approved by: R. E. Wild

11-19-2013
Head of the Graduate Program

Date

FLUOROUS-PHASE SYNTHESIS OF HEPARAN SULFATE DISACCHARIDES &
LOW-MOLECULAR WEIGHT ADDITIVES FOR ENHANCING THE
PERFORMANCE OF LITHIUM-ION BATTERIES

A Dissertation
Submitted to the Faculty
of
Purdue University
by
Matthew D. Casselman

In Partial Fulfillment of the
Requirements for the Degree
of
Doctor of Philosophy

December 2013
Purdue University
West Lafayette, Indiana

ii

For my parents Daniel and Teresa Casselman, and the rest of my family

iii

ACKNOWLEDGMENTS

I must first acknowledge my advisor, Professor Alexander Wei, for the guidance
he has provided during my Ph.D. studies. He has instilled in me a curiosity to explore the
chemical universe and that is an invaluable quality. I must also acknowledge those who
have come before me in our research group: Dr. Gang Cheng, Dr. Runhui Liu and Dr.
Panuwat Pandungros. They were essential in preparing me to work in a research
laboratory environment. I must thank the scientific staff at Purdue as well: in particular,
Dr. John Harwood, Dr. Karl Wood, and Dr. Patricia Bishop. Their support was essential
in keeping my research projects afloat. I would like to thank my committee members for
their support over the years: Dr. David Thompson, Dr. Yu Xia, and Dr. Mingji Dai. I
must thank my friends in the Wei group, both past and present: Jie, David, Oscar, Jon,
Hari, Naveen, Anh, Thora, Jason, and Nigam.

iv

"

TABLE OF CONTENTS

Page
LIST OF TABLES ............................................................................................................. vi
LIST OF FIGURES .......................................................................................................... vii
LIST OF ABBREVIATIONS ............................................................................................. x
ABSTRACT..................................................................................................................... xiv
CHAPTER I – INTRODUCTION ...................................................................................... 1
1.1 Heparin and Heparan Sulfate – Structure and Biosynthesis ................................... 1
1.2 Role of Heparin and Heparan Sulfate in Biology ................................................... 3
1.3 Chemical Synthesis of Heparin-Like Oligosaccharides ......................................... 5
1.4 New Technologies for Carbohydrate Synthesis ...................................................... 8
1.5 Fluorous Separations............................................................................................... 9
1.6 References ............................................................................................................. 12
"
CHAPTER II – SYNTHESIS OF HEPARAN SULFATE SULFOFORMS VIA
FLUOROUS METHODS ................................................................................................. 14

"
"
"
"
"
"

2.1 Synthesis of Orthogonally Protected α-Glucosamines ......................................... 14
2.2 Synthesis of First-Generation Fluorous Sulfoforms ............................................. 15
2.3 Synthesis of Bis-PFO Tags ................................................................................... 21
2.4 Synthesis of Mono-PFO Benzyl Carbamate ......................................................... 30
2.5 Synthesis of Single-PFO Benzyl Glycosides ........................................................ 35
2.6 Materials and Methods.......................................................................................... 41
2.7 References ............................................................................................................. 82

"

v
Page

CHAPTER III – SYNTHESIS AND TESTING OF LITHIUM-ION BATTERY
ADDITIVES WITH PERFLUOROALKYL CHAINS .................................................... 84
3.1 Introduction ........................................................................................................... 84
3.1.1 Importance of Lithium-Ion Batteries ........................................................... 84
3.1.2 Challenges in Improving LIB Performance ................................................. 85
3.1.3 Additive Approach to Improving LIB Performance .................................... 86
3.1.4 Perfluoroalkyl-Substituted Additives for LIBs ............................................ 87
3.2 (2-Perfluorooctyl)Ethyl Vinyl Sulfone ................................................................. 88
3.3 The Perfluoroalkyl Ethylene Carbonate Series ..................................................... 90
3.4 Perfluorooctyl-Substituted Thiophenes ................................................................ 95
3.5 p-(Perfluorooctylphenyl) Diphenylphosphine Oxide ........................................... 98
3.6 Boronic Esters of 2-(Perfluoroalkyl)ethylene Glycols ......................................... 99
3.7 Conclusions ........................................................................................................... 99
3.8 General Methods And Experimentals ................................................................. 100
3.9 References ........................................................................................................... 107
VITA ............................................................................................................................... 108
PUBLICATION .............................................................................................................. 109

vi

LIST OF TABLES

Table

Page

Table 2.1. Retention factors of intermediates 14-16 on F-TLC........................................ 19
Table 2.2. Deprotection and sulfonation conditions for disaccharide 62. ........................ 40

vii

LIST OF FIGURES

Figure

Page

Figure 1.1 Basic structure of heparin and heparan sulfate.
R = H, Ac, SO3-. R’=H, SO3-. ............................................................................................. 1
Figure 1.2 Biosynthesis of heparin/HS. ............................................................................. 3
Figure 1.3 Heterogeneous structure of heparan sulfate. ..................................................... 3
Figure 1.4 AT-III-binding heparin pentasaccharide, fondaparinux. ................................... 4
Figure 1.5 Target-oriented synthesis of a bioactive oligosaccharide sulfoform. ................ 6
Figure 1.6 Diversity-oriented approach to disaccharide sulfoform libraries ...................... 7
Figure 1.7 Solid-phase synthesis of glucosamine sulfoforms. ............................................ 9
Figure 2.1 Synthesis of glucosaminyl thioglycoside donor 6. .......................................... 15
Figure 2.2 Synthesis of a 3-perfluorooctyl-1-propanol 8.................................................. 16
Figure 2.3 Synthesis of an orthogonally protected -glucosaminoside
with a PFO tag (13). .......................................................................................................... 17
Figure 2.4 Deprotection and sulfonation of orthogonally protected glucosaminoglycoside 13 .................................................................................................. 18
Figure 2.5 Synthesis of double PFO alcohol 19 and double PFO sulfoform 21............... 21
Figure 2.6 Synthesis of bis-PFO Cbz analogue 22. .......................................................... 22

viii
Figure

Page

Figure 2.7 Synthesis of bis-PFO-Cbz-protected aminoethyl -glycoside 23. .................. 22
Figure 2.8 Synthesis of bis-PFO Cbz analogue 28. .......................................................... 24
Figure 2.9 Synthesis of Bis-PFO tagged aminoethyl -Glucosaminoside 29................... 24
Figure 2.10 Attempted sulfonation of bis-PFO-tagged -glucosaminoside 29,
following azide reduction and N-sulfonation.................................................................... 26
Figure 2.11 Proposed mechanism of decomposition of 29 under sulfonation. ................. 28
Figure 2.12 A) Synthesis of homologated bis-PFO tag 34.
B) Synthesis of bis-PFO labeled -aminoethyl glycoside 35. .......................................... 29
Figure 2.13 A) Synthesis of mono-PFO tag 38. B) Synthesis of mono-PFO tagged
aminoethyl -glycoside 39. ............................................................................................... 31
Figure 2.14 Synthesis of aminoethyl-GlcA acceptors 44 – 46. ........................................ 33
Figure 2.15 Synthesis of orthogonally protected, PFO-tagged dissacharide 49. .............. 34
Figure 2.16 Synthesis of p-((2-PFO)ethyl) benzyl -glucosaminoside 51. ...................... 36
Figure 2.17 Synthesis of 3,4-PMB-protected thioglucoside donor 56.............................. 37
Figure 2.18 Synthesis of disaccharide 57. ........................................................................ 38
Figure 2.19 Synthesis of Nap-protected glycosyl donor 61. ............................................. 39
Figure 2.20 Synthesis of disaccharide 62. ........................................................................ 39
Figure 3.1 Schematic of Lithium-ion Battery. .................................................................. 85
Figure 3.2 Proposed mechanism of cathode protection using oxidatively reactive
additives. (A) Additive design; (B) Proposed mode of action. ......................................... 88
Figure 3.3 Synthesis of (2-perfluorooctyl)ethyl vinyl sulfone. ........................................ 89
Figure 3.4 Cycle versus discharge capacity, with and without 1 wt% vinyl sulfone 63. . 90
Figure 3.5 Synthesis of PFA-EC derivatives 65a-d.......................................................... 91

ix
Figure

Page

Figure 3.6 Cycle versus discharge capacity, with and without perfluorobutyl-EC
(PFB-EC) 65a. .................................................................................................................. 92
Figure 3.7 Cycle versus discharge capacity, with and without perfluorohexyl-EC
(PFH-EC) 65b. .................................................................................................................. 92
Figure 3.8 Cycle versus discharge capacity, with and without perfluorooctyl-EC
(PFO-EC) 65c. .................................................................................................................. 93
Figure 3.9 Cycle versus discharge capacity over 200 cycles, with and without 0.5 wt%
PFO-EC 65c. ..................................................................................................................... 94
Figure 3.10 AC impedance spectra, with and without PFO-EC (65c), after cell
cycling. .............................................................................................................................. 95
Figure 3.11 Synthesis of perfluorooctyl(vinyl) thiophene (68) and perfluorooctyl(ethyl)
thiophene (70). .................................................................................................................. 96
Figure 3.12 Cycle versus discharge capacity, with and without 3-(PFO-vinylene)
thiophene (68). .................................................................................................................. 97
Figure 3.13 Cycle versus discharge capacity, with and without 3-(PFO-ethylene)
thiophene (70).. ................................................................................................................. 98
Figure 3.14 Synthesis of p-(perfluorooctylphenyl) diphenylphosphine oxide 71. ........... 99
Figure 3.15 Synthesis of 2-perfluorodecyl ethylene glycol phenyl boronic ester 72 ....... 99

x

LIST OF ABBREVIATIONS

Ac

acetyl

AIBN

azobisisobutyronitrile

aq

aqueous

Bn

benzyl

br

broad

Bu

butyl

CAN

ceric ammonium nitrate

Cbz

benzyloxycarbonyl

CSA

camphorsulfonic acid

d

doublet

DBU

1,8-Diazabicyclo[5.4.0]undec-7-ene

DCM

dichloromethane

DCE

1,2-dichloroethane

DIPEA

N,N-diisopropylethylamine

DMA

dimethylacetal

DMAP

N,N-dimethyl-4-aminopyridine

DMF

N,N-dimethylformamide

DMSO

dimethylsulfoxide

xi
equiv

equivalent

en

ethylenediamine

ESI

electrospray ionization

Et

ethyl

EtOAc

ethyl acetate

FPSE

fluorous solid-phase extraction

Glc

glucose

GlcN

glucosamine

GlcA

gluronic acid

h

hour

HBP

heparan binding protein

HS

heparan sulfate

IBX

2-iodoxybenzoic acid

IR

infrared

IdoA

iduronic acid

LAH

lithium aluminum hydride

LIB

lithium-ion battery

Me

methyl

min

minute

NHS

N-hydroxysuccinimide

NIS

N-iodosuccinimide

Np

p-nitrophenyl

MS

mass spectrometry

xii
MW

microwave

NMR

nuclear magnetic resonance

MP

4-methoxyphenyl

Nap

2-naphthylmethyl

Np

4-nitrophenyl

o/n

overnight

PFA

perfluoroalkyl

PFB

perfluorobutyl

PFH

perfluorohexyl

PFO

perfluorooctyl

Ph

phenyl

Phth

phthalic

PMB

p-methoxybenzyl

PMBDMA

p-methoxybenzyidine dimethyl acetal

pyr

pyridine

q

quartet

rt

room temperature

s

singlet

sat

saturated

SEM

trimethylsilylethoxymethyl

SEI

solid-electrolyte interface

t

triplet

TBAI

tetrabutylammonium iodide

xiii
TBDPS

tert-butyldiphenylsilyl

TCEP

tris(2-carboxyethyl)phosphine

TEMPO

2,2,6,6-tetramethyl-1-piperidinyloxy

Tf

trifluoromethanesulfonyl

TFT

trifluorotoluene

THF

tetrahydrofuran

Tol

toluene

TLC

thin layer chromatography

xiv

"

ABSTRACT

Casselman, Matthew D. Ph.D., Purdue University, December 2013. Fluorous-Phase
Synthesis of Heparan Sulfate Disaccharides & Low-Molecular Weight Additives for
Enhancing the Performance of Lithium-Ion Batteries. Major Professor: Alexander Wei.

Heparan sulfate is a complex cell-surface proteoglycan that serves many
important roles in biology, such as growth and development, immune response and
pathogenesis. Heparan sulfate is structurally heterogeneous due to the variable postglycosylation modifications, particularly the generation of diverse sets of sulfate esters
(sulfoforms) for any given disaccharide unit. In order to establish useful relationships
between heparan sulfate structure and biological activity, a set of well-defined sulfoforms
is necessary to support binding affinity screening. In this thesis, we describe the
generation of diverse sulfoforms from heparan disaccharides using a fluorous tag to
facilitate purification of highly charged intermediates, and their subsequent
immobilizaion on substrates for affinity binding studies.
A library of heparan disaccharide sulfoforms was prepared from a single
intermediate using an orthogonal protecting group system, to enable the controlled
unmasking of hydroxyls or amines for subsequent sulfonation. A practical challenge of
this approach is the need to carry highly polar intermediates through multiple synthetic
steps. This was addressed by installing a perfluoroalkyl (fluorous) tag on the reducing

xv
end of the orthogonally protected disaccharide. The fluorous tag facilitated the separation
of polar intermediates from non-fluorous byproducts via a two-stage solid-phase
extraction. In this manner, a library of 1,4-linked disaccharides comprised of glucuronic
acid (GlcA) and glucosamine (GlcN) could be prepared with a variable set of sulfonated
substituents. The fluorous tag was retained on the final product to enable their noncovalent adhesion onto perfluoroalkyl-functionalized glass slides in microarray format,
for biological screening against L-selectin, FGF2, and urokinase.
Lithium ion batteries have quickly become an important energy source and
storage medium for electronics in recent years. Increasing the useful lifetime of batteries
is a key challenge in their wide use. A number of perfluoroalkyl-functionalized small
molecules were prepared as performance-enhancing additives for lithium ion batteries.
Perfluorooctyl ethylene carbonate was identified as a candidate that had positive effects
on both cell cycling and cell impedance.

1"
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CHAPTER I – INTRODUCTION

1.1 Heparin and Heparan Sulfate – Structure and Biosynthesis
Carbohydrates are a class of biomolecules with importance in biology with
respect to recognition and regulation of biochemical processes. Important classes of
carbohydrates are the glycosaminoglycans, a family of related carbohydrates found on the
cell surface as part of glycoproteins.1 Of particular interest to us are heparin and heparan
sulfate. Heparin and heparin sulfate in their primary sequence are made up of a repeating
disaccharide unit of glucoamine and hexuronic acid. The oligosaccharide is then made
more complex by the presence of post-glycosational modifications that produce a diverse
and heterogeneous set of substructures. These modifications include the presence of
sulfate esters, at various positions, as well as the isomerization of the D-glucuronic acids
(GlcA) into L-iduronic acid (IdoA) units (Figure 1.1). We collectively describe these
modified heparan structures as sulfoforms.2,3
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Figure 1.1 Basic structure of heparin and heparan sulfate. R = H, Ac, SO3-. R’=H, SO3-.
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The biosynthesis of heparin and heparan sulfate are similar in which N-acetyl
glucosamine (GlcNAc) and D-glucuronic acid units are copolyermized from a peptidebound core tetrasaccharide. Following the elongation of the heparan chain, a number of
post-glycosylational modifications are effected by various enzymes (Figure 1.2).1
Modification sites on GlcNAc include the amine (NHAc, NHSO3-, or NH2) and the
sulfonation of the C3 or C6 hydroxyls. The D-glucuronic unit can be sulfonated at the C2
position and epimerized at the C5 position into L-iduronic acid. The first step in the
biosynthesis involves N-deacetylation and sulfate transfer (NDST) to afford heparan Nsulfate. Epimerization (EPI) of the D-glucuronic acid to L-iduronic acid is next, followed
by sulfonation at the C2 hydroxyl (2-OST) of the uronic acid unit and the C6 hydroxyl
(6-OST) of glucosamine being the most common modification sites. Sulfonation of the
C3 hydroxyl (3-OST) of glucosamine is the last step in the biosynthesis and is often
considered an uncommon or rare modification (and a key signaling factor for various
heparin-binding proteins.) This multistep, post-glycosylational biosynthesis results in a
complex and heterogeneous structure, as each biosynthetic operation does not proceed
with 100% efficiency, with segments that are highly modified (NS-domain), segments
with few modifications (NA/NS-domain) and segments with no modifications (NAdomain) (Figure 1.3).
One disaccharide unit can generate up to 48 sulfoforms, though approximately
half of the unique disaccharide sulfoforms have been isolated. When considered in the
context of larger oligosaccharides, an inordinately large number of potential sulfoforms
results. As an example, there are over 5.3 million sulfoforms are possible for heparan
octasaccharides.

3

Figure 1.2 Biosynthesis of heparin/HS.

Figure 1.3 Heterogeneous structure of heparan sulfate.

1.2 Role of Heparin and Heparan Sulfate in Biology
Heparin and HS have many documented roles in key biological processes.
Perhaps the most well known example heparin plays in biological processes is its role in
the blood coagulation pathway. Clinically heparin is used as an anti-coagulant:

4
interaction with antithrombin III (AT-III) leads to the inactivation of thrombin. This
interaction is quite well studied, and a minimum size fragment (pentasaccharide) has
been identified for activation of AT-III (Figure 1.4). This heparin fragment possesses the
relatively uncommon 3-O-sulfate, which is critical for biological activity.4 This
pentasaccharide has been synthesized and is now sold on the market under the name
fondaparinux (trade name Arixtra).

Figure 1.4 AT-III-binding heparin pentasaccharide, fondaparinux.

Heparan sulfate is present on the surface of nearly all mammalian cells, and is
well known to be a ligand for extracellular signaling proteins. It is implicated in the
recruitment of growth factors, particularly fibroblast growth factor5–8 and vascular
endothelial growth factor9. Research suggests that heparin sulfoform expression is related
to cellular conditions and environment. L-selectin, a cell-adhesion protein, is found on
lymphocytes and is known to have some affinity for heparan sulfate. It is thought that
interactions with heparan sulfate on endothelial cells can slow the rolling of the
lymphocytes along the surfaces of blood vessels, giving more time for the interaction
between highly specific receptors to take place.

5
A number of bacteria and viruses also have strong affinities for heparin. Human
immunodeficiency virus (HIV) is one such example, specifically the envelope
glycoprotein gp41.10 Herpes simplex virus also has affinity for heparin, and in vitro
experiments have shown that exogenous heparin can inhibit infection of cells.11–13
Chlamydia has also been show to interact with heparin, and may be involved in the initial
infection of human epithelial cells.14
While many heparin-binding proteins (HBPs) have been identified, the converse
is not well known. Very few sequences of heparin/HS have been characterized as highaffinity ligands for various HBPs. This is because well-defined structures of heparin/HS
oligosaccharides are not easily isolated from natural sources, which presents an
opportunity for synthetic organic chemists to obtain them abiotically.

1.3 Chemical Synthesis of Heparin-Like Oligosaccharides
Until very recently, all chemical synthesis of well-defined HS fragments has been
completed by one of two synthetic approaches. The first is by a target-oriented approach,
where a single sulfoform of HS is synthesized and screened for its biological activity; the
second is by a diversity-oriented approach, where a library of HS sulfoforms is
synthesized and screened for structure-activity relationships.
The target-oriented approach has found significant support in the literature for the
synthesis of larger HS fragments. This approach typically involves the task of preparing a
large library of monosaccharide intermediates that are differentially protected.15 These
monosaccharide donors each require multiple steps of functionalization to afford each
desired sulfoform pattern, and are coupled by a stepwise glycosylation approach, where
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the oligosaccharide is built up one unit at a time with the sulfonation patterns preprogrammed at specific positions. Recently libraries of protected monosaccharides have
been synthesized and used to make a small number of structurally complex and
biologically active octasaccharide sulfoforms (Figure 1.5).11 The disadvantage of this
approach is that structure-activity relationships for all possible sulfoforms is simply not
possible due to the large number of possible oligosaccharide sulfoforms.

Figure 1.5 Target-oriented synthesis of a bioactive oligosaccharide sulfoform.11

More recently, chemical biology methods have been advanced to the extent where
a number of sulfotransferases have been isolated, produced and purified from bacterial
growths.16 These enzymes have since found use in the semi-synthetic synthesis of
biologically relevant oligosaccharide sulfoforms.17 Core heparin structures were
synthesized, the oligosaccharide chain was elongated enzymatically, and controlled
sulfonation using sulfotransferase enzymes was used to prepare single sulfoforms with
relatively high purity.

7
A complementary approach to the target-oriented synthesis of sulfoforms is the
diversity-oriented synthesis of libraries consisting of shorter heparin-inspired fragments.
In this strategy, a single monosaccharide or disaccharide fragment is synthesized with a
unique protecting group system. This protecting group system allows for the selective
deprotection of any one position to enable the conversion to a sulfonate ester. Further
deprotection reveals the desired sulfoform. In this manner, a single intermediate can
produce a library of all possible sulfoforms (Figure 1.6).18 This strategy also enables
structure-activity relationships between sulfoform structure and protein to be identified.
These relatively weak relationships may then be used to develop longer oligosaccharides,
which may exhibit stronger and more specific interactions with heparin binding proteins.
The synthesis of heparan sulfate sequences enables the discovery of high affinity ligands
for individual heparan binding proteins.

Figure 1.6. Diversity-oriented approach to disaccharide sulfoform libraries.
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1.4 New Technologies for Carbohydrate Synthesis
In addition to various synthetic strategies for sulfoform generation, a number of
practical methods have been developed recently in the area of carbohydrate chemistry.
Polypeptide synthesis was revolutionized by the introduction of solid-phase synthesis,
enabling the automated, step-wise synthesis of large peptide fragments without the
tedious manipulations of traditional solution-phase chemistry. The translation of solidphase methods to carbohydrate chemistry has been on-going, and presents its own unique
challenges.
More recently, solid-phase supported synthesis has been applied to sulfoform
chemistry. Previous work in our research group has involved the development of solid
phase methods for the generation of sulfoforms.2 By this method, differentially protected
carbohydrates are tethered to standard polystyrene resins. Subsequent deprotection and
sulfonation afford sulfoforms in good yields (Figure 1.7). The advantage of this approach
is that reaction intermediates need not be handled between reactions and only a single
purification at the end of the synthesis is necessary. However, these advantages are not
without drawbacks. The use of the polystyrene resin makes all reactions heterogeneous in
nature and thus reduces the reactivity of bound carbohydrates. This is most apparent in
the sulfonation step itself, where generating highly charged molecules on resin is quite
challenging and is the limiting step in this method.

9

Figure 1.7 Solid-phase synthesis of glucosamine sulfoforms.2

1.5 Fluorous Separations
Fluorous-based separations involves the use of perfluoroalkyl chains (fluorous
tags) that allow for the separation of tagged molecules from untagged molecules.19 The
unique materials properties of perfluoroalkyl-functionalized molecules have been known
for years20, but only recently have their application towards separations been realized.
Fluorous chains have the unique quality of having both hydrophobic and lipophobic
qualities, and prefer to associate with other fluorous molecules, hence the term fluorous
phase. In a fluorous separation, a mixture of tagged and untagged molecules is partitioned
between fluorous and non-fluorous phases.21 Fluorous phases include fluorinated
solvents, such as perfluorohexanes or hydrofluoroethers, or fluorinated solid phases, such
as perfluoroalkyl-functionalized silica gel or Teflon surfaces. Using an organic solvent
with a fraction of aqueous solvent effectively partitions fluorous-tagged molecules into
the fluorous phase, while untagged molecules are left in the non-fluorous phase.
Molecules with a single perfluoroalkyl chain are termed ‘light fluorous’ typically do not
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partition efficiently into liquid fluorous phases, but can be partitioned and separated using
fluorous solid-phase extraction. Molecules with multiple perfluoroalkyl groups are
termed ‘heavy fluorous’ and can partition into liquid or solid fluorous phases.
The typical fluorous separation is completed by fluorous solid-phase extraction
(FSPE).21 In this method, a mixture of compounds is loaded onto a small cartridge of
fluorous silica gel, then eluted in two stages. The first elution is a fluorophobic solvent
such as a mixture of methanol and water (in a 9:1 or lower ratio). The fluorous
compounds are retained on the fluorous silica and any non-fluorous compounds are not.
The second elution is a fluorophilic solvent, which is typically acetone, THF or
anhydrous methanol. This wash elutes the fluorous compounds efficiently. A typical
FSPE separation takes mere minutes, and the time savings over tedious column
chromatography can be significant.
Fluorous methods have found use in a wide variety of organic synthesis
applications,

including

diversity-oriented

mixture

synthesis,

polypeptide22

and

oligonucleotide23 synthesis. One area of organic synthesis that has seen significant
adoption of fluorous methods is carbohydrate chemistry.24–28 Here the advantages in
terms of carbohydrate synthesis are apparent: Carbohydrate synthesis typically involves
multistep synthesis that requires purification after each step, whereas fluorous methods
streamline purifications in such linear syntheses. Fluorous methods are also compatible
with the use of large excesses of reagents to drive reactions to completion without
concern for post-reaction purification, as fluorous separations are straightforward and
efficient. In general, these syntheses use a fluorous protecting group to introduce the tag
which is cleaved at the end of the synthesis to afford the desired product in high yield.

11
Fluorous compounds behave very similarly to their non-fluorous counterparts. They also
can be monitored by standard solution-phase methods (TLC, NMR, IR, etc.), and are
easily purified and isolated by FSPE, and thus have a significant advantage over both
solid-phase and solution-phase purification methods.
Due to the solvophobic profiles of fluorous compounds, it is also possible to
selectively immobilize them onto fluorous surfaces. This idea has been used to present
fluorous-tagged molecules, including carbohydrates, for biological assays. Pohl and
coworkers28 first demonstrated that fluorous-tagged carbohydrates could be printed onto
perfluoroalkyl-functionalized glass slides and used to study protein-carbohydrate
interactions in a microarray format. The microarrays proved to be robust and able to
withstand aqueous washing, protein binding, and antibody hybridization over multiple
steps. This provides additional motive to synthesize a library of heparin-like sulfoforms
and to screen their affinity toward heparin-binding proteins, using fluorous methods for
both phases of the project.

12
1.6 References
(1)

Essentials of Glycobiology; Varki, A.; Cummings, R. D.; Esko, J. D.; Freeze, H.
H.; Stanley, P.; Bertozzi, C. R.; Hart, G. W.; Etzler, M. E., Eds.; Cold Spring
Harbor Laboratory Press, 2009.

(2)

Liu, R.; Wei, A. J. Carb. Chem. 2012, 31, 384–419.

(3)

Liu, R.; Morales-Collazo, O.; Wei, A. Carb. Res. 2012, 355, 19–27.

(4)

Zhang, W.; Swanson, R.; Izaguirre, G.; Xiong, Y.; Lau, L. F.; Olson, S. T. Blood
2005, 106, 1621–8.

(5)

Pagano, K.; Torella, R.; Foglieni, C.; Bugatti, A.; Tomaselli, S.; Zetta, L.; Presta,
M.; Rusnati, M.; Taraboletti, G.; Colombo, G.; Ragona, L. PloS One 2012, 7,
e36990.

(6)

Goodger, S. J.; Robinson, C. J.; Murphy, K. J.; Gasiunas, N.; Harmer, N. J.;
Blundell, T. L.; Pye, D. A; Gallagher, J. T. J. Biol. Chem. 2008, 283, 13001–8.

(7)

Noti, C.; de Paz, J. L.; Polito, L.; Seeberger, P. H. Chem. Eur. J. 2006, 12, 8664–
86.

(8)

De Paz, J. L.; Angulo, J.; Lassaletta, J. M.; Nieto, P. M.; Redondo-Horcajo, M.;
Lozano, R. M.; Giménez-Gallego, G.; Martín-Lomas, M. ChemBioChem 2001, 2,
673–85.

(9)

Thompson, C. A; Purushothaman, A.; Ramani, V. C.; Vlodavsky, I.; Sanderson, R.
D. J. Biol. Chem 2013, 288, 10093–10099.

(10) Cladera, J.; Martin, I.; O’Shea, P. EMBO Journal 2001, 266, 19–26.
(11) Hu, Y.-P.; Lin, S.-Y.; Huang, C.-Y.; Zulueta, M. M. L.; Liu, J.-Y.; Chang, W.;
Hung, S.-C. Nature Chem. 2011, 3, 557–63.
(12)

Copeland, R.; Balasubramaniam, A.; Tiwari, V.; Zhang, F.; Bridges, A.; Linhardt,
R. J.; Shukla, D.; Liu, J. Biochemistry 2008, 47, 5774–83.

(13) Chen, J.; Duncan, M. B.; Carrick, K.; Pope, R. M.; Liu, J. Glycobiology 2003, 13,
785–94.
(14)

Stephens, R. S.; Koshiyama, K.; Lewis, E.; Kubo, A.; Mol. Microbiol. 2001, 40,
691–9.

13
(15) Hu, Y.-P.; Zhong, Y.-Q.; Chen, Z.-G.; Chen, C.-Y.; Shi, Z.; Zulueta, M. M. L.;
Ku, C.-C.; Lee, P.-Y.; Wang, C.-C.; Hung, S.-C. J. Am. Chem. Soc. 2012, 134,
20722–7.
(16) Casu, B.; Naggi, A.; Torri, G. Matrix Biol. 2010, 29, 442–52.
(17)

Liu, R.; Xu, Y.; Chen, M.; Weïwer, M.; Zhou, X.; Bridges, A. S.; DeAngelis, P.
L.; Zhang, Q.; Linhardt, R. J.; Liu, J. J. Biol. Chem. 2010, 285, 34240–9.

(18) Fan, R.-H.; Achkar, J.; Hernández-Torres, J. M.; Wei, A. Org. Lett. 2005, 7, 5095–
8.
(19) Horvath, I. T.; Rabai, J. Science 1994, 266, 72–75.
(20) Vincent, J.-M. Chem. Commun. 2012, 48, 11382–91.
(21) Zhang, W. Tetrahedron 2003, 59, 4475–4489.
(22) Mizuno, M.; Goto, K.; Miura, T.; Matsuura, T.; Inazu, T. Tetrahedron Lett. 2004,
45, 3425–3428.
(23) Pearson, W.; Berry, D.; Stoy, P. J. Org. Chem. 2005, 2005, 7114–7122.
(24) Tanaka, H.; Tateno, Y.; Takahashi, T. Org. Biomol. Chem. 2012, 10, 9570–82.
(25) Mamidyala, S. K.; Ko, K.-S.; Jaipuri, F. a.; Park, G.; Pohl, N. L. J. Fluorine Chem.
2006, 127, 571–579.
(26)

Zong, C.; Venot, A.; Dhamale, O.; Boons, G.-J. Org. Lett. 2013, 15, 342–5.

(27) Jaipuri, F. A; Collet, B. Y. M.; Pohl, N. L. Angewandte Chemie Int. Ed. 2008, 47,
1707–10.
(28) Ko, K.-S.; Jaipuri, F. A; Pohl, N. L. J. Am. Chem. Soc. 2005, 127, 13162–3.

14

"

CHAPTER II – SYNTHESIS OF HEPARAN SULFATE SULFOFORMS VIA
FLUOROUS METHODS
2.1 Synthesis of Orthogonally Protected α-Glucosamines
Glucosamine donor 6 was synthesized according to modified literature
conditions.1 Compound 1 was synthesized in 2 steps from glucosamine hydrochloride salt
as a mixture of anomers via phthalimide protection of the amino moiety and subsequent
per-O-acetylation in 51% yield. Thioglycoside 2 was prepared under Lewis-acid
mediated conditions with p-thiocresol and boron trifluoride in 81% yield. Only the β
anomer is formed, due to anchimeric assistance. Zemplén deacetylation and pmethoxybenzylidine protection of the resulting 4,6-diol afforded acetal 3 in 83% yield.
Deprotection of the phthalimide with ethylenediamine and subsequent conversion of the
free amine to the corresponding azide was completed by treatment with triflyl azide and
copper sulfate in 80% yield. The intermediate azidosugar was then acetylated to afford 4.
A modified procedure for azide transfer was utilized to minimize the amount of
potentially explosive triflyl azide reagent.2 Regioselective acetal reduction using
Bu2BOTf and borane cleanly afforded primary alcohol 5 in 91% yield.3 Treatment with
TBDPS-Cl afforded orthogonally protected glucoamine donor 6 in 95% yield after
careful chromatographic separation from TBDPS byproducts. Overall yield from
glucosamine was 24% (Figure 2.1).
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Figure 2.1 Synthesis of glucosaminyl thioglycoside donor 6.

2.2 Synthesis of First-Generation Fluorous Sulfoforms
Prior to undertaking this project, there were no examples of highly polar
carbohydrates being prepared via a fluorous approach. We first tested the feasibility of
such an approach with a simple perfluoroalkyl glycoside. The fluorous tag was
synthesized by the radical-mediated addition of perfluorooctyl iodide to allyl alcohol in
the presence of AIBN to afford halohydrin 7 in quantitative yield (Figure 2.2).4
Dehalogenation of 7 with tributyltin hydride produced alcohol 8 in good yield, but
required tedious purification to remove all traces of tin byproducts as both product and
reaction byproducts are sufficiently non-polar. FSPE separation of tin byproducts from 8
was not feasible due to the hydrophobic character of the fluorous silica used. However,
treatment of halohydrin 7 with hydrazine and Raney nickel5 cleanly afforded alcohol 8 in
71% yield and high purity after filtering through a silica plug.
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Figure 2.2 Synthesis of a 3-perfluorooctyl-1-propanol 8.

Synthesis of the fluorous-tagged glucosamine 13 was completed according to
Figure 2.3. Compound 1 was treated with acceptor 8 under Lewis acid conditions to
afford -glycoside 9 in 55% yield. Deacetylation and protection of the 4,6-diol afforded
p-methoxybenzylidene acetal 10 in 79% yield. Conversion of the phthalimide to azide
was achieved first by treatment with ethylenediamine, then triflyl azide, followed by 3-Oacetylation in 86% yield over 3 steps. Regioselective reduction of the 4,6-acetal afforded
the 4-O-PMB ether 12 in 65% yield, and subsequent TBDPS protection afforded
orthogonally protected glucosamine 13 in 93% yield. Yields for this synthetic sequence
were unaffected by the presence of the fluorous chain, despite the electron-withdrawing
nature of the PFO moiety. Purifications were performed by either standard silica gel
chromatography or fluorous solid phase extraction (FSPE) depending on the cleanliness
and completeness of the reaction. In particular, decomposition byproducts with fluorous
tags cannot be separated by FSPE.
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Figure 2.3 Synthesis of an orthogonally protected -glucosaminoside
with a PFO tag (13).

With orthogonally protected glucosamine derivative 13 in hand, we evaluated the
compatibility of deprotection and sulfonation conditions and efficacy of purification with
FSPE (Figure 2.4). Standard FSPE conditions were used to separate the fluorous-tagged
intermediates from reaction byproducts, using 80% aqueous methanol to retain fluorous
compounds and 100% methanol to elute them. Deprotection of the azide with
tributylphosphine and subsequent sulfonation using SO3•pyridine under microwave
conditions afforded an N-sulfonate, followed by TBDPS deprotection (using TBAF) and
saponification (using NaOMe) to produce PMB-protected sulfoform 14. Stepwise
deprotection of 6-O-TBDPS and 3-O-acetate and sulfonation of the corresponding
hydroxyls afforded 3,6-di-O-sulfate 15. While standard FSPE conditions were used to
isolate intermediates after the first few deprotection steps, these were less successful
following sulfonation, and gave a lower yield was recovered. Compound 16 was prepared
by TBDPS protection, acetate removal, azide reduction and finally sulfonation under
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microwave conditions. Very little trisulfate 16 was isolated by FSPE following
sulfonation; most of the fluorous compound was found in the methanolic wash with
additional pyridinium salts.
The low recovery of 15 and 16 motivated us to example the fluorophobic fraction.
Analysis of the fluorophobic fractions by TLC and NMR showed that some fluorous
compound was present in the fluorophobic fractions. This indicated that retention on the
fluorous silica gel was compromised by the presence of sulfate esters.

Figure 2.4 Deprotection and sulfonation of orthogonally protected
-glucosaminoglycoside 13

We then attempted to isolate sulfonated compounds 14, 15, and 16 by modifying
FSPE conditions. These were first tested using fluorous thin layer chromatography, to
predict whether a FSPE separation will be successful. Under FSPE separations, the polar
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fluorophobic wash typically causes the fluorous compound to be retained onto the
fluorous substrate while washing away any salts and non-fluorous byproducts. A
retention factor of zero indicates a strong absorption onto the fluorous silica of the FSPE
cartridge. 80% aqueous methanol was successful in separating and isolating monosulfate
14, but disulfate 15 and trisulfate 16 were not successfully isolated. The Rf values as
determined by fluorous TLC reflect this trend (Table 2.1): The high mobilities of 15 and
16 initially suggest that the polar intermediates have low affinity for the fluorous solid
support. Increasing the water content of the eluent to 40% decreased Rf values for 14, 15,
and 16. But even at this eluent composition, some undesired elution of the more polar
compounds is observed. Increasing the water fraction in the eluent to 80% resulted in
complete retention, suggesting complete partitioning of the tagged sulfoforms onto the
fluorous support. It is widely assumed that fluorophilicity is orthogonal to polarity.6 But
the above results demonstrate that fluorous character is also influenced by polarity and
amphiphilic tendencies.

Table 2.1. Retention factors of intermediates 14-16 on F-TLC.
Compound

80% aq. MeOH

40% aq. MeOH

20% aq. MeOH

14

0.1

0

0

15

0.6

0.3

0.1

16

0.8

0.4

0.1
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Given the challenges of retaining highly polar intermediates on fluorous-phase
substrates with a single PFO tag, an alternative strategy was developed to better enable
FPSE separations under standard conditions. Pohl and coworkers had shown that
molecules with two fluorous tags permitted better separation by FSPE relative to
compounds with just one.7 We also envisioned a "double PFO" tag would increase the
partitioning ratio onto the fluorous silica solid phase (Figure 2.5). 3-PFO-propanol 8 was
converted to tosylate 17 in 87% yield, which was used to alkylate methyl 3,5dihydroxybenzoate to afford the bis-PFO labeled methyl ester 18 in 96% yield. Reduction
of ester 18 by LiAlH4 afforded bis-PFO benzyl alcohol 19 in 74% yield. Using alcohol 19
as an acceptor in NIS/TfOH-promoted glycosylation with thioglycoside 2 resulted in bisPFO tagged glucosamine 20 in low yield (22%), which was saponified and sulfonated to
afford the trisulfate 21. Fluorous thin layer chromatography with 80% aqueous methanol
as eluent resulted in full immobilization, which suggests that FSPE separation under
standard conditions would be successful. This proved to be the case and tri-O-sulfonate
21 was recovered in high yield. This result suggested that the low partitioning of highly
polar sulfoforms could be mitigated using bis-PFO tags.
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Figure 2.5. Synthesis of double PFO alcohol 19 and double PFO sulfoform 21.

2.3 Synthesis of Bis-PFO Tags
Having confirmed that two PFO chains are able to impart fluorous character onto
highly polar sulfoforms, the next goal would be to transition from a non-cleavable tag to
one that can be cleaved after all deprotection and sulfonation steps are performed. In the
original orthogonal protecting group system1, there is no linker or protecting group
present at the reducing end. In this study we introduced a 2-aminoethyl linker at the
reducing end protected by a benzyl carbamate (Cbz) analogue, which is orthogonal to the
other protecting groups on glucosamine and presumed to be stable under sulfonation
conditions.
The first attempt towards bis-PFO benzyl carbamate (Cbz) protecting group
utilized benzyl alcohol 19, which was treated with triphosgene to form the chloroformate
intermediate, and converted to NHS ester 22 in 40% overall yield (Figure 2.6).
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Figure 2.6 Synthesis of bis-PFO Cbz analogue 22.

Glycosyl donor 6 and Fmoc-protected aminoethanol were coupled using
NIS/TfOH conditions to afford corresponding glycoside 23 in 88% yield as a 4:1 :
mixture of anomers (Figure 2.7). The anomers could be efficiently separated by silica gel
chromatography using a THF/hexane eluent gradient. -Glycoside 23 was then treated
with 20% piperidine in DMF to afford the free amine in nearly quantitative yield, and
conjugation with the activated NHS-carbonate 22 afforded protected aminoethyl
glycoside 24 in 80% overall yield. :

Figure 2.7 Synthesis of bis-PFO-Cbz-protected aminoethyl -glycoside 23.

-
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Bis-PFO-tagged glycoside 24 was then subjected to orthogonal deprotection and
sulfonation conditions. Treatment with TBAF removed the TBDPS group efficiently, but
also caused the unexpected cleavage of a fluorous tag. Analysis of the reaction mixture
by mass spectrometry revealed fragment ions that suggested elimination of one or more
ether-linked PFO chains. It was possible that the reaction conditions were sufficiently
basic to cause elimination of the phenolic unit, aided by the inductive effects of the PFO
chain on the

-hydrogens. This sensitivity to basic conditions was also potentially

problematic for the clean removal of acetate. It was observed that compound 24 slowly
decomposed when exposed to ambient conditions. It is known that the 3,5dimethoxybenzyl carbamate group can be photolabile,8 which decreased the reliability of
this unit as a linker for sulfoform generation via a multi-step sequence.
With the problematic reactivity of bis-PFO tag 22, an alterative fluorous motif
was designed based on the cross coupling of perfluoroalkyl iodides with aryl iodides
using a copper-catalyzed Ullmann reaction.9 Perfluorooctyl iodide was coupled with
methyl 3,5-diiodobenzoate in the presence of copper bronze to afford bis-PFO-substituted
benzoate 25 in 74% yield. Reduction of the methyl ester with LiAlH4 afforded bis-PFO
benzyl alcohol 26 in quantitative yield. Attempts to synthesize the activated NHScarbonate were unsuccessful, but treatment with carbonyldiimidazole afforded imidazole
carbamate 27 in 85% yield (Figure 2.8). Activation of the acyl imidazole for conjugation
to amines is typically achieved by alkylation to afford the activated acyl imidazolinium
species, however treatment of 27 with either methyl iodide or trimethyloxonium
tetrafluoroborate did not result in an acyl imidazolium, but led instead to a complex
mixture. We then treated alcohol 26 with p-nitrophenyl chloroformate to afford mixed
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carbonate 28 in 87% yield. Carbonate 28 was sufficiently stable for purification by
column chromatography, yet reactive enough to form carbamates under mild conditions.
Conjugation of 28 with the aminoethyl -glycoside was straightforward, resulting in bisPFO tagged product 29 in 98% yield (Figure 2.9).

Figure 2.8 Synthesis of bis-PFO Cbz analogue 28.

Figure 2.9 Synthesis of Bis-PFO tagged aminoethyl -Glucosaminoside 29.

25
Compared to the O-linked bis-PFO tag 24, the C-linked bis-PFO derivative 29
was quite stable at ambient conditions. Deprotection of TBDPS with TBAF, unbuffered
or buffered with an equimolar amount of acetic acid, smoothly afforded the desired
alcohol. Separation of reaction byproducts from the bis-PFO tagged carbohydrate was
easily achieved under standard FSPE conditions. Deprotection of acetate by sodium
methoxide also cleanly afforded the corresponding alcohol; simple neutralization of the
reaction mixture with proton exchange resin cleanly afforded the desired product. Azide
deprotection was slightly problematic; conditions previously used in our group involved:
reduction with tributylphosphine, followed by hydrolysis of the aza-ylide.1 While
reduction of the azide with excess tributylphosphine was fascile, hydrolysis of the azaylide was often sluggish. To address this issue, alterative reducing agents were
considered, including tris(2-carboxyethyl)phosphine (TCEP). TCEP is a water-soluble
reducing agent often used the reduction of disulfides, but it is also known to reduce
azides to primary amines.10 A slight excess of TCEP could reducing 29 in “wet” DMF to
afford the desired primary amine in as little as two hours, as opposed to 18-24 hours as
needed with tributylphosphine. TCEP was also more easily separated from the desired
reaction products; in fact, a simple aqueous wash in a separatory funnel was sufficient to
remove water-soluble TCEP. Tributylphosphine, being fairly hydrophobic in character,
was sometimes hard to remove under FSPE conditions when high fractions of water were
used in the eluent, which cause the fluorous silica gel to act similarly to reversed-phase
media.
The controlled reactivity of 29 under a variety of deprotection conditions did not
seem significantly affected by the presence of the bis-PFO tags, however solubility was a
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common problem. DMF and DMSO were often necessary to increase solvation, where
non-polar solvents such as DCM and chloroform were ineffective. This was particularly
true in cases where the products had a significant amphiphilic character, with a
hydrophilic sulfoform “headgroup” and solvophobic PFO tails.
Furthermore, while deprotection of 29 was largely successful, using sulfonation of
the free alcohols and amines was problematic (Figure 2.10). Using the standard
conditions for sulfonation established in our group (SO3•pyridine in 1:5 Et3N/pyridine),
very little product was isolated by FSPE under either standard or modified conditions.
Analysis of the fluorous fractions by NMR revealed diminished peak intensities of the
carbohydrate region, relative to the bis-PFO tag. ESI-MS negative mode analysis of the
reaction mixture revealed peaks corresponding to the desired sulfonated product, but also
a high intensity peak centered at 1023 m/z, which was attributed to cleavage of the bisPFO Cbz tag. This result was unexpected, but appeared to be a significant problem only
when N-sulfonation was attempted. When sulfonation was attempted in the presence of
azide or NHAc derivative, cleavage of the bis-PFO Cbz linkage was greatly reduced.

Figure 2.10 Attempted sulfonation of bis-PFO-tagged -glucosaminoside 29, following
azide reduction and N-sulfonation.
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Having isolated fluorous decomposition product after sulfonation, we sought to
understand how reaction byproduct was formed. Our hypothesis is proposed as in Figure
2.11: Following reduction of azide 29 and N-sulfonation, the corresponding sulfamate
transfer its SO3 group to the carbamate in an intramolecular fashion. It is already known
that amides and carbamates can be sulfonated under certain conditions.11 It may be
possible that N-to-N or N-to-O sulfate transfer may occur upon treatment with
SO3•pyridine. Intramolecular SN2 may follow and ultimately decarboxylation causes
cleavage of sulfated benzylic alcohol 30 from the aminoethyl -glucosaminoside.
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Figure 2.11 Proposed mechanism of decomposition of 29 under sulfonation.

Given the lability of the carbamate linkage in glycoside 29, we hypothesized that
the dual PFO moieties may activate the benzylic position by inductive effects. To
mitigate this, additional methylene spacers should be introduced to sufficiently insulate
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the carbamate center from the PFO groups. With this in mind, homologated fluorous
alcohol 33 was prepared and converted to a mixed carbonate for amine functionalization
(Figure 2.12A). Benzylic alcohol 26, it was oxidized with 2-iodoxybenzoic acid to afford
the bis-PFO benzaldhyde 31 in 94% yield. Bis-PFO benzaldehyde 31 was then
homologated under Horner-Wadsworth-Emmons reaction conditions to afford substituted
cinnaminic acid 32 in 87% yield. Chemoselective hydrogenation and ester reduction
using LiAlH4 afforded bishomobenzylic alcohol 33 in 92% yield. Conversion to mixed
carbonate 34 with nitrophenyl chloroformate was completed in 65% yield,

and

conjugation of 34 with aminoethyl -glycoside 23 following Fmoc deprotection afforded
bis-PFO labeled 35 in 72% yield (Figure 2.12B).

Figure 2.12 A) Synthesis of homologated bis-PFO tag 34.
B) Synthesis of bis-PFO labeled -aminoethyl glycoside 35.
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Once again, the compatibility of bis-PFO tagged glucosamine 35 was tested using
our standard deprotection sequence conditions. No incompatibilities were noted during
TBDPS, acetate or azide deprotections, and the deprotected intermediates were easily
isolated and purified by FSPE under standard conditions. However, sulfonation with the
free amine resulted in the formation of the analogous cleavage product and little desired
carbohydrate product was recovered. Despite the additional two methylene units to
“insulate” the carbamate from the effects of the PFO moieties, the cross reactivity of the
carbamate with sulfonation conditions was not diminished. Furthermore, solubility of this
compound was again problematic; the direct attachment of the PFO units to the arene ring
may be the reason for poor solvation.

2.4 Synthesis of Mono-PFO Benzyl Carbamate
As discussed previously, the double PFO carbamate approach was problematic for
two reasons: (i) the carbamate was reactive under sulfonation conditions, with possible
activation by the dual PFO moieties, and (ii) the bis-PFO tagged intermediates displayed
poor solubility and amphiphilic character. As shown in previous studies, sulfoforms
bearing a single PFO tag were not well retained during FSPE under standard conditions,
however modifying the elution conditions might improve separation and isolation of the
mono-PFO tagged sulfoforms. We thus decided to revisit the single-PFO tag approach to
see if both issues could be surmounted.
A single-PFO Cbz tag was synthesized according to the scheme in Figure 2.13A.
Ethyl p-aminobenzoate was treated with amyl nitrite and BF3•Et2O to afford a diazonium
tetrafluoroborate intermediate salt, which was coupled under Pd-catalyzed Heck
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conditions12 to afford the fluorous alkene 36 in 69% yield. Reduction of the olefin and
ester moieties afforded the fluorous benzyl alcohol 37 in 95% yield, and treatment of 37
with p-nitrophenyl chloroformate afforded the activated mixed carbonate 38 in 92%
yield. Subsequent conjugation of single-PFO Cbz tag 38 to aminoethyl -glycoside 23
following Fmoc deprotection afforded single-PFO tagged glycoside 39 in 84% yield
(Figure 2.13B).

Figure 2.13 A) Synthesis of mono-PFO tag 38.
B) Synthesis of mono-PFO tagged aminoethyl -glycoside 39.

Initial tests on the mono-PFO tagged 39 by stepwise deprotection followed the
same pattern of compatibility as noted for compound 29. Sulfonation was again
problematic, particularly when N-sulfonation was attempted. ESI-MS analysis in negative
mode suggested that Cbz cleavage once again resulted in a sulfonated benzyl alcohol, as
evidenced by a peak at 634 m/z. It thus appears that the reactivity of the Cbz linkage is
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not solely due to PFO activation, as the use of spacer methylenes does not significantly
affect the rate of decomposition. The most likely explanation is the 2-aminoethyl linker
on -glucosamine is short enough that an intramolecular sulfonate transfer is facile and
thus problematic.
Place glucosamine at the reducing end adjacent to the cleavable carbamate linker
seems to be the root of the problem. If the C2 amino group is indeed responsible for the
cleavage of the carbamate linkage, preparing a disaccharide with -uronic acid at the
reducing end may mitigate carbamate cleavage. To explore this strategy, a new
orthogonally-protected disaccharide was prepared (Figure 2.14). Glucose pentaacetate
was glycosylated with bromoethanol using BF3•Et2O then treated with sodium azide to
afford the -(2-azidoethyl) glucoside 40 in 57% yield. Deacetylation and protection as the
4,6-benzylidene acetal afforded 2,3-diol 41 in 91% yield. Regioselective alkylation with
p-methoxybenzyl chloride at the C3 hydroxyl was attempted using a stannylene acetal
intermediate; however, a 3:2 mixture of 2- and 3-O-PMB ethers was obtained. The
regioisomers were separated and desired 3-O-PMB ether was benzoylated to afford full
protected glucoside 42 in 31% yield over three steps. Azide reduction using Zn and
ammonium chloride13 afforded the free amine, which was then protected with 38 to
afford PFO-carbamate 43 in 72% yield over two steps. Removal of the benzylidene acetal
with camphorsulfonic acid in methanol afforded a 4,6-diol, which was protected or
oxidized at the C6 position to afford various PFO-tagged GlcA donors 44-46 in good to
high yields.
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Figure 2.14 Synthesis of aminoethyl-GlcA acceptors 44 – 46.

Glycosylation using thioglycoside donor 47 and acceptor 44 was unsuccessful due
to the sensitivity of trityl protecting group at the C6 position to Lewis acids, which
resulted in the formation of 1,6-linked saccharides rather than the desired 1,4-linked
disaccharide. Attempts to couple donor 47 with GlcA methyl ester 46 were attempted but
the nucleophilicity of acceptor 46 was too low due to the electron withdrawing C5
carboxyl group. However, the 2-bromoisobutyryl (2-BiB) ester 45 proved to be a
competent acceptor for glycosyl coupling, and the desired -1,4-linked disaccharide 48
was obtained in 43% yield (Figure 2.15). Further deprotection of the 2-BiB ester,
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TEMPO oxidation and methylation afforded orthogonally protected heparan disaccharide
49 in 76% yield.

Figure 2.15 Synthesis of orthogonally protected, PFO-tagged dissacharide 49.

With the orthogonally protected PFO-tagged disaccharide 49 in hand, we
performed tests to determine if the carbamate linkage was stable under N-sulfonation
conditions. Cleavage of alcohol protecting groups such as TBDPS, SEM and benzoate
were successful, and subsequent sulfonation caused minimal decomposition of the monoPFO Cbz linkage as evidenced by ESI-MS analysis in negative-ion mode. However,
azide reduction and N-sulfonation, increased cleavage of the carbamate regardless of the
choice of sulfonation conditions. This confirmed that the carbamate linkage itself is labile
in the presence of N-sulfamates, despite its widespread use in organic synthesis.
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2.5 Synthesis of Single-PFO Benzyl Glycosides
Having extensively explored the chemistry of sulfoforms with a Cbz-protected
aminoethyl linker, we altered our synthetic goals and returned to the simpler objective of
synthesizing PFO-tagged sulfoforms without a terminal aminoethyl linker, while
retaining the ability to cleave the fluorous tag after generating and purifying the
penultimate sulfoforms. We envisioned that a benzylic ether at the reducing end of the
disaccharide should cleanly address these concerns. Cleavage of the fluorous tag would
be accomplished by hydrogenation, as with the case with the benzyl carbamate linkage
previously considered, but using a more stable ether linkage would prevent premature
cleavage of the fluorous tag.
Glycosyl coupling of with glucosamine donor 6 and p-substituted (2-PFO)ethyl
benzyl alcohol 37 afforded the PFO-tagged -glucosaminoside 50 in 95% yield as a
single isomer (Figure 2.16). Donor 6 provided the highest coupling yield, replacing the 3O-acetate with a SEM ether or Lev ester resulted in diminished yields. Exchange of the 3O-acetate for the SEM ether and PMB deprotection was completed in three steps to
afford -glucosamine acceptor 51 in 65% yield. Intermediates were isolated solely by
FSPE, and the final donor was purified by column chromatography to ensure efficient
glycosylation in the next step.
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Figure 2.16 Synthesis of p-((2-PFO)ethyl) benzyl -glucosaminoside 51.

A new thioglycosyl donor was synthesized as a GlcA donor equivalent (Figure
2.17): Glucose pentaacetate was treated with thiophenol and BF3•Et2O to afford

-

thioglycoside 52 in 57% yield14; Zémplen deacetylation and protection as the 4,6anisilidene acetal afforded 53 in 81% yield15; Regioselective alkylation of the 2,3stannylene acetal with PMB-Cl and subsequent benzoylation afforded 54 in 79% yield. In
contrast to the poor regioselectivity of 2,3-stannylene acetals prepared from Oglycosides, that of the S-glycoside exclusively afforded the 3-O-PMB product.
Regioselective reduction of the p-methoxybenzylidene acetal resulted in the 4-O-PMB
ether 55 in 91% yield. Protection of the C6 hydroxyl as the p-nitrobenzoyl (PNBz) ester
afforded thioglycoside donor 56 in 86% yield (29% total yield over 8 steps).
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Figure 2.17 Synthesis of 3,4-PMB-protected thioglucoside donor 56.

Glycosyl coupling with acceptor 51 and donor 56 under NIS-promoted conditions
afforded disaccharide 57 in fair to low yields (Figure 2.18). It was generally observed that
that the donor was fully consumed, but decomposed prior to coupling. Other acceptors
were explored, by replacing 3-O-SEM ether with acetate or Lev esters, but no desired
product was isolated in these cases. Alternative activating reagents were also explored,
such as replacing triflic acid with silver triflate, however neither the yield nor efficiency
of this reaction could be improved. Lowering the temperature did not have a positive
effect on reaction outcome, and simply increased the amount of time needed for donor
activation without increasing overall disaccharide yield. Glycosylation promoted by
(benzenesulfonyl)piperidine (BSP)16 and triflic anhydride was also attempted, but no
successful coupling products were isolated in this case. Isolation of decomposition
products by column chromatography and NMR analysis suggested loss of one or both of
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the PMB ethers on the glycosyl donor as a potential source of problems. There are
documented examples of PMB ethers being deprotected in situ under acid-catalyzed
coupling conditions.17

Figure 2.18 Synthesis of disaccharide 57.

We reasoned that replacing the PMB ethers with less acid-labile protecting groups
should improve the glycosylation yield under NIS/TfOH-mediated conditions. We choose
to investigate the 2-naphthylmethyl (Nap) ether as a more stable alternative to the PMB
ether, but one that is selectively cleaved under oxidative conditions.18 Nap-protected
donor 61 was synthesized in an analogous manner to donor 56 (Figure 2.19): Protection
of thiophenyl glucoside 52 as the 4,6-naphthylidene acetal 58 was completed in 2 steps in
76% yield; regioselective 3-O-alkylation with 2-(bromomethyl)naphthylene and
subsequent 2-O-benzoylation afforded 59 in 75% yield; Regioselective cleavage of the
naphthylidene acetal was accomplished with dibutyl boron triflate and borane to afford
primary alcohol 60 in 80% yield. The C6 alcohol was protected as the p-nitrobenzoate to
afford donor 61 in 82% yield.

39

Figure 2.19 Synthesis of Nap-protected glycosyl donor 61.

With Nap-protected donor 61 in hand, glycosylation of acceptor 51 was
conducted under NIS/TfOH-mediated conditions to afford disaccharide 62 in modest
yield (Figure 2.20). Analysis of the reaction by TLC appears to be significantly cleaner
than with the PMB-protected donor, although the conversion is still incomplete: Despite
using 1.5 eq of donor to 1 eq of acceptor, the latter was still left over in appreciable
quantity. This suggested that the nucleophilicity of the acceptor needed to be boosted.
The low coupling yield suggests that the glucosamine acceptor 51 may be a difficult
coupling partner in this reaction, possibly the result of high steric hindrance due to the 6O-TBDPS ether.

Figure 2.20 Synthesis of disaccharide 62.
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With disaccharide 62 synthesized, all that is needed to generate the library of
disaccharide sulfoforms is stepwise deprotection and sulfonation. Conditions for
deprotecting other orthogonally protected heparan sulfate ligands have been previously
established, except for Nap ether deprotection, and are summarized Table 2.2. To ensure
the stability of the fluorous tag linkage, the azide was deprotected with TCEP and
subsequently sulfonated. ESI-MS of the reaction mixture did not indicate linker cleavage;
only the expected molecular ion peak was observed. Similarly, the cleavage of the Nap
ethers was explored in the presence of the PFO-Bn ether. Treatment of 62 under
hydrogenation conditions with Pd/C did not show any reaction after 24 hours, but
treatment with CAN quickly afforded the 3,4-diol.

Table 2.2. Deprotection and sulfonation conditions for disaccharide 62.
Operation

Conditions

Azide Deprotection

TCEP (1.5 eq), DMF, rt.

SEM Deprotection

MgBr2•Et2O (10 eq), MeNO2 (20 eq), Et2O, rt.

TBDPS Deprotection

TBAF (3 eq), THF, rt.

Bz Deprotection

NaOMe (1 eq), MeOH, rt.

Nap Deprotection

CAN (3 eq/Nap), 90% aq. MeCN, rt.

O-Sulfonation

SO3•Me3N (10 eq/OH), DMF, 100 °C.

N-Sulfonation

SO3•pyridine (5 eq), pH 8 buffer, rt.
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2.6 Materials and Methods
All starting materials and reagents were obtained from commercial sources and
used as received unless otherwise noted. All solvents were freshly distilled prior to use.
1

H NMR spectra were recorded at 300 or 400 MHz; 13C NMR spectra were recorded at

75 or 100 MHz.

19

F NMR spectra were recorded at 282 MHz.

31

P NMR spectra were

recorded at 121 MHz. Chemical shifts were referenced to the solvent used ( 7.27 and
77.00 for CDCl3,

3.31 and 49.15 for CD3OD, and

4.80 in D2O). Mass spectra were

acquired using either a Hewlett-Packard 5989B or a Finnigan 40000 mass spectrometer.
Optical rotations were measured by polarimetry at room temperature.

1,3,4,6-Tetra-O-acetyl-2-phthalimido-2-deoxy- -D-glucopyranoside

(1).

Glucosamine hydrochloride (30.0 g, 1 equiv) was suspended in 1 M NaOMe solution (1
equiv, 135 mL) and stirred for 4 hours until dissolved. Phthalic anhydride (22.8 g, 1.1
equiv) and triethylamine (22 mL, 1.1 equiv) were added in 2 portions at rt. The reaction
was mechanically stirred for 2 days. The reaction was cooled to –20 °C and the solids
were removed by filtration. The filtered solids were then dissolved in a pyridine and
acetic anhydride mixture (2:1) and stirred at rt for 2 days. Solvent was removed by rotary
evaporation and the residue was azeotroped with toluene. The material was dissolved in
DCM and passed through a silica plug to remove much of the highly colored byproducts.
The residue was recrystallized from ethanol to afford 23.1 g (51%) of tetraacetate 1 as an
off-white solid. 1H NMR was compared to literature reported values and confirmed
correct product was obtained.19
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Thiotolyl

3,4,6-O-acetyl-2-deoxy-2-phthalimido-

-D-glucopyranoside

(2).

Tetraacetate 1 (1.72 g, 1 equiv) and p-thiocresol (578 mg, 1.3 equiv) were dissolved in 3
mL of dry DCM at 0 °C. BF3•Et2O (0.6 mL, 1.3 equiv) was added dropwise. The reaction
allowed to warm to rt and stirred for 40 hours. The reaction was quenched with sat. aq.
NaHCO3 and extracted with DCM. The organic extracts were washed with brine and
dried over sodium sulfate. The organic extracts were then concentrated by rotary
evaporation. The residue was purified by column chromatography using a 33% EtOAc in
hexane to afford 1.59 g (81%) of 2 as an off-white solid.

1

H NMR was compared to

literature reported values and confirmed correct product was obtained.20
Thiotolyl 4,6-O-anisilidine-2-deoxy-2-phthalimido- -D-glucopyranoside (3).
Triacetate 2 (2.01 g, 1 equiv) was dissolved in DCM and methanol (3:2, 16 mL) and
cooled to –30 °C. NaOMe (1M in MeOH, 1.6 mL, 0.3 equiv) was added and the reaction
was stirred from –30 °C to –10 °C until TLC indicated reaction was complete. The
reaction was quenched with acidic ion-exchange resin (Dowex-50WX8), filtered and
concentrated by rotary evaporation to afford the intermediate triol as a white solid in
quantitative yield.
The crude triol was azeotroped with toluene three times and then dissolved in
toluene (25 mL). PMBDMA (1.3 mL, 2 equiv) and CSA (182 mg, 0.2 equiv) were added.
The reaction was stirred at 90 °C for 2 hours. Additional portions of PMBDMA (1.3 mL,
2 equiv) and CSA (182 mg, 0.2 equiv) were added and the reaction was stirred for an
additional 1 hour at 90 °C until reaction was complete. The reaction was quenched with
sat. aq. NaHCO3 and extracted with ethyl acetate. The organic extracts were dried over

43
sodium sulfate and concentrated by rotary evaporation. The residue was crystallized from
ethanol to afford 567 mg (29%) of acetal 3 as a white solid. The mother liquors were
subjected to column chromatography (gradient 10% to 50% EtOAc in hexane) to afford
1.07 g (54%) of acetal 3. Combined yield of 3 was 1.63 g (83%). 1H NMR was compared
to literature reported values and confirmed correct product was obtained.21
Thiotolyl

3-O-acetyl-4,6-O-anisilidine-2-azido-2-deoxy- -D-glucopyranoside

(4).

Acetal 3 (83 mg, 1 equiv) was suspended in n-butanol (1 mL) in a sealed reaction tube.
Ethylenediamine (250 µL, 24 equiv) was added and the mixture was stirred at 100 °C for
16 hours, at which time the solution was homogeneous. The reaction mixture was
concentrated by rotary evaporation and azeotroped with toluene to afford the intermediate
amine used crude in the next step.
Trifyl azide (TfN3) was prepared according to the procedure of Yan et al.2
Caution: Triflyl azide is potentially explosive and should only be handled as a dilute
solution and in small amounts. It should only be prepared and handled behind a blast
shield in a fume hood. It should be used immediately after preparation and not stored.
NaN3 (62 mg, 4.5 equiv) was suspended in pyridine (3 mL). At 0 °C, triflic anhydride
(125 L, 4 equiv) was added dropwise. The reaction was stirred for 3 hours at 0 °C until
it was ready for use.
The crude amine, triethylamine (70

L, 2 equiv), copper sulfate (4 mg) were

dissolved in pyridine (1 mL) and cooled to 0 °C. The TfN3 solution was then added
dropwise by disposable glass pipette. The reaction was then stirred from 0 °C to rt

44
overnight. The reaction was concentrated under rotary evaporation to remove solvent.
The residue was dissolved in pyridine and acetic anhydride (1:1, 5 mL) and stirrted at rt
until reaction was deemed complete by TLC. The reaction was concentrated and residue
was purified by column chromatography (20% to 40% EtOAc in hexane) to afford 54 mg
(81%) of azide 4 as a white solid. 1H NMR was compared to literature reported values
and confirmed that correct product was obtained.1
Thiotolyl 3-O-acetyl-2-azido-4-O-methyoxybenzyl-2-deoxy- -D-glucopyranoside (5).
Azide 4 (3.25 g, 1 equiv) was dissolved in BH3•THF (1 M in THF, 35 mL, 5 equiv) and
cooled to 0 °C. Bu2BOTf (1 M in toluene, 7 mL, 1.1 equiv) was added dropwise and the
reaction was stirred at 0 °C for 2 hours. The reaction was cooled to –78 °C and quenched
with triethylamine (1.5 equiv) and methanol. It was warmed slowly to room temperature,
then concentrated by rotary evaporation to afford crude 4-O-PMB ether. The residue was
dissolved in methanol and concentrated three times. The residue was then purified by
column chromatography (20% to 30% EtOAc inhexane) to afford 3.24 g (91%) of 4-OPMB ether 5 as a white solid. 1H NMR (300 MHz, CDCl3)

7.45 (d, J = 8.1 Hz, 2H),

7.17 (dd, J = 8.2, 3.1 Hz, 4H), 6.86 (d, J = 8.6 Hz, 2H), 5.13 (t, J = 9.5 Hz, 1H), 4.60 –
4.36 (m, 3H), 3.89 (dd, J = 12.3, 2.5 Hz, 1H), 3.79 (s, 3H), 3.70 (dd, J = 12.2, 3.9 Hz,
1H), 3.54 (t, J = 9.5 Hz, 1H), 3.39 (ddd, J = 9.7, 3.9, 2.5 Hz, 1H), 3.27 (t, J = 10.0 Hz,
1H), 2.37 (s, 3H), 2.04 (s, 3H), 0.00 (s, 9H).
Thiotolyl

3-O-acetyl-2-azido-4-O-benzyl-6-O-(tert-butyldiphenylsilyl)-2-deoxy- -D-

glucopyranoside (6). Alcohol 5 (3.24 g, 1 equiv) and imidazole (1260 mg, 3 equiv) were
dissolved in DMF (15 mL). At room temperature, TBDPS-Cl (3.3 mL, 1.2 equiv) was
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added and the reaction was stirred at rt overnight. The reaction was concentrated by
rotary evaporation and was purified by column chromatography (0-20% EtOAc in
hexane) to afford 4.63 g (95%) of silyl ether 13 as crystalline white solid. 1H NMR (300
MHz, CDCl3)

7.76 (ddd, J = 6.9, 3.5, 1.6 Hz, 4H), 7.57 – 7.34 (m, 8H), 7.24 – 7.16 (m,

2H), 7.14 – 7.07 (m, 2H), 6.90 (dd, J = 8.7, 1.2 Hz, 2H), 5.65 (dd, J = 5.5, 1.1 Hz, 1H),
5.58 – 5.39 (m, 1H), 4.68 (d, J = 1.6 Hz, 2H), 4.49 – 4.31 (m, 1H), 4.12 – 3.86 (m, 4H),
3.83 (s, 3H), 2.37 (s, 3H), 2.15 (s, 3H), 1.17 (s, 9H).
2-iodo-3-perfluorooctyl-proan-1-ol (7). Perfluorooctyl iodide (3.0 mL, 1 equiv) and 1
M aq Na2S2O3 (3 mL) are placed in a flask. The reaction mixture is heated to 80 °C and a
solution of 5% AIBN in allyl alcohol (2 mL) is added dropwise over 30 minutes. After 2
hours, the reaction is cooled to room temperature and extracted with DCM. The organic
extracts were dried over sodium sulfate and concentrated by rotary evaporation to afford
crude halohydrin 7 as a white solid in quantitative yield.
3-perfluorooctyl-proan-1-ol (8).

Halohydrin 7 (183 mg, 1 equiv) was dissolved in

methanol (2 mL). A small amount of Raney Nickel (a spatula tip) was added as a slurry
in water. The reaction flask was purged with argon and cooled to 0 °C. Hydrazine hydrate
(50 µL, 2 equiv) was added dropwise. Upon addition, small bubbles of gas are formed on
the catalyst surface. The reaction was stirred for 1 hour at 0 °C to rt. The catalyst was
removed by filtration, the reaction mixture was diluted with water, extracted with DCM
and dried over sodium sulfate. The organic extracts were treated with activated carbon
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and filtered through a pad of celite. The extracts were concentrated by rotary evaporation
to afford 107 mg (71%) alcohol 8 as a white solid. 1H NMR (300 MHz, CDCl3)

3.73 (t,

J = 6.1 Hz, 2H), 2.32 – 2.09 (m, 2H), 1.93 – 1.77 (m, 2H).
(3-perfluorooctyl)propyl 3,4,6-O-acetyl-2-deoxy-2-phthalimido- -D-glucopyranoside
(9). Tetraacetate 2 (227 mg, 1.3 equiv) and alcohol 8 (205 mg, 1 equiv) were dissolved in
DCM (5 mL) and cooled to 0 °C. BF3•Et2O (1 mL, 8 equiv) was added and the reaction
was stirred and warmed to rt. The reaction was quenched with sat. aq. NaHCO3 and
extracted with DCM. The organic extracts were washed with brine and dried over sodium
sulfate, then concentrated by rotary evaporation. The residue was purified by column
chromatography using a 20% EtOAc in hexane eluent to afford 226 mg (55%) of 9 as an
off-white solid. 1H NMR (300 MHz, CDCl3)

7.82 (dd, J = 5.5, 3.1 Hz, 2H), 7.70 (dd, J

= 5.5, 3.1 Hz, 2H), 5.76 (dd, J = 10.8, 9.1 Hz, 1H), 5.37 (d, J = 8.5 Hz, 1H), 5.16 (dd, J =
10.1, 9.1 Hz, 1H), 4.39 – 4.24 (m, 2H), 4.15 (dd, J = 12.3, 2.3 Hz, 1H), 3.97 – 3.78 (m,
2H), 3.53 (ddd, J = 10.0, 7.1, 4.8 Hz, 1H), 2.08 (s, 3H), 2.01 (s, 3H), 1.84 (s, 3H), 1.83 –
1.68 (m, 2H).
(3-perfluorooctyl)propyl 4,6-O-anisilidine-2-deoxy-2-phthalimido- -Dglucopyranoside (10). Triacetate 9 (1881 mg) was dissolved in DCM and methanol (3:2,
50 mL) and treated with NaOMe (1M in methanol, 600 µL, 0.3 equiv) at –20 °C for 14
hours. The reaction was quenched with acidic ion-exchange resin (Dowex-50WX8),
filtered and concentrated under rotary evaporation to afford intermediate triol used crude
in the next step.
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The crude triol was azeotroped with toluene and dissolved in THF. PMBDMA
(1.3 mL, 4 equiv) and CSA (25 mg, 5 mol%) were added in a single portion and the
reaction was refluxed at 70 °C overnight. The reaction was cooled to rt and quenched
with sat. aq. NaHCO3. The reaction was extracted with ethyl acetate, dried over sodium
sulfate and concentrated by rotary evaporation. The residue was crystallized from
EtOAc/hexane to afford 1.17 g of acetal 10 as white solid. The mother liquors were
purified by column chromatography (20% EtOAc in hexane with 1% Et3N) to afford 313
mg of acetal 10. Combined yield of acetal 10 was 1.48 g (79%).
(3-perfluorooctyl)propyl 3-O-acetyl-4,6-O-anisilidine-2-azido-2-deoxy- -Dglucopyranoside (11). Acetal 10 (51 mg, 1 equiv) was treated with ethylenediamine
(100 µL, 24 equiv) in n-butanol (2 mL) at 100 °C in a sealed tube for 14 hours. The
reaction mixture was concentrated by rotary evaporation and azeotroped with toluene.
The intermediate amine was used crude in the next step.
The crude amine, copper sulfate and triethylamine were dissolved in pyridine (2
mL) was treated with a solution of TfN3 in pyridine (8 equiv) at 0 °C for 14 hours. (See 4
for the preparation of TfN3.) The reaction was concentrated by rotary evaporation and
treated with acetic anhydride and pyridine (1:1, 5 mL) for 12 hours. The reaction was
concentrated by rotary evaporation and purified by column chromatography (10-20%
EtOAc in hexane) to afford 39 mg (86%) of azide 11 as a white solid. 1H NMR (300
MHz, CDCl3)

7.42 – 7.29 (m, 2H), 6.88 (d, J = 8.8 Hz, 2H), 5.45 (s, 1H), 5.13 (t, J =

9.8 Hz, 1H), 4.48 (d, J = 7.9 Hz, 1H), 4.31 (dd, J = 10.5, 4.9 Hz, 1H), 4.01 (dt, J = 9.6,
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5.8 Hz, 1H), 3.79 (s, 3H), 3.72 (dd, J = 16.8, 10.0 Hz, 2H), 3.60 (t, J = 9.5 Hz, 1H), 3.54
– 3.42 (m, 2H), 2.25 (ddp, J = 14.8, 11.4, 3.5 Hz, 2H), 2.13 (s, 3H), 2.04 – 1.89 (m, 2H).
(3-perfluorooctyl)propyl 3-O-acetyl-2-azido-4-O-methyoxybenzyl-2-deoxy- -Dglucopyranoside (12). Azide 11 (734 mg, 1 equiv) was dissolved in 6 mL BH3•THF (1
M in THF, 5 equiv) at 0 °C. Bu2BOTf (1M in DCM, 940 µL, 1.1 equiv) was added
dropwise and the reaction was stirred at 0 °C for 2 hours. The reaction was cooled to –78
°C and quenched with triethylamine (2 equiv) and methanol (2 equiv). The reaction
mixture was concentrated by rotary evaporation to afford the crude 4-O-PMB product.
The residue was dissolved in methanol and concentrated three times. The residue was
then purified by column chromatography (20% to 30% EtOAc/hexane) to afford 514 mg
(65%) of 4-O-PMB ether 12 as a white solid. 1H NMR (300 MHz, CDCl3)

7.19 (d, J =

8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 5.03 (dd, J = 10.4, 9.3 Hz, 1H), 4.53 (d, J = 1.1 Hz,
2H), 4.39 (d, J = 8.0 Hz, 1H), 4.00 (dt, J = 9.7, 5.7 Hz, 1H), 3.92 – 3.81 (m, 1H), 3.78 (s,
4H), 3.68 – 3.57 (m, 2H), 3.43 – 3.27 (m, 2H), 2.37 – 2.06 (m, 3H), 2.05 (s, 3H), 2.01 –
1.85 (m, 2H).
(3-perfluorooctyl)propyl 3-O-acetyl-2-azido-2-deoxy-4-O-p-methoxybenzyl-6-O-(tertbutyldiphenylsilyl)- -D-glucopyranoside (13). Primary alcohol 12 (514 mg, 1 equiv)
and imidazole (129 mg, 3 equiv) were dissolved in DMF (2 mL). At room temperature,
TBDPS-Cl (340 µL, 2 equiv) was added and the reaction was stirred overnight. The
reaction mixture was applied directly to an FSPE cartridge, washed with 5 volumes (25
mL) of 90% aq. methanol, and eluted with 100% methanol to afford 617 mg (93%) of
silyl ether 13 as a colorless oil. 1H NMR (300 MHz, CDCl3)

7.71 (tt, J = 8.0, 1.5 Hz,
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4H), 7.51 – 7.30 (m, 6H), 7.10 (d, J = 8.6 Hz, 2H), 6.81 (d, J = 8.7 Hz, 2H), 5.03 (dd, J =
10.4, 9.3 Hz, 1H), 4.63 – 4.47 (m, 2H), 4.36 (d, J = 8.0 Hz, 1H), 4.06 – 3.94 (m, 1H),
3.91 (d, J = 2.7 Hz, 2H), 3.84 – 3.71 (m, 4H), 3.59 (dt, J = 9.5, 6.1 Hz, 1H), 3.48 – 3.31
(m, 2H), 2.26 (s, 2H), 2.07 (d, J = 1.1 Hz, 2H), 1.99 (q, J = 7.1, 6.6 Hz, 2H), 1.09 (s, 8H).
Typical FSPE procedure under standard conditions: Typical samples separated on a 5
gram FSPE cartridge were 30-500 mg in size. FSPE cartridges upon first use were
washed with DMF to remove any plasticizer or other contaminants. The FSPE cartridges
were then pre-conditioned using methanol and water (4:1) (10–20 mL). The reaction
mixture was dissolved in 0.5 mL DMF (minimum volume) and loaded on the top of the
FSPE cartridge. A gentle vacuum is applied to lower the sample into the silica bed. A
drop rate of 1–2 drops per second is ideal. Another 0.5 mL DMF is used to wash the flask
and is loaded onto the FSPE cartridge as before. After loading, the cartridge is first eluted
with 4–5 column volumes of fluorophobic eluent (20–25 mL, methanol/water 4:1) and is
collected as a single fraction. The FSPE cartridge is then eluted until nearly dry, then
eluted with 4–5 column volumes of fluorophilic eluent (20–25 mL, methanol, acetone, or
THF) and is collected as a single fraction. A small amount of ethanol is typically added to
the fluorous fraction prior to concentration by rotary evaporation to avoid foaming and
bumping. Reducing the vacuum on the rotary evaporator may be beneficial in reducing
the tendency of samples to foam and bump. If foaming and bumping is problematic, a
centrifugal evaporator may be useful to avoid these problems.
(3-perfluorooctyl)propyl

2-deoxy-2-N-sulfonato-4-O-p-methoxybenzyl- -D-gluco-

pyranoside (14). 13 (36 mg, 1 equiv) was dissolved in DCM (1 mL) and treated with
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tributylphosphine (40 µL, 3 equiv) at rt for 5 hours. Water (1.5 mL) was added to
hydrolyze the intermediate ylide. The reaction was vigorously stirred at rt overnight. The
layers were separated and the aqueous layer was extracted with DCM. The organic
extracts were concentrated and the residue was purified by FSPE under standard
conditions to afford the free amine. The deprotected carbohydrate was then dissolved in
acetonitrile (2 mL). SO3•pyridine (50 mg, 9 equiv) and pyridine (80 µL, 10 equiv) were
added. The reaction was heated to 70 °C under microwave conditions for 1 hour. The
reaction mixture was then concentrated and subjected to FSPE purification to isolate the
desired sulfoform. The intermediate sulfoform was dissolved in THF (2 mL) and treated
with TBAF (1 M in THF, 150 µL, 3 equiv) at rt overnight. The reaction mixture was
concentrated by rotary evaporation and purified by FSPE under standard conditions to
afford the intermediate alcohol. The intermediate was then dissolved in methanol (2 mL)
and treated with NaOMe (1M in MeOH, 30 µL, 0.3 equiv) at rt, overnight, then the
reaction was neutralized with acidic ion-exchange resin (Dowex-50WX8), filtered and
concentrated to afford the diol. 1H NMR (300 MHz, MeOH-d4)

7.30 (d, J = 8.6 Hz,

2H), 6.89 (d, J = 8.7 Hz, 2H), 4.85 (d, J = 10.5 Hz, 1H), 4.58 (d, J = 10.7 Hz, 1H), 4.22
(d, J = 8.0 Hz, 1H), 4.04 – 3.92 (m, 1H), 3.78 (s, 3H), 3.64 (dt, J = 9.9, 3.9 Hz, 2H), 3.47
– 3.34 (m, 4H), 3.31 (p, J = 1.6 Hz, 11H), 2.63 (dd, J = 9.5, 8.0 Hz, 1H), 2.44 – 2.18 (m,
2H), 1.98 – 1.85 (m, 3H), 1.84 – 1.69 (m, 11H), 1.62 – 1.38 (m, 22H), 0.97 (t, J = 7.2 Hz,
16H).
(3-perfluorooctyl)propyl 2-azido-2-deoxy-3,6-di-O-sulfonato-4-O-p-methoxybenzyl-D-glucopyranoside (15). 13 (31 mg, 1 equiv) was dissolved in THF (2 mL) and treated
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with TBAF (1 M in THF, 150 µL, 3 equiv) at rt overnight. Then the reaction mixture was
concentrated by rotary evaporation and purified by FSPE under standard conditions to
afford the intermediate alcohol. The intermediate alcohol was then dissolved in methanol
(3 mL) and treated with NaOMe (1M in MeOH, 20 µL, 0.3 equiv) at rt overnight. The
reaction was neutralized with acidic ion-exchange resin (Dowex-50WX8), filtered and
concentrated to afford the diol. The deprotected carbohydrate was then dissolved in
acetonitrile (2 mL). SO3•pyridine (103 mg, 18 equiv) and pyridine (80 µL, 20 equiv)
were added. The reaction was heated to 70 °C under microwave conditions for 1 hour.
The reaction mixture was then concentrated and subjected to FSPE purification to isolate
the desired sulfoform. 1H NMR (300 MHz, CDCl3) 7.31 – 7.26 (m, 2H), 6.90 (d, J = 8.6
Hz, 2H), 4.81 – 4.61 (m, 2H), 4.33 (d, J = 8.0 Hz, 1H), 4.07 – 3.92 (m, 1H), 3.87 (dd, J =
12.2, 2.7 Hz, 1H), 3.80 (s, 3H), 3.74 (dd, J = 12.1, 4.1 Hz, 1H), 3.63 (dt, J = 9.6, 6.2 Hz,
1H), 3.53 – 3.44 (m, 2H), 3.38 – 3.23 (m, 2H), 2.35 – 2.13 (m, 2H), 1.95 (m, 2H).
(3-perfluorooctyl)propyl 2-deoxy-2,3,6-tri-N,O,O-sulfonato-4-O-p-methoxybenzyl- D-glucopyranoside (16). 13 (45 mg, 1 equiv) was dissolved in THF (1 mL) and treated

with TBAF (1 M in THF, 130 µL, 3 equiv) at rt overnight. The reaction mixture was
concentrated by rotary evaporation and purified by FSPE under standard conditions to
afford the intermediate alcohol. The intermediate alcohol was then dissolved in methanol
(1.5 mL) and treated with NaOMe (1M in MeOH, 15 µL, 0.3 equiv) at rt, overnight. The
reaction was neutralized with acidic ion-exchange resin (Dowex-50WX8), filtered and
concentrated to afford the diol. The diol was then dissolved in DCM (1.5 mL) and treated
with tributylphosphine (40 µL, 3 equiv) at rt for 5 hours. Water (1.5 mL) was added to
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hydrolyze the intermediate ylide. The reaction was vigorously stirred at rt overnight. The
layers were separated and the aqueous layer was extracted with DCM. The organic
extracts were concentrated and the residue was purified by FSPE under standard
conditions to afford the free amine. The deprotected carbohydrate was then dissolved in
pyridine and triethylamine (5:1, 3 mL) and SO3•pyridine (160 mg, 30 equiv) was added.
The reaction was heated to 70 °C under microwave conditions for 1 hour. The reaction
mixture was then concentrated and subjected to FSPE purification to isolate the desired
sulfoform. 1H NMR (300 MHz, d4-MeOH) 7.32 (d, J = 8.5 Hz, 2H), 6.86 (d, J = 8.4 Hz,
2H), 4.83 – 4.77 (m, 1H), 4.51 – 4.43 (m, 2H), 4.25 (t, J = 8.5 Hz, 1H), 4.03 (d, J = 10.5
Hz, 1H), 3.96 (s, 1H), 3.78 (s, 2H), 3.70 (s, 3H), 3.66 (d, J = 5.1 Hz, 1H), 3.60 (d, J = 9.9
Hz, 2H).
(3-perfluorooctyl)propyl 4-methylbenzenesulfonate (17). Alcohol 8 (750 mg, 1 equiv),
4-methylbenzenesulfonyl chloride (460 mg, 1.5 equiv) and pyridine (200 µL, 1.5 equiv)
were dissolved in DCM (15 mL) and stirred at rt. Silver oxide (440 mg, 1.5 equiv) was
added and the reaction commenced with formation of white precipitate. The reaction was
filtered through Celite and concentrated by rotary evaporation. The residue was purified
by column chromatography (0% to 20% EtOAc in hexane) to afford 865 mg (87%) of
tosylate 17 as a white solid. 1H NMR (300 MHz, CDCl3)

7.80 (d, J = 8.3 Hz, 2H), 7.37

(dt, J = 8.1, 0.7 Hz, 2H), 4.11 (t, J = 5.9 Hz, 2H), 2.46 (s, 4H), 2.28 – 1.88 (m, 4H). 19F
NMR (282 MHz, CDCl3)

-82.25, -82.29, -82.33, -115.99, -116.05, -116.11, -123.48, -

124.27, -125.02, -127.62, -127.67.
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Methyl 3,5-bis((3-perfluorooctyl)propyloxy)benzoate (18). Tosylate 17 (549 mg, 2.2
equiv), methyl 3,5-dihydroxybenzoate (68 mg, 1 equiv) and potassium carbonate (210
mg, 5 equiv) were dissolved in 3 mL of DMF. The reaction was heated to 50 °C for 14
hours. The reaction was diluted with diethyl ether and washed with water to remove
DMF and inorganic salts. The organic extracts were dried over sodium sulfate and
concentrated by rotary evaporation. The residue was purified by column chromatography
to afford 448 mg (98%) of methyl ester 18 as an off-white solid. 1H NMR (300 MHz,
CDCl3) 7.19 (dd, J = 2.5, 0.7 Hz, 2H), 6.64 (td, J = 2.3, 0.7 Hz, 1H), 4.07 (t, J = 5.8 Hz,
4H), 3.91 (d, J = 0.7 Hz, 3H), 2.30 (td, J = 18.3, 9.8 Hz, 4H), 2.18 – 2.02 (m, 4H).
(3,5-bis((3-perfluorooctyl)propyloxy)phenyl)methanol (19). Methyl ester 18 (483 mg,
1 equiv) was dissolved in DCM (20 mL). The reaction was cooled to –78 °C and
diisobutylaluminum hydride (1M in hexane, 1.3 mL, 3 equiv) was added dropwise. The
reaction mixture was stirred and warmed to rt. The reaction then was cooled to 0 °C and
quenched with solid Glauber’s salt. Solids were removed by filtration and the organic
fraction was concentrated. The residue was purified by column chromatography to afford
306 mg (72%) of benzyl alcohol 19 as a white solid. 1H NMR (300 MHz, CDCl3)

6.65

– 6.51 (m, 2H), 6.42 (t, J = 2.3 Hz, 1H), 4.57 (d, J = 5.6 Hz, 2H), 4.13 (t, J = 6.0 Hz, 3H),
2.46 (tt, J = 19.2, 8.5 Hz, 4H), 2.18 – 2.05 (m, 4H).
3,5-bis((3-perfluorooctyl)propyloxy)benzyl 3,4,6-tri-O-acetyl-2-deoxy-2-Nphthalimido- -D-glucopyranoside (20). Benzyl alcohol 19 (104 mg, 1 equiv) and GlcN
donor 2 (63 mg, 1.5 equiv) azeotroped with toluene, dried on a high vacuum line, and
then dissolved in dry DCM (1.5 mL). 4 Å MS (50 mg) were added and the reaction was
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stirred at room temperature for 30 minutes. NIS (90 mg, 2 equiv) was added and the
reaction mixture was cooled to 0 °C. TfOH (5 µL, 0.3 equiv) was added and the reaction
was stirred at 0 °C until TLC indicates consumption of donor. Upon completion, the
reaction was quenched with diisopropylethylamine, filtered through a pad of Celite, and
concentrated. The residue was purified by column chromatography to afford 30 mg
(22%) of glucoside 20. 1H NMR (300 MHz, CDCl3)

7.89 – 7.49 (m, 4H), 6.97 (d, J =

8.0 Hz, 1H), 6.80 (d, J = 8.0 Hz, 1H), 6.33 (d, J = 6.0 Hz, 1H), 5.79 – 5.64 (m, 1H), 5.42
– 4.95 (m, 4H), 4.45 – 4.15 (m, 3H), 2.36 (m, 4H), 2.13 (s, 3H), 2.01 (s, 3H), 1.84 (s,
3H).
3,5-bis((3-perfluorooctyl)propyloxy)benzyl 3,4,6-tri-O-sulfonato-2-deoxy-2-Nphthalimido- -D-glucopyranoside (21). Glucoside 20 was dissolved in methanol and
trifluorotoluene (2:1, 6 mL), cooled to –30 °C and treated with NaOMe (1M in MeOH,
50 µL, 0.3 equiv). The reaction was slowly warmed to –10 °C and after 5 hours the
reaction was neutralized with acidic ion-exchange resin (Dowex-50WX8) to afford the
intermediate tri-alcohol. The intermediate triol was then dissolved in acetonitrile (2 mL)
and treated with SO3•pyridine (95 mg, 27 equiv) and pyridine (60 µL, 30 equiv). The
mixture was heated to 70 °C under microwave conditions to afford tri-O-sulfonate 21.
Half of the reaction mixture was subjected to standard FSPE conditions with slow
loading (1 drop per 3 seconds) and slow fluorophobic elution (1 drop per second).
Fluorophlilic elution with 100% methanol afforded the desired sulfoform as 15 mg (88%)
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of a white solid. 1H NMR (300 MHz, MeOH-d4)

7.88 – 7.47 (m, 3H), 5.34 (t, J = 8.9

Hz, 1H), 5.14 – 4.94 (m, 2H), 4.29 – 3.89 (m, 4H), 3.71 – 3.49 (m, 1H), 2.59 – 2.30 (m,
2H), 2.17 – 1.96 (m, 2H).
3,5-bis((3-perfluorooctyl)propyloxy)benzyl (N-hydroxysuccinimidyl)carbonate (22).
Benzyl alcohol 19 (74 mg, 1 equiv) was dissolved in DCM (4 mL) at rt. Triphosgene (33
mg, 4 equiv) and triethylamine (40 µL, 4 equiv) were added athe reaction was stirred at
room temperature overnight. NHS (50 mg, 8 equiv) and triethylamine (80 µL, 8 equiv)
were added and the reaction stirred at room temperature for 2 hours. The reation was
quenched with sat. aq. NaHCO3 and extracted with DCM. The organic extracts were
dried over sodium sulfate and concentrated via rotary evaporation. The residue was
purified by column chromatography (0% to 20% EtOAc/hexane) to afford 33 mg (40%)
of NHS carbonate 22. 1H NMR (300 MHz, CDCl3)

6.53 (d, J = 2.2 Hz, 2H), 6.45 (t, J =

2.2 Hz, 1H), 5.24 (s, 2H), 4.04 (t, J = 5.8 Hz, 4H), 2.84 (s, 4H), 2.30 (td, J = 18.3, 9.1 Hz,
4H), 2.11 (dt, J = 10.3, 5.5 Hz, 4H).

13

C NMR (75 MHz, CDCl3)

168.41, 159.91,

135.53, 106.58, 102.08, 72.25, 66.38, 27.80, 25.33, 20.39.
2’-(9H-Fluoren-9-yl)methoxycarbonylaminoethyl 3-O-acetyl-2-azido-4-O-pmethoxybenzyl-6-O-(tert-butyldiphenylsilyl)-2-deoxy- -D-glucopyranoside

(23).

GlcN donor 6 (477 mg, 1 equiv) and Fmoc-protected ethanolamine (237 mg, 1.2 equiv)
were azeotroped with toluene in a flame-dried flask and dried on vacuum line. The
compounds were dissolved in a mixture of DCE and Et2O (1:3, 20 mL) with flame-dried
4 Å MS (1 gram). The reaction was stirred for 30 minutes before addition of NIS (189
mg, 1.2 equiv). The reaction mixture was cooled to -20 °C and TfOH (20 µL, 0.3 equiv)
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was added to the reaction mixture and was stirred at –20 °C for 5 hours. Upon
completion, the reaction was quenched with diisopropylethylamine, filtered through a pad
of Celite, and concentrated by rotary evaporation. The residue was purified by column
chromatography (0% to 20% THF in hexane) to afford 513 mg (88%, 4:1 / ) of aminoethyl glucoside 23. 1H NMR (300 MHz, CDCl3)

7.78 – 7.72 (m, 2H), 7.68 (ddt, J

= 6.5, 4.8, 1.6 Hz, 4H), 7.62 – 7.55 (m, 2H), 7.47 – 7.33 (m, 9H), 7.32 – 7.27 (m, 5H),
7.21 – 7.14 (m, 2H), 5.66 – 5.52 (m, 1H), 5.36 (t, J = 6.0 Hz, 1H), 4.99 (d, J = 3.5 Hz,
1H), 4.64 (s, 2H), 4.34 (d, J = 7.2 Hz, 2H), 4.20 (t, J = 7.2 Hz, 1H), 3.99 – 3.83 (m, 3H),
3.79 (d, J = 5.6 Hz, 3H), 3.55 (dt, J = 9.8, 4.8 Hz, 2H), 3.39 – 3.23 (m, 1H), 3.14 (dd, J =
10.7, 3.5 Hz, 1H), 2.07 (s, 3H), 1.09 (s, 9H).
2’-3,5-bis((3-perfluorooctyl)propyl)oxy)benzyloxycarbonylaminoethyl 3-O-acetyl-2azido-2-deoxy-4-O-p-methoxybenzyl-6-O-(tert-butyldiphenylsilyl)- -Dglucopyranoside (24). Glucoside 23 (25 mg, 1 equiv) was deprotected with 20%
piperidine in DMF at room temperature for 30 minutes. The reaction mixture was
concentrated by rotary evaporation and was purified by a short silica plug to afford 21 mg
(quantitative) of the intermediate free amine.
The intermediate amine (21 mg, 1 equiv) and NHS carbonate 22 were dissolved in
acetonitrile (1 mL) with triethylamine (3 µL, 1 equiv) and stirred at rt o/n. The reaction
mixture was concentrated and directly purified by column chromatography (0-20%
EtOAc in hexane) to afford 38 mg (80%) of tagged glucoside 24 as a colorless oil. 1H
NMR (300 MHz, CDCl3)

7.79 – 7.57 (m, 4H), 7.51 – 7.31 (m, 5H), 7.05 (d, J = 8.6 Hz,

2H), 6.79 (d, J = 8.6 Hz, 2H), 6.49 (d, J = 2.2 Hz, 2H), 6.37 (t, J = 2.3 Hz, 1H), 5.60 –
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5.45 (m, 1H), 5.26 (d, J = 8.5 Hz, 1H), 5.01 (s, 2H), 4.97 (d, J = 3.5 Hz, 1H), 4.59 – 4.46
(m, 2H), 4.01 (t, J = 5.8 Hz, 3H), 3.87 (s, 2H), 3.78 (s, 3H), 3.74 (s, 2H), 3.55 (t, J = 8.8
Hz, 2H), 3.32 (s, 1H), 3.12 (dd, J = 10.7, 3.5 Hz, 1H), 2.28 (dd, J = 17.5, 9.6 Hz, 4H),
2.15 – 2.00 (m, 7H), 1.07 (s, 9H).
Methyl 3,5-bis(perfluorooctyl)benzoate (25). Methyl 3,5-diiodobenzoate (770 mg, 1
equiv) and perfluorooctyl iodide (1600 µL, 3 equiv) were dissolved in DMSO. Freshly
activated Cu dust (800 mg, 6 equiv) was added and the reaction mixture was degassed for
15 minutes by bubbling Ar through the solution. The reaction was heated to 125 °C in a
sealed flask under Argon o/n. The reaction mixture was then cooled, filtered through a
bed of Celite, diluted with water and extracted with diethyl ether. The organic extracts
were washed with brine, dried over sodium sulfate, and concentrated by rotary
evaporation. The residue was used in the next step of the reaction without purification. 1H
NMR (300 MHz, CDCl3) 8.53 – 8.43 (m, 2H), 7.98 (s, 1H), 4.01 (s, 3H). 19F NMR (282
MHz, CDCl3) -82.62, -112.85, -122.87, -123.52, -124.49, -127.93.
(3,5-bis(perfluorooctyl)phenyl)methanol (26).

Crude methyl ester 25 was dissolved

in THF and LAH (1M in THF, 3 mL, 1.5 equiv) was added to the reaction at room
temperature. The reaction was stirred for 4 hours at room temperature. The reaction was
quenched by the careful addition of sat. aq. NH4Cl and extracted with diethyl ether. The
organic extracts were dried over sodium sulfate and concentrated to afford the crude
benzyl alcohol 26. The crude reaction mixture was crystallized from hexane to afford 755
mg of benzyl alcohol 26. The mother liquors were purified by column chromatography
(0% to 20% EtOAc in hexane) to afford 631 mg of alcohol 26. Combined yield of 26
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over 2 steps was 1386 mg (74%). 1H NMR (300 MHz, Acetone-d6)

8.06 (d, J = 1.7 Hz,

2H), 7.80 (s, 1H), 4.91 (s, 2H).
3,5-bis(perfluorooctyl)benzyl 1H-imidazole-1-carboxylate (27). Benzyl alcohol 26
(118 mg, 1 equiv) and carbonyl diimidazole (180 mg, 5 equiv) were dissolved in THF (12
mL) stirred o/n at rt. The reaction mixture was concentrated by rotary evaporation and the
residue was passed through a silica plug to afford 110 mg (85%) of imidazole carbamate
27 as a white solid. 1H NMR (300 MHz, CDCl3) 8.16 (s, 1H), 7.95 – 7.89 (m, 2H), 7.85
(d, J = 1.8 Hz, 1H), 7.48 – 7.35 (m, 1H), 7.10 (t, J = 1.2 Hz, 1H), 5.55 (s, 2H). 19F NMR
(282 MHz, CDCl3)

-82.36 (t, J = 9.9 Hz), -112.68 (t, J = 14.3 Hz), -122.74 , -123.43

(m), -124.32 (s), -127.73 (t, J = 13.8 Hz).
3,5-bis(perfluorooctyl)benzyl (4-nitrophenyl) carbonate (28).

Benzyl

alcohol

26

(490 mg, 1 equiv) and p-nitrophenyl chloroformate (220 mg, 2 equiv) were dissolved in
THF (10 mL) at rt. Triethylamine (150 µL, 2 equiv) was added and the reaction was
stirred at rt for 2h. The reaction was quenched with sat. aq. NaHCO3 and extracted with
diethyl ether, dried over sodium sulfate and concentrated under reduced pressure. The
residue was purified by column chromatography (0–50% chloroform in hexane) to afford
498 mg (87%) of carbonate 28 as a pale-yellow solid. 1H NMR (300 MHz, CDCl3) 8.35
– 8.25 (m, 2H), 7.90 (d, J = 1.9 Hz, 2H), 7.83 (s, 1H), 7.45 – 7.33 (m, 2H), 5.42 (s, 2H).
2’-3,5-bis((3-perfluorooctyl)benzyloxycarbonylaminoethyl 3-O-acetyl-2-azido-4-O-pmethoxybenzyl-6-O-(tert-butyldiphenylsilyl)- -D-glucopyranoside (29). Glucoside 23
(89 mg, 1 equiv) was treated with 20% piperidine in DMF at rt for 30 minutes. The
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reaction mixture was concentrated by rotary evaporation and was purified by a short
silica plug to afford quantitative recovery of the intermediate free amine.
The intermediate free amine and carbonate 28 (140 mg, 1.2 equiv) were dissolved
in DCM (5 mL) with a catalytic grain of DMAP and triethylamine (15 µL, 1.2 equiv).
The reaction was stirred at rt o/n. The reaction mixture was then quenched with sat. aq.
NaHCO3, extracted with DCM, washed with brine, dried over sodium sulfate and
concentrated under reduced pressure. The residue was purified by column
chromatography (10-30% EtOAc in hexane) to afford 150 mg (90%) of tagged
glucosamine 29 as an off-white solid. 1H NMR (300 MHz, CDCl3) 7.84 – 7.64 (m, 6H),
7.46 – 7.32 (m, 5H), 7.26 – 7.14 (m, 3H), 7.05 (d, J = 8.6 Hz, 2H), 6.79 (d, J = 8.6 Hz,
2H), 5.54 (dd, J = 10.7, 7.9 Hz, 1H), 5.38 (d, J = 6.1 Hz, 1H), 5.28 – 5.10 (m, 2H), 4.96
(d, J = 3.5 Hz, 1H), 4.52 (d, J = 4.3 Hz, 2H), 3.87 (d, J = 2.4 Hz, 2H), 3.76 (d, J = 11.1
Hz, 6H), 3.55 (dd, J = 14.2, 6.1 Hz, 2H), 3.39 – 3.24 (m, 1H), 3.12 (dd, J = 10.7, 3.5 Hz,
1H), 2.08 (s, 3H), 1.07 (s, 9H).
3,5-bis(perfluorooctyl)benzaldehyde (31). Benzyl alcohol 26 (222 mg, 1 equiv) and 2iodosoxybezene (152 mg, 2 equiv) were dissolved in a mixture of DMSO and TFT (1:1,
10 mL). The reaction was heated at 40 °C until 2-iodosoxybezene dissolved into solution
and stirred at that that temperature for 3 hours. The reaction mixture was then partitioned
between water and diethyl ether. The organic extracts were washed with brine, dried over
sodium sulfate and concentrated under reduced pressure to cleanly afford 197 mg (89%)
of benzaldehyde 31 as an amorphous white solid. 1H NMR (300 MHz, CDCl3) 10.16 (s,
1H), 8.34 (d, J = 1.5 Hz, 1H), 8.05 (d, J = 1.9 Hz, 1H). 19F NMR (282 MHz, CDCl3)

-
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81.88 – -82.95 (m), -112.06 – -113.54 (m), -122.71 , -123.45 (d, J = 48.5 Hz), -124.34 , 127.75 (d, J = 17.4 Hz).
(E)-ethyl 3-(3,5-bis(perfluorooctyl)phenyl)acrylate (32). Benzaldhyde 31 (197 mg, 1
equiv) and triethyl phosphonoacetate (85 µL, 1.5 equiv) were dissolved in THF (15 mL).
NaH (60% dispersion in mineral oil, 18 mg, 1.5 equiv) was added and the reaction was
stirred at rt o/n. The reaction quenched with sat. aq. NH4Cl and extracted with diethyl
ether. The organic extracts were dried over sodium sulfate and concentrated under
reduced pressure. The residue was purified by column chromatography (0–50%
chloroform in hexane) to afford 185 mg (87%) of alkene 32 as a white solid. 1H NMR
(300 MHz, CDCl3) 7.92 (d, J = 1.5 Hz, 2H), 7.84 – 7.66 (m, 2H), 6.59 (dd, J = 16.0, 0.8
Hz, 1H), 4.36 – 4.23 (m, 2H), 1.38 – 1.32 (m, 3H).
3-(3,5-bis(perfluorooctyl)phenyl)propan-1-ol (33). Alkene 32 (185 mg, 1 equiv) was
dissolved in THF (10 mL) with HOAc (10 drops) added. Pd/C (ca. 20 mg) was added and
the reaction was stirred under hydrogen for 36 hours. The reaction was then filtered
through a pad of Celite and concentrated under reduced pressure to afford the reduced
product in quantitative yield. The crude product was used in the next step without
purification.
The crude ethyl ester was dissolved in THF (6 mL) and cooled to –78 °C with
stirring. A solution of LAH (1M in THF, 200 µL, excess) was added and the reaction was
allowed to warm to rt over 3h. The reaction was carefully quenched with sat. aq. NH4Cl
and extracted with diethyl ether. The organic extracts were washed with brine, dried over
sodium sulfate and concentrated under reduced pressure. The residue was passed through
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a silica gel plug to afford 164 mg (92% over 2 steps) of homologated alcohol 33 as a
colorless oil. 1H NMR (300 MHz, CDCl3)

7.64 (s, 3H), 3.70 (t, J = 6.2 Hz, 2H), 2.99 –

2.81 (m, 2H), 1.93 (ddt, J = 9.8, 7.9, 6.2 Hz, 2H).
3-(3,5-bis(perfluorooctyl)phenyl)propyl (4-nitrophenyl) carbonate (34). Homologated
alcohol 33 (42 mg, 1 equiv) and p-nitrophenyl chloroformate (19 mg, 2 equiv) were
dissolved in THF (2 mL) at rt. Triethylamine (15 µL, 2 equiv) was added and the reaction
was stirred at rt for 2h. The reaction was quenched with sat. aq. NaHCO3 and extracted
with diethyl ether. The organic extracts were dried over sodium sulfate and concentrated
under reduced pressure. The residue was purified by column chromatography (0–50%
chloroform in hexane) to afford 32 mg (65%) of carbonate 34 as a pale-yellow solid. 1H
NMR (300 MHz, CDCl3)

8.35 – 8.21 (m, 2H), 7.68 (s, 3H), 7.43 – 7.33 (m, 2H), 4.34

(t, J = 6.2 Hz, 2H), 2.96 (dd, J = 9.2, 6.5 Hz, 2H), 2.15 (dq, J = 9.9, 6.2 Hz, 2H).
2’-3-(3,5-bis(perfluorooctyl)phenyl)propyloxycarbonylaminoethyl

3-O-acetyl-2-

azido-4-O-p-methoxybenzyl-6-O-(tert-butyldiphenylsilyl)- -D-glucopyranoside (35).
Glucoside 23 (292 mg, 1 equiv) was treated with 20% piperidine in DMF at rt for 30
minutes. The reaction mixture was concentrated by rotary evaporation and was purified
by a short silica plug to afford quantitative recovery of the intermediate free amine.
The intermediate free amine and carbonate 34 (465 mg, 1.2 equiv) were dissolved
in DCM (10 mL) with a catalytic grain of DMAP and triethylamine (100 µL, 1.2 equiv).
The reaction was stirred at rt o/n. The reaction mixture was then quenched with sat. aq.
NaHCO3 and extracted with DCM. The organic extracts were washed with brine, dried
over sodium sulfate and concentrated under reduced pressure. The residue was purified
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by column chromatography (10–30% EtOAc in hexane) to afford 496 mg (72%) of
tagged glucosamine 35 as a white solid. 1H NMR (300 MHz, CDCl3)

7.75 – 7.58 (m,

7H), 7.50 – 7.31 (m, 6H), 7.05 (d, J = 8.5 Hz, 2H), 6.85 – 6.73 (m, 2H), 5.66 – 5.43 (m,
1H), 5.21 (s, 1H), 4.98 (d, J = 3.6 Hz, 1H), 4.63 – 4.43 (m, 2H), 4.19 – 4.01 (m, 3H), 3.87
(s, 2H), 3.83 – 3.66 (m, 6H), 3.65 – 3.43 (m, 3H), 3.40 – 3.21 (m, 2H), 3.13 (dd, J = 10.6,
3.5 Hz, 1H), 2.82 (t, J = 8.0 Hz, 2H), 2.08 (d, J = 0.8 Hz, 3H), 1.94 (d, J = 8.1 Hz, 2H),
1.08 (s, 9H).
(E)-ethyl 4-(1H,1H,2H,2H-perfluorodec-1-en-1-yl)benzoate (36). Benzocaine (500
mg, 1 equiv) was dissolved in THF (15 mL) and cooled to –20 °C. BF3•Et2O (900 µL, 3
equiv) and isoamyl nitrite (800 µL, 2 equiv) were added dropwise sequentially. The
reaction was stirred at –20 °C until a cloudy suspension resulted. The reaction warmed to
0 °C and then was diluted with diethyl ether to precipitate the diazonium salt. The solid
was filtered and used crude in the next step of the reaction sequence.
The intermediate diazonium tetrafluoroborate salt was suspended in methanol (15
mL). 1H,1H,2H-perfluorodecene (450 µL, 1 equiv) and Pd(OAc)2 (20 mg, 5 mol%) were
added and reaction was stirred at 40 °C. At 40 °C the reaction commenced with
effervescence and was refluxed for 30 minutes. The reaction mixture was cooled and
concentrated under reduced pressure. The residue was redissolved in DCM and passed
through a short silica plug to remove Pd salts. The organic fraction was concentrated by
rotary evaporation and 1.20 g (69%) of alkene 36 was isolated as a white solid without
purification. 1H NMR (300 MHz, CDCl3)

8.12 – 8.00 (m, 2H), 7.60 – 7.43 (m, 2H),

7.20 (d, J = 16.6 Hz, 1H), 6.30 (dt, J = 16.1, 12.0 Hz, 1H), 4.39 (qd, J = 7.1, 1.2 Hz, 2H),
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1.44 – 1.36 (m, 3H).

13

C NMR (75 MHz, CDCl3)

165.71, 138.56, 137.37, 131.68,

129.98, 127.35, 116.50, 61.11, 14.05. 19F NMR (282 MHz, CDCl3)

-82.61 (t, J = 10.0

Hz), -113.21 (d, J = 12.6 Hz), -122.77 – -123.36 (m), -123.66 (tt, J = 19.5, 10.0 Hz), 124.49 (d, J = 16.4 Hz), -124.64 – -125.02 (m), -127.60 – -128.69 (m).
(4-(1H,1H,2H,2H-perfluorodecyl)phenyl)methanol (37). Alkene 36 (1.20 g, 1 equiv)
was dissolved in a mixture of THF and methanol (1:4, 20 mL) at room temperature. A
small amount of Pd/C was added and the reaction mixture was stirred under hydrogen
o/n. The reaction mixture was filtered through a pad of Celite to afford 1.20 g
(quantitative) of the hydrogenated intermediate.
The intermediate ester was then dissolved in THF (30 mL) and cooled to 0 °C.
Diisobutylaluminum hydride solution (1M in hexane, 8 mL, 3 equiv) was added and the
reaction was stirred at 0 °C to rt o/n. The reaction was quenched with EtOAc and treated
with sat. aq. Rochelle’s salt solution. The mixture was extracted with diethyl ether and
washed with brine. The extracts were dried over sodium sulfate and concentrated under
reduced pressure. The residue was passed through a silica plug to afford 1.06 g (95%
over 2 steps) of benzyl alcohol 37 as a white solid. 1H NMR (300 MHz, CDCl3)

7.40 –

7.13 (m, 4H), 4.99 (s, 2H), 3.09 – 2.76 (m, 2H), 2.42 (dq, J = 18.3, 9.8, 9.1 Hz, 2H).
4-(1H,1H,2H,2H-perfluorodecyl)benzyl (4-nitrophenyl) carbonate (38). Beznyl
alcohol 37 (3.38 g, 1 equiv) and p-nitrophenyl chloroformate (1.87, 1.5 equiv) were
dissolved in THF (70 mL) at 0 °C. Triethylamine (2.0 mL, 2 equiv) was added and the
reaction was stirred from 0 °C to rt o/n. The reaction was quenched with sat. aq. NaHCO3
and extracted with diethyl ether. The organic extracts were dried over sodium sulfate and
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concentrated under reduced pressure. The residue was purified by column
chromatography (0–50% chloroform in hexane) to afford 4.02 mg (92%) of carbonate 38
as a pale-yellow solid. 1H NMR (300 MHz, CDCl3)

8.34 – 8.20 (m, 2H), 7.47 – 7.32

(m, 4H), 7.28 (d, J = 7.8 Hz, 2H), 5.28 (s, 2H), 3.06 – 2.85 (m, 2H), 2.40 (dq, J = 18.6,
9.3 Hz, 2H).
2’-(4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyl)aminoethyl

3-O-acetyl-2-

azido-4-O-p-methoxybenzyl-6-O-(tert-butyldiphenylsilyl)- -D-glucopyranoside (13).
(39). Glucoside 23 (738 mg, 1 equiv) was treated with 20% piperidine in DMF at rt for
30 minutes. The reaction mixture was concentrated by rotary evaporation and was
purified by a short silica plug to afford quantitative recovery of the intermediate free
amine.
The intermediate free amine and carbonate 38 (804 mg, 1.2 equiv) were dissolved
in THF (20 mL) with a catalytic grain of DMAP and triethylamine (180 µL, 1.2 equiv).
The reaction was stirred at rt o/n. The reaction mixture was then quenched with sat. aq.
NaHCO3 and extracted with DCM. The organic extracts were washed with brine, dried
over sodium sulfate and concentrated under reduced pressure. The residue was purified
by column chromatography (10–30% EtOAc/hexane) to afford 998 mg (84%) of tagged
glucosamine 39 as a colorless oil. 1H NMR (300 MHz, CDCl3)

7.73 – 7.64 (m, 4H),

7.48 – 7.33 (m, 6H), 7.29 (d, J = 8.1 Hz, 2H), 7.17 (d, J = 8.1 Hz, 2H), 7.07 (d, J = 8.6
Hz, 2H), 6.81 (d, J = 8.6 Hz, 2H), 5.54 (ddd, J = 10.7, 6.3, 2.7 Hz, 1H), 5.27 (t, J = 5.9
Hz, 1H), 5.06 (s, 2H), 4.97 (d, J = 3.5 Hz, 1H), 4.62 – 4.46 (m, 2H), 3.88 (t, J = 1.7 Hz,
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2H), 3.77 (d, J = 9.1 Hz, 6H), 3.62 – 3.45 (m, 2H), 3.39 – 3.26 (m, 1H), 3.14 (dd, J =
10.7, 3.5 Hz, 1H), 2.95 – 2.85 (m, 2H), 2.46 – 2.25 (m, 2H), 2.09 (s, 3H), 1.08 (s, 9H).
2’-azidoethyl per-O-acetyl- -D-glucopyranoside (40). Per-O-acetyl- -D-glucose (7.8 g,
1 equiv) and 2-bromoethanol (2.8 mL, 2 equiv) were dissolved in DCM (35 mL) at rt.
BF3•Et2O (5.0 mL, 2 equiv) was added dropwise and the reaction mixture was sonicated
for 40 minutes. The reaction mixture was quenched with sat. aq. NaHCO3 and extracted
with DCM. The organic extracts were washed with brine, dried over sodium sulfate, and
concentrated under reduced pressure. The residue was purified by dry column vacuum
chromatography to afford 5.48 g (61%) of 2-bromoethyl -glucoside as an amorphous
solid.
2-Bromoethyl -glucoside (5.48 g, 1 equiv) and sodium azide (3.16 g, 4 equiv)
were dissolved in a mixture of acetone and water (4:1, 50 mL). The reaction mixture was
refluxed o/n. The reaction was then extracted with DCM. The organic extracts were
washed with brine, dried over sodium sulfate and concentrated to afford 4.82 g (96%,
57% over 2 steps) of azidoethyl -glucoside 40 as a white solid. 1H NMR (300 MHz,
CDCl3)

5.17 (td, J = 9.5, 1.1 Hz, 1H), 5.11 – 4.91 (m, 2H), 4.54 (dd, J = 8.0, 1.1 Hz,

1H), 4.27 – 4.16 (m, 1H), 4.16 – 4.04 (m, 2H), 3.92 – 3.81 (m, 2H), 3.77 (m, 1H), 3.71 –
3.62 (m, 1H), 3.53 – 3.37 (m, 3H), 2.09 – 1.92 (m, 12H).
2’-azidoethyl 4,6-O-benzylidine- -D-glucopyranoside (41). Tetraacetate 40 (3.17 g, 1
equiv) was dissolved in DCM and methanol (1:1, 50 mL) and cooled to 0 °C. NaOMe
(1M in MeOH, 3 mL, 0.3 equiv) was added and the reaction was stirred at 0 °C.
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The reaction was quenched with acidic ion-exchange resin (Dowex-50WX8), filtered and
concentrated by rotary evaporation to afford the intermediate tetraol in quantitative yield.
The crude tetraol was azeotroped with toluene three times and then dissolved in
THF (30 mL). Benzylidene dimethyl acetal (2.5 mL, 2 equiv) and CSA (50 mg, 3 mol%)
were added. The reaction was refluxed o/n. The reaction was quenched with sat. aq.
NaHCO3 and extracted with ethyl acetate. The organic extracts were dried over sodium
sulfate and concentrated by rotary evaporation. The residue was purified by dry column
vacuum chromatography to afford 2.42 g (87%) of acetal 41 as a white solid. 1H NMR
(300 MHz, CDCl3)

7.65 (d, J = 8.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 5.40 (s, 1H), 4.63

(d, J = 3.8 Hz, 1H), 4.22 (dd, J = 10.1, 4.9 Hz, 1H), 4.05 (t, J = 9.3 Hz, 1H), 3.93 (td, J =
9.6, 3.5 Hz, 1H), 3.65 (dd, J = 9.3, 4.0 Hz, 1H), 3.55 (t, J = 10.3 Hz, 1H), 3.41 (t, J = 9.4
Hz, 2H), 3.35 (s, 4H), 3.06 – 2.91 (m, 2H), 2.69 (dd, J = 5.7, 4.4 Hz, 2H).
2’-azidoethyl 2-O-benzoyl-4,6-O-benzylidene-3-O-p-methoxybenzyl- -Dglucopyranoside (42). Acetal 41 (690 mg, 1 equiv) and dibutyl tin oxide (767, 1.5 equiv)
were dissolved in toluene. The reaction was heated to reflux and when the reaction
mixture was homogeneous, the reaction was cooled to rt. The solvent was removed under
reduced pressure and the residue was azeotroped three times with toluene to afford the
crude stannylene acetal.
The stannylene acetal intermediate was dissolved in THF and DMF (10:1, 30
mL). PMB-Cl (900 µL, 3 equiv), CsF (450 mg, 1.5 equiv) and TBAI (100 mg, 10 mol%)
were added. The reaction was stirred at rt o/n. The reaction mixture was then filtered
through a pad of Celite and concentrated to afford a mixture of alkylated products. The

67
residue was purified by column chromatography to afford 320 mg of the desired 3-OPMB ether. The product was treated with 3 equiv benzoyl chloride in pyridine and passed
through a silica plug to afford 259 mg (31% over 3 steps) of glucoside 42 as a white
solid. 1H NMR (300 MHz, CDCl3)

8.07 – 7.93 (m, 2H), 7.65 – 7.54 (m, 1H), 7.52 –

7.39 (m, 4H), 7.11 – 7.01 (m, 2H), 6.99 – 6.89 (m, 2H), 6.68 – 6.55 (m, 2H), 5.58 (s, 1H),
5.37 – 5.21 (m, 1H), 4.81 – 4.56 (m, 3H), 4.38 (dd, J = 10.5, 4.9 Hz, 1H), 4.04 – 3.90 (m,
2H), 3.90 – 3.78 (m, 6H), 3.70 (s, 3H), 3.62 – 3.44 (m, 1H), 3.44 – 3.23 (m, 2H).
2’-(4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyl)aminoethyl

2-O-benzoyl-

4,6-O-benzylidine-3-O-p-methoxybenzyl- -D-glucopyranoside (43). Azidoethyl

-

glucoside 42 (259 mg, 1 equiv) was dissolved in a mixture of EtOAc, ethanol and water
(1:4:4, 10 mL) and treated with Zn powder (50 mg, 2 equiv) and sat. aq. NH4Cl (100 µL,
4 equiv). The reaction was refluxed for 1h. The intermediate amine was isolated after
organic extraction in 228 mg (93%) yield.
The intermediate free amine (738 mg) and carbonate 38 (1.29 g, 1.2 equiv) were
dissolved in THF (40 mL) with a catalytic grain of DMAP and triethylamine (500 µL, 2
equiv). The reaction was stirred at rt o/n. The reaction mixture was then quenched with
sat. aq. NaHCO3 and extracted with DCM. The organic extracts were washed with brine,
dried over sodium sulfate and concentrated under reduced pressure. The residue was
purified by column chromatography (10–30% EtOAc in hexane) to afford 1345 mg
(87%, 72% over 2 steps) of tagged glucosamine 43 as a white solid. 1H NMR (300 MHz,
CDCl3)

8.01 – 7.88 (m, 2H), 7.59 – 7.47 (m, 3H), 7.47 – 7.35 (m, 5H), 7.21 (q, J = 8.5,

8.1 Hz, 4H), 7.06 (d, J = 8.6 Hz, 2H), 6.65 – 6.57 (m, 2H), 5.61 (s, 1H), 5.23 (t, J = 8.3
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Hz, 1H), 5.09 (t, J = 5.8 Hz, 1H), 5.05 – 4.81 (m, 2H), 4.81 – 4.60 (m, 2H), 4.58 (d, J =
7.9 Hz, 1H), 4.37 (dd, J = 10.5, 4.9 Hz, 1H), 3.92 – 3.75 (m, 4H), 3.70 (s, 3H), 3.67 –
3.43 (m, 2H), 3.31 (s, 2H), 2.97 – 2.85 (m, 2H), 2.48 – 2.25 (m, 2H).
2’-(4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyl)aminoethyl 2-O-benzoyl-3O-p-methoxybenzyl-6-O-monomethoxytrityl- -D-glucopyranoside (44). Acetal 43
(504 mg, 1 equiv) was dissolved in a mixture of methanol and DCM (1:1, 10 mL), treated
with CSA (ca. 10 mg) and refluxed for 3 hours. FSPE purification under standard
conditions afforded 420 mg (90%) of the intermediate 4,6-diol.
The intermediate diol (420 mg, 1 equiv) was dissolved in DCM and pyridine (5:1,
6 ml) and treated with monomethoxytrityl chloride (1.7 equiv, 200 mg) and catalytic
DMAP. The reaction was refluxed 6 hours. The reaction mixture was concentrated under
reduced pressure and purification by column chromatography (20–50% EtOAc in hexane
afforded 430 mg (81%) of trityl ether 44. 1H NMR (300 MHz, CDCl3)

8.03 (dt, J = 7.2,

1.4 Hz, 2H), 7.65 – 7.58 (m, 1H), 7.56 – 7.44 (m, 8H), 7.38 – 7.25 (m, 19H), 7.19 (q, J =
8.2 Hz, 4H), 7.14 – 7.09 (m, 2H), 6.79 – 6.63 (m, 2H), 5.36 (dd, J = 9.4, 7.9 Hz, 1H),
4.91 (d, J = 12.6 Hz, 1H), 4.70 (d, J = 12.8 Hz, 1H), 4.63 (d, J = 6.5 Hz, 1H), 4.58 (d, J =
8.0 Hz, 1H), 4.47 (s, 2H), 3.86 (t, J = 9.1 Hz, 1H), 3.72 (d, J = 1.2 Hz, 3H), 3.60 (t, J =
9.2 Hz, 1H), 3.53 (t, J = 6.0 Hz, 2H), 3.49 – 3.42 (m, 3H), 2.87 (s, 1H), 2.50 (s, 1H), 2.35
– 2.10 (m, 2H), 1.92 (dq, J = 12.1, 6.3 Hz, 2H).
2’-(4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyl)aminoethyl 2-O-benzoyl-6O-(2-bromo)isobutyryl-3-O-p-methoxybenzyl- -D-glucopyranoside (45). Intermediate
diol (as prepared as in 44, 220 mg, 1 equiv), catalytic DMAP (ca. 10 mg), and DIPEA (45
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µL, 1.5 equiv) were dissolved in DCM (3 mL). 2-bromoisobutyryl bromide (40 µL, 1.4
equiv) was added and the reaction was stirred at 0 °C for 2 hours. The reaction was
quenched with sat. aq. NaHCO3 and extracted with DCM. The organic extracts were
dried over sodium sulfate and concentrated under reduced pressure. The residue was
purified by column chromatography (20–50% EtOAc in hexane) to afford 240 mg (95%)
of ester 45 as a colorless oil. 1H NMR (300 MHz, CDCl3)

8.10 – 7.93 (m, 2H), 7.65 –

7.49 (m, 1H), 7.49 – 7.32 (m, 2H), 7.32 – 7.05 (m, 6H), 6.73 (dd, J = 8.5, 1.5 Hz, 2H),
5.27 – 5.12 (m, 2H), 5.08 – 4.82 (m, 2H), 4.73 – 4.47 (m, 4H), 4.41 (dd, J = 11.8, 5.1 Hz,
1H), 3.81 (d, J = 5.1 Hz, 1H), 3.72 (s, 2H), 3.70 – 3.56 (m, 4H), 3.37 – 3.27 (m, 2H), 3.02
– 2.80 (m, 3H), 2.38 (dq, J = 17.4, 9.9, 9.0 Hz, 2H), 2.03 – 1.84 (m, 6H).
2’-(4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyl)aminoethyl 2-O-benzoyl-3O-p-methoxybenzyl- -D-gluronate methyl ester (46). Intermediate diol (as prepared as
in 44, 140 mg, 1 equiv), bis(acetoxy)iodobenzene (134 mg, 3 equiv) and TEMPO (6 mg,
0.4 equiv) were dissolved in DCM and water (2:1, 8 mL). The reaction was stirred
vigorously at rt for 45 min. The reaction was extracted with DCM and concentrated. The
residue was purified by FSPE under standard conditions to afford 130 mg (92%) of the
intermediate GlcA acid.
The intermediate free acid was dissolved in DCM (5 mL). Iodomethane (0.5 mL),
tetraoctylammonium bromide (ca. 10 mg), and sat. aq. NaHCO3 (1 mL) were added. The
reaction was stirred o/n at rt. The organic layer was separated and concentrated. The
residue was purified by FSPE under standard conditions to afford 131 mg (90% yield) of
methyl ester 46 as a white solid.
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Thiotolyl 2-azido-4-O-benzyl-6-O-(tert-butyldiphenylsilyl)-3-O-(2trimethylsilylethoxymethyl)- -D-glucopyranoside (47). Thioglycoside 6 (260 mg, 1
equiv) was dissolved in methanol and DCM (1:1, 10 mL) and treated with potassium
carbonate (ca. 50 mg). When the reaction was complete, the mixture was concentrated
under reduced pressure and the residue was used crude in the next step.
The crude alcohol (250 mg, 1 equiv) was dissolved in DCM (4 mL) and treated
with SEM-Cl (270 µL, 4 equiv), TBAI (27 mg, 10 mol%) and DIPEA (400 µL, 5 equiv).
The reaction was refluxed for 6 hours until deemed complete by TLC. The reaction
mixture was concentrated and purified by column chromatography to afford 205 mg
(69%) of SEM ether 92 as a colorless oil. Note: 2-trimethylsilylethanol (by-product of the
protection) can be removed high vacuum rotary evaporation at 45 °C after 30 minutes.
1

H NMR (300 MHz, CDCl3)

7.84 – 7.77 (m, 2H), 7.77 – 7.70 (m, 2H), 7.59 – 7.52 (m,

2H), 7.50 – 7.30 (m, 6H), 7.12 – 6.99 (m, 4H), 6.84 – 6.74 (m, 2H), 4.99 (d, J = 6.4 Hz,
1H), 4.89 (d, J = 6.4 Hz, 1H), 4.69 (d, J = 10.2 Hz, 1H), 4.60 (d, J = 10.3 Hz, 1H), 4.40
(d, J = 10.1 Hz, 1H), 4.01 (dd, J = 11.4, 1.8 Hz, 1H), 3.91 (dd, J = 11.4, 3.3 Hz, 1H), 3.84
– 3.77 (m, 4H), 3.75 – 3.61 (m, 2H), 3.60 – 3.51 (m, 1H), 3.35 – 3.23 (m, 2H), 2.33 (s,
3H), 1.12 (s, 9H), 1.03 – 0.92 (m, 2H), 0.01 (s, 9H).
2’-(4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyl)aminoethyl 2-O-benzoyl-6O-(2-bromo)isobutyryl-3-O-p-methoxybenzyl- -D-glucopyranosyl)-3-O-acetyl-2azido-2-deoxy-4-O-p-methoxybenzyl-6-O-(tert-butyldiphenylsilyl)- -Dglucopyranoside (48). GlcN donor 6 (103 mg, 1 equiv) and GlcA acceptor 45 (240 mg,
1.5 equiv) were carefully azeotroped with toluene, dried on a high vacuum line, and then
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dissolved in dry DCM (2.5 mL). 4 Å MS (100 mg) were added and the reaction was
stirred at room temperature for 30 minutes. NIS (90 mg, 2 equiv) was added and the
reaction mixture was cooled to 0 °C. TfOH (1 µL, 0.1 equiv) was added and the reaction
was stirred at 0 °C until TLC indicates consumption of donor. Upon completion, the
reaction was quenched with diisopropylethylamine, filtered through a pad of celite, and
concentrated. The residue was purified by column chromatography to afford 104 mg
(73%) of disaccharide 48 as a clear oil. 1H NMR (300 MHz, CDCl3)

8.10 – 8.01 (m,

1H), 7.73 – 7.60 (m, 5H), 7.56 (t, J = 7.4 Hz, 2H), 7.51 – 7.29 (m, 11H), 7.25 – 7.08 (m,
9H), 6.79 (m, 4H), 5.67 (d, J = 3.9 Hz, 1H), 5.27 (t, J = 8.6 Hz, 1H), 5.12 (d, J = 5.5 Hz,
1H), 5.04 (t, J = 6.9 Hz, 2H), 5.00 – 4.87 (m, 3H), 4.82 – 4.70 (m, 3H), 4.70 – 4.52 (m,
5H), 4.15 (dd, J = 11.9, 5.1 Hz, 1H), 3.89 (dt, J = 14.2, 3.6 Hz, 9H), 3.80 (s, 4H), 3.74 (s,
3H), 3.72 – 3.60 (m, 6H), 3.31 (s, 3H), 3.12 (dd, J = 10.4, 3.9 Hz, 1H), 2.97 – 2.87 (m,
2H), 2.48 – 2.26 (m, 2H), 1.07 (s, 9H), 1.04 (m, 2H), 0.03 (s, 9H).
2’-(4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyl)aminoethyl 2-O-benzoyl-3O-p-methoxybenzyl- -D-glucuronate)-3-O-acetyl-2-azido-2-deoxy-4-O-pmethoxybenzyl-6-O-(tert-butyldiphenylsilyl)- -D-glucopyranoside methyl ester(49).
Dissaccharide 48 (255 mg, 1 equiv) was dissolved in a mixture of methanol and THF
(1:1) and treated with DBU (25 µL, 1 equiv) at rt o/n. The reaction mixture was
concentrated under reduced pressure and the residue was purified by FSPE under
standard conditions to afford 240 mg of 6-OH disaccharide.
Intermediate 6-OH alcohol (240 mg, 1 equiv), bis(acetoxy)iodobenzene (62 mg, 3
equiv) and TEMPO (2 mg, 0.4 equiv) were dissolved in DCM and water (2:1, 3 mL). The
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reaction was stirred vigorously at rt for o/n. The reaction was extracted with DCM and
concentrated. The residue was treated with an excess of diazomethane and carefully
concentrated. The residue was purified by FSPE under standard conditions to afford 180
mg (76% over 3 steps) of disaccharide 49 as a clear oil. 1H NMR (300 MHz, CDCl3)
8.03 (d, J = 7.7 Hz, 2H), 7.73 – 7.61 (m, 5H), 7.55 (t, J = 7.4 Hz, 1H), 7.37 (dt, J = 22.3,
6.9 Hz, 10H), 7.16 (dt, J = 18.6, 9.5 Hz, 9H), 6.86 – 6.78 (m, 2H), 6.78 – 6.71 (m, 2H),
5.50 (d, J = 3.6 Hz, 1H), 5.31 (t, J = 7.7 Hz, 1H), 5.12 (d, J = 6.1 Hz, 1H), 5.05 – 4.93 (m,
3H), 4.89 (d, J = 6.0 Hz, 2H), 4.68 (ddd, J = 22.2, 12.9, 8.6 Hz, 6H), 4.20 (d, J = 8.5 Hz,
1H), 4.07 – 3.85 (m, 7H), 3.81 (s, 6H), 3.73 (s, 4H), 3.66 – 3.56 (m, 3H), 3.50 (s, 3H),
3.42 – 3.23 (m, 4H), 3.10 (dd, J = 10.4, 3.7 Hz, 1H), 2.96 – 2.86 (m, 2H), 2.37 (dq, J =
18.0, 9.2, 8.5 Hz, 2H), 1.07 (s, 9H), 1.04 – 1.00 (m, 2H), 0.02 (s, 9H).
4-(1H,1H,2H,2H-perfluorodecyl)benzyl 3-O-acetyl-2-azido-4-O-p-methoxybenzyl-6O-(tert-butyldiphenylsilyl)- -D-glucopyranoside (50). GlcN donor 6 (184 mg, 1 equiv)
and benzyl alcohol 37 (240 mg, 1.5 equiv) were azeotroped with toluene in a flame-dried
flask and dried on vacuum line. The compounds were dissolved in a mixture of diethyl
ether and DCM (9:1, 5 mL) with flame-dried 4 Å MS (0.5 gram). The reaction was
stirred for 30 minutes before addition of NIS (78 mg, 1.5 equiv). The reaction mixture
was cooled to –20 °C and TfOH (6 µL, 0.3 equiv) was added to the reaction mixture. The
reaction was stirred at –20 °C for 5 hours until TLC indicated the disappearance of donor.
Upon completion, the reaction was quenched with diisopropylethylamine, filtered
through a pad of celite, and concentrated. The residue was purified by column
chromatography (0% to 20% EtOAc in hexane) to afford 264 mg (89%,

only) of benzyl
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glycoside 50 as a white solid. 1H NMR (300 MHz, CDCl3)

7.82 – 7.61 (m, 4H), 7.56 –

7.35 (m, 7H), 7.35 – 7.23 (m, 2H), 7.17 (d, J = 7.9 Hz, 2H), 7.15 – 7.04 (m, 2H), 6.92 –
6.77 (m, 2H), 5.67 – 5.54 (m, 1H), 5.04 (d, J = 3.5 Hz, 1H), 4.69 (d, J = 11.9 Hz, 1H),
4.63 – 4.50 (m, 3H), 3.99 – 3.66 (m, 7H), 3.17 (ddd, J = 10.6, 3.6, 0.9 Hz, 1H), 2.97 –
2.82 (m, 2H), 2.36 (tt, J = 17.7, 7.8 Hz, 2H), 2.15 – 2.02 (m, 3H), 1.12 (d, J = 1.0 Hz,
9H).
4-(1H,1H,2H,2H-perfluorodecyl)benzyl 3-O-(2-trimethylsilylethoxymethyl)-2-azido6-O-(tert-butyldiphenylsilyl)- -D-glucopyranoside (51). Glucoside 50 (264 mg, 1
equiv) was treated with potassium carbonate in MeOH to afford the 3-OH intermediate.
The crude alcohol was dissolved in DCM (2 mL) and refluxed with SEM-Cl (35 µL, 1.1
equiv), DIPEA (80 µL, 1.5 equiv) and TBAI (10 mg, 0.1 equiv). The reaction was
concentrated under reduced pressure and the residue was subjected to FSPE under
standard conditions to afford 181 mg (65%) of intermediate 3-O-SEM ether.
The intermediate 3-O-SEM ether (181 mg, 1 equiv) was dissolved acetone,
acetonitrile and water (4:4:1, 10 mL) and treated with CAN (750 mg, 9 equiv). The
reaction mixture was directly applied to an FSPE cartridge and the 4-OH product 51 was
isolated in 89 mg (55%) yield as a colorless oil. 1H NMR (300 MHz, CDCl3)

7.81 –

7.66 (m, 4H), 7.49 – 7.35 (m, 7H), 7.35 – 7.29 (m, 2H), 7.20 (d, J = 8.1 Hz, 2H), 5.03 –
4.90 (m, 2H), 4.79 (d, J = 7.3 Hz, 1H), 4.77 – 4.71 (m, 1H), 4.64 (d, J = 1.2 Hz, 1H), 4.56
(d, J = 12.0 Hz, 1H), 4.01 – 3.74 (m, 6H), 3.66 – 3.53 (m, 2H), 3.35 (dd, J = 10.2, 3.6 Hz,
1H), 2.98 – 2.83 (m, 2H), 2.49 – 2.25 (m, 2H), 1.09 (s, 9H), 1.05 – 0.95 (m, 2H), 0.02 (s,
9H).
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Thiophenyl per-O-acetyl- -D-glucopyranoside (52). Per-O-acetyl- -D-glucose (8.9 g, 1
equiv) and thiophenol (2.2 mL, 1 equiv) were dissolved in DCM (50 mL) at rt. BF3•Et2O
(2.8 mL, 1 equiv) was added dropwise and the reaction mixture was sonicated for 60
minutes. The reaction mixture was quenched with sat. aq. NaHCO3 and extracted with
DCM. The organic extracts were washed with brine, dried over sodium sulfate, and
concentrated under reduced pressure. The residue was purified by dry column vacuum
chromatography to afford 5.48 g (57%) of thioglycoside 52 as a cream-colored solid. 1H
NMR was compared to literature reported values and confirmed that the correct product
was obtained.14
Thiophenyl 4,6-O-p-methoxybenzylidine- -D-glucopyranoside (53).

Tetraacetate

52 (2.13 g, 1 equiv) was dissolved in methanol (50 mL) and cooled to 0 °C. NaOMe (1M
in MeOH, 3 mL, 0.3 equiv) was added and the reaction was stirred at 0 °C. The reaction
was quenched with acidic ion-exchange resin (Dowex-50WX8), filtered and concentrated
by rotary evaporation to afford the intermediate tetraol in quantitative yield.
The crude tetraol was azeotroped with toluene three times and then dissolved in
THF (30 mL). PMBDMA (1.2 mL, 1.5 equiv) and CSA (112 mg, 10 mol%) were added.
The reaction was refluxed o/n. The reaction was quenched with sat. aq. NaHCO3 and
extracted with ethyl acetate. The organic extracts were dried over sodium sulfate and
concentrated by rotary evaporation. The residue was purified by dry column vacuum
chromatography to afford 1.52 g (81%) of acetal 53 as a white solid. 1H NMR was
compared to literature reported values and confirmed that the correct product was
obtained.15
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Thiophenyl

2-O-benzoyl-3-O-p-methoxybenzyl-4,6-O-p-methoxybenzylidine- -D-

glucopyranoside (54). Acetal 53 (1.45 mg, 1 equiv) and dibutyl tin oxide (1.39 g, 1.5
equiv) were dissolved in toluene. The reaction was heated to reflux and when the reaction
mixture was homogeneous, the reaction was cooled to rt. The solvent was removed under
reduced pressure and the residue was azeotroped three times with toluene to afford the
crude stannylene acetal.
The stannylene acetal intermediate was dissolved in THF and DMF (10:1, 30
mL). PMB-Cl (1.5 mL, 3 equiv), CsF (836 mg, 1.5 equiv) and TBAI (80 mg, 10 mol%)
were added. The reaction was stirred at rt o/n. The reaction mixture was then filtered
through a pad of Celite and concentrated to afford the desired 3-O-PMB ether. The crude
ether was treated with benzoyl chloride in pyridine and purified by column
chromatography to afford 1.85 g (79% over 3 steps) of glycoside 54 as a white solid. 1H
NMR (300 MHz, CDCl3)

8.06 – 7.94 (m, 2H), 7.67 – 7.57 (m, 1H), 7.53 – 7.39 (m,

6H), 7.34 – 7.22 (m, 3H), 7.10 – 7.00 (m, 2H), 7.00 – 6.87 (m, 2H), 6.66 – 6.54 (m, 2H),
5.57 (s, 1H), 5.35 – 5.18 (m, 1H), 4.84 (d, J = 10.1 Hz, 1H), 4.73 (d, J = 11.6 Hz, 1H),
4.60 (d, J = 11.7 Hz, 1H), 4.41 (dd, J = 10.5, 4.9 Hz, 1H), 3.93 – 3.73 (m, 7H), 3.69 (s,
3H), 3.65 – 3.51 (m, 1H).
Thiophenyl 2-O-benzoyl-3-O-p-methoxybenzyl-4-O-p-methoxybenzyl- -Dglucopyranoside (55). Glycoside 54 (1.47 g, 1 equiv) was dissolved in BH3•THF (1 M in
THF, 12.5 mL, 5 equiv) and cooled to 0 °C. Bu2BOTf (1 M in toluene, 5 mL, 1.1 equiv)
was added dropwise and the reaction was stirred for 2 hours. The reaction was cooled to
–78 °C and quenched with triethylamine (1.5 equiv) and methanol. It was warmed slowly

76
to room temperature. The reaction mixture was concentrated by rotary evaporation to
afford the crude 4-O-PMB ether. The residue was dissolved in methanol and concentrated
three times. The residue was then purified by column chromatography (20% to 30%
EtOAc in hexane) to afford 1.42 g (91%) of 4-O-PMB ether 55 as a white solid. 1H NMR
(300 MHz, CDCl3)

8.11 – 7.95 (m, 2H), 7.68 – 7.53 (m, 1H), 7.53 – 7.35 (m, 4H), 7.31

– 7.23 (m, 5H), 7.11 – 6.99 (m, 2H), 6.94 – 6.81 (m, 2H), 6.70 – 6.58 (m, 2H), 5.24 (dd, J
= 10.1, 9.0 Hz, 1H), 4.81 (dd, J = 10.3, 5.6 Hz, 2H), 4.75 – 4.55 (m, 3H), 3.96 – 3.87 (m,
1H), 3.81 (s, 4H), 3.73 (td, J = 3.8, 1.4 Hz, 1H), 3.69 (s, 4H), 3.48 (ddd, J = 9.7, 4.8, 2.6
Hz, 1H).
Thiophenyl 2-O-benzoyl-3-O-p-methoxybenzyl-4-O-p-methoxybenzyl-6-O-pnitrobenzoyl- -D-glucopyranoside (56). Alcohol 55 (1.42 g, 1 equiv) and pnitrobenzoyl chloride (871 mg, 1.5 equiv) were dissolved in DCM (20 mL). Catalytic
DMAP and triethylamine (700 µL, 2 equiv) were added. The reaction was stirred at rt
o/n. The reaction was quenched with sat. aq. NaHCO3 and extracted with DCM. The
organic extracts were dried with sodium sulfate and concentrated under reduced pressure.
The residue was purified by column chromatography (10–30% EtOAc in hexane) to
afford 1.61 g (97%) of donor 56 as a white solid. 1H NMR (300 MHz, CDCl3)

8.34 –

8.20 (m, 2H), 8.15 – 8.00 (m, 4H), 7.68 – 7.56 (m, 1H), 7.56 – 7.36 (m, 4H), 7.26 – 7.01
(m, 6H), 6.80 – 6.73 (m, 2H), 6.73 – 6.60 (m, 2H), 5.25 (dd, J = 10.0, 9.1 Hz, 1H), 4.81
(dd, J = 10.5, 2.3 Hz, 2H), 4.75 – 4.50 (m, 4H), 4.43 (dd, J = 11.9, 4.5 Hz, 1H), 3.89 (t, J
= 8.7 Hz, 1H), 3.71 (dd, J = 2.5, 0.9 Hz, 7H).
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2-O-benzoyl-3,4-O-p-methoxybenzyl-6-O-p-nitrobenzoyl- (1,4)-D-glucopyranosyl(4-(1H,1H,2H,2H-perfluorodecyl)-beznyl)-2-azido-3-O-(2trimethylsilylethoxymethyl)-6-O-(tert-butyldiphenylsilyl)- -D-glucopyranoside (57).
GlcN donor 56 (103 mg, 1 equiv) and GlcA acceptor 51 (240 mg, 1.5 equiv) were
carefully azeotroped with toluene, dried on a high vacuum line, and then dissolved in dry
DCM (2.5 mL). 4 Å MS (100 mg) were added and the reaction was stirred at room
temperature for 30 minutes. NIS (90 mg, 2 equiv) was added and the reaction mixture
was cooled to 0 °C. TfOH (1 µL, 0.1 equiv) was added and the reaction was stirred at 0
°C until TLC indicates consumption of donor. Upon completion, the reaction was
quenched with diisopropylethylamine, filtered through a pad of Celite, and concentrated.
The residue was purified by column chromatography to afford 104 mg (40%) of
disaccharide 57 as a colorless oil. 1H NMR (300 MHz, CDCl3)

8.32 – 8.23 (m, 2H),

8.16 (dd, J = 8.9, 1.3 Hz, 2H), 7.81 – 7.73 (m, 4H), 7.69 (dd, J = 6.7, 1.4 Hz, 2H), 7.57 –
7.27 (m, 10H), 7.18 (dd, J = 12.2, 7.9 Hz, 4H), 7.06 (d, J = 8.2 Hz, 2H), 7.00 (d, J = 7.9
Hz, 2H), 6.76 (dd, J = 8.6, 1.3 Hz, 2H), 6.68 (dd, J = 8.7, 1.3 Hz, 2H), 5.32 – 5.21 (m,
1H), 5.00 – 4.86 (m, 3H), 4.83 – 4.69 (m, 3H), 4.62 – 4.51 (m, 4H), 4.51 – 4.36 (m, 2H),
4.01 (p, J = 8.9 Hz, 2H), 3.70 (dd, J = 8.8, 1.2 Hz, 10H), 3.54 – 3.39 (m, 1H), 3.29 (q, J =
9.2, 8.8 Hz, 2H), 2.92 (dd, J = 9.5, 3.9 Hz, 1H), 2.86 – 2.72 (m, 2H), 2.41 – 2.15 (m, 2H),
1.04 (s, 9H), 0.88 – 0.70 (m, 2H), -0.08 (s, 9H).
Thiophenyl 4,6-O-(2-naphthylidene)- -D-glucopyranoside (58). Tetraacetate 52 (1.50
g, 1 equiv) was dissolved in methanol (20 mL) and cooled to 0 °C. NaOMe (1M in
MeOH, 2 mL, 0.3 equiv) was added and the reaction was stirred at 0 °C. The reaction
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was quenched with acidic ion-exchange resin (Dowex-50WX8), filtered and concentrated
by rotary evaporation to afford the intermediate tetraol in quantitative yield.
The crude tetraol was azeotroped with toluene three times and then dissolved in
THF (30 mL). 2-naphthaldehyde dimethyl acetal (875 mg, 1.5 equiv) and CSA (80 mg,
10 mol%) were added. The reaction was refluxed o/n. The reaction was quenched with
sat. aq. NaHCO3 and extracted with ethyl acetate. The organic extracts were dried over
sodium sulfate and concentrated by rotary evaporation. The residue was purified by dry
column vacuum chromatography to afford 551 mg (39%) of acetal 58 as a white solid. 1H
NMR (300 MHz, CDCl3)

8.03 – 7.79 (m, 5H), 7.65 – 7.44 (m, 6H), 7.40 – 7.24 (m,

3H), 5.74 (d, J = 4.5 Hz, 1H), 4.88 – 4.71 (m, 2H), 4.64 (d, J = 4.8 Hz, 1H), 4.32 (dd, J =
10.1, 4.5 Hz, 2H), 3.85 – 3.70 (m, 3H), 3.67 – 3.34 (m, 4H).
Thiophenyl 2-O-benzoyl-3-O-(2-naphthyl)-4,6-O-(2-naphthylidene)- -Dglucopyranoside (59). Acetal 53 (550 mg, 1 equiv) and dibutyl tin oxide (502 mg, 1.5
equiv) were dissolved in toluene (15 mL). The reaction was heated to reflux and when the
reaction mixture was homogeneous, the reaction was cooled to rt. The solvent was
removed under reduced pressure and the residue was azeotroped three times with toluene
to afford the crude stannylene acetal.
The stannylene acetal intermediate was dissolved in THF and DMF (10:1, 30
mL). 2-Nap-Br (582 mg, 2 equiv), CsF (298 mg, 1.5 equiv) and TBAI (45 mg, 10 mol%)
were added. The reaction was stirred at rt o/n. The reaction mixture was then filtered
through a pad of Celite and concentrated to afford desired 3-O-PMB ether. The crude
ether was treated with benzoyl chloride in pyridine and purified by column
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chromatography to afford 598 mg (81% over 3 steps) of glycoside 59 as a white solid. 1H
NMR (300 MHz, CDCl3)

7.97 (d, J = 1.4 Hz, 1H), 7.90 – 7.72 (m, 10H), 7.68 – 7.27

(m, 17H), 5.72 (s, 1H), 5.15 – 4.92 (m, 2H), 4.83 (d, J = 5.1 Hz, 2H), 4.64 (d, J = 9.7 Hz,
1H), 4.42 (dd, J = 10.5, 4.9 Hz, 1H), 3.89 – 3.78 (m, 1H), 3.78 – 3.70 (m, 2H), 3.57 (tdd,
J = 10.9, 8.5, 3.6 Hz, 2H), 2.90 (d, J = 2.6 Hz, 1H).
Thiophenyl 2-O-benzoyl-3,4-di-O-(2-naphthyl)- -D-glucopyranoside (60). Glycoside
59 (1.83 g, 1 equiv) was dissolved in BH3•THF (1 M in THF, 15 mL, 5 equiv) and cooled
to 0 °C. Bu2BOTf (1 M in toluene, 3 mL, 1.1 equiv) was added dropwise and the reaction
was stirred at 0 °C for 2 hours. The reaction was cooled to –78 °C and quenched with
triethylamine (1.5 equiv) and methanol. It was warmed slowly to room temperature. The
reaction mixture was concentrated by rotary evaporation to afford the crude 4-O-PMB
ether. The residue was dissolved in methanol and concentrated three times. The residue
was then purified by column chromatography (20% to 30% EtOAc in hexane) to afford
1.46 g (80%) of 4-O-Nap ether 60 as a white solid. 1H NMR (300 MHz, CDCl3)

8.01

(dd, J = 8.4, 1.4 Hz, 2H), 7.88 – 7.65 (m, 6H), 7.63 – 7.35 (m, 15H), 7.35 – 7.22 (m, 5H),
5.35 (dd, J = 10.1, 9.0 Hz, 1H), 5.09 – 4.79 (m, 5H), 3.97 (t, J = 9.0 Hz, 2H), 3.81 (t, J =
9.3 Hz, 2H), 3.58 (ddd, J = 9.7, 4.7, 2.5 Hz, 1H).
Thiophenyl 2-O-benzoyl-3,4-di-O-(2-naphthyl)-6-O-p-nitrobenzoyl- -Dglucopyranoside (61). Alcohol 60 (1.46 g, 1 equiv) and p-nitrobenzoyl chloride (778 mg,
1.5 equiv) were dissolved in DCM (30 mL); then catalytic DMAP and triethylamine (800
µL, 2 equiv) were added. The reaction was stirred at rt o/n. The reaction was quenched
with sat. aq. NaHCO3 and extracted with DCM. The organic extracts were dried with
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sodium sulfate and concentrated under reduced pressure. The residue was purified by
column chromatography (10–30% EtOAc in hexane) to afford 1.81 g (80%) of donor 56.
1

H NMR (300 MHz, CDCl3)

8.33 – 8.17 (m, 2H), 8.06 (ddd, J = 17.9, 7.7, 1.7 Hz, 4H),

7.89 – 7.81 (m, 2H), 7.75 – 7.52 (m, 10H), 7.39 (dddd, J = 14.0, 9.4, 5.5, 2.3 Hz, 11H),
7.33 – 7.18 (m, 5H), 7.12 (dd, J = 8.2, 6.6 Hz, 2H), 5.31 (d, J = 7.4 Hz, 3H), 5.08 – 4.78
(m, 6H), 4.67 (dd, J = 12.0, 1.5 Hz, 1H), 4.52 – 4.40 (m, 2H), 4.08 – 3.98 (m, 1H), 3.86 –
3.71 (m, 3H), 3.52 – 3.37 (m, 1H).
2-O-benzoyl-3,4-O-p-(2-naphthyl)-6-O-p-nitrobenzoyl- (1,4)-D-glucopyranosyl-

(4-

(1H,1H,2H,2H-perfluorodecyl)-beznyl)-2-azido-3-O-(2-trimethylsilylethoxymethyl)6-O-(tert-butyldiphenylsilyl)- -D-glucopyranoside (62). GlcN donor 61 (103 mg, 1
equiv) and GlcA acceptor 51 (240 mg, 1.5 equiv) were carefully azeotroped with toluene,
dried on a high vacuum line, and then dissolved in dry DCM (2.5 mL). 4 Å MS (100 mg)
were added and the reaction was stirred at room temperature for 30 minutes. NIS (90 mg,
2 equiv) was added and the reaction mixture was cooled to 0 °C. TfOH (1 µL, 0.1 equiv)
was added and the reaction was stirred at 0 °C until TLC indicates consumption of donor.
Upon completion, the reaction was quenched with diisopropylethylamine, filtered
through a pad of Celite, and concentrated. The residue was purified by column
chromatography to afford 104 mg (41%) of disaccharide 62 as a colorless oil. 1H NMR
(300 MHz, CDCl3)

8.10 – 8.03 (m, 2H), 7.87 (dd, J = 8.9, 1.9 Hz, 2H), 7.80 – 7.53 (m,

17H), 7.51 – 7.11 (m, 27H), 7.03 – 6.95 (m, 2H), 5.34 (t, J = 8.6 Hz, 1H), 5.10 – 4.77 (m,
8H), 4.75 – 4.65 (m, 1H), 4.61 (d, J = 7.2 Hz, 1H), 4.55 (d, J = 2.8 Hz, 2H), 4.48 – 4.36
(m, 3H), 4.02 (dd, J = 12.4, 9.6 Hz, 2H), 3.94 – 3.81 (m, 3H), 3.73 (d, J = 10.7 Hz, 2H),
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3.68 – 3.58 (m, 2H), 3.50 – 3.40 (m, 2H), 3.36 (s, 1H), 3.29 (d, J = 9.3 Hz, 1H), 3.18 (dt,
J = 11.2, 8.1 Hz, 1H), 2.99 – 2.85 (m, 2H), 2.85 – 2.72 (m, 2H), 2.25 (d, J = 19.0 Hz,
3H), 1.98 – 1.82 (m, 2H), 1.05 (s, 9H), 0.96 – 0.84 (m, 2H), -0.12 (d, J = 1.8 Hz, 9H).
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CHAPTER III – SYNTHESIS AND TESTING OF LITHIUM-ION BATTERY
ADDITIVES WITH PERFLUOROALKYL CHAINS
3.1 Introduction

3.1.1 Importance of Lithium-Ion Batteries
Rechargeable lithium-ion batteries (LIBs) have quickly become an important
energy source and storage medium for electronics in recent years. Current use for lithium
ion batteries includes electronics, but target applications for lithium-ion technologies
include high-power demand applications, such as transportation. Recent advances in
electrode materials chemistry has increase the capacity and power that LIBs are able to
deliver in these applications.1 However a number of challenges must be addressed before
LIBs are a viable energy storage solution in high capacity, high power applications.2 In
particular, the ability of a battery to cycle repeatedly with high capacity and discharge
rates. As batteries age over many cycles, a number of changes in the internal chemistry
occurs which ultimately reduces performance.3
LIBs function by shuttling lithium ions from the cathode to the anode for charge
storage (Figure 3.1). As current is drawn from the battery, the lithium ions move from the
anode back to the cathode. LIB cathodes and anodes are constructed from a lithium
mixed metal oxide composite and a graphitic composite respectively; these are physically
separated from each other by an ion-permeable polymer membrane and both placed in an

85
electrolyte solution. The most common electrolytes are simple organic carbonates, such
as dimethyl carbonate, ethyl methyl carbonate, or ethylene carbonate. These solvents are
compatible the lithium-ion source, which is typically lithium hexafluorophosphate
(LiPF6).

Li+

Li+

Li+

Li+

Li+

Li+
Li+

Li+

Li+

Li+

Li+
Li+

Li+

Anode

Cathode

Electron ﬂow during charge

Electrolyte
Electron ﬂow during discharge

Figure 3.1 Schematic of Lithium-ion Battery.

3.1.2 Challenges in Improving LIB Performance
There are a number of barriers limiting the performance of lithium-ion batteries.
An ever-present challenge is increasing the battery life, which is the number of times a
battery can be charged and discharged. In addition to reusability, other aspects of LIB
performance to be optimized include: energy density, power, durability, safety, and cost.
Cell capacity loss occurs primarily at the anode forming a solid-electrolyte interface
(SEI), while cell impedance rise occurs primarily due to thin film formation at the
cathode surface. Many efforts have been focused on designing more robust electrode
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materials, and numerous advances have been made in this regard. However, degradation
of LIB performance over many cycle numbers remains an issue.4 One area that has seen
relatively few developments is the electrolyte itself. Organic carbonates are relatively
inert to the voltages used in LIBs, but can still decompose at cathode or anode surfaces at
high cell potential over multiple cycles. Electrolyte degradation can affect battery
performance in various ways, such as decreasing the amount of free lithium ion present in
the electrolyte (cell capacity fade), or by decreasing the mobility of lithium ions to
migrate between cathode and anode (cell impedance rise).

3.1.3 Additive Approach to Improving LIB Performance
The use of additives in electrolyte formulations is a simple and practical method
to enhance the stability and performance of LIB electrodes.5 Additives have been
developed with diverse objectives in mind, including control over SEI formation,
stabilization of the cathode structure, stabilizing anions and salts, fire retardants, and
overcharge protection. Recent advancements in cathode materials have made cathode
protection a priority. In this regard, our collaborators at Argonne National Laboratory
have tested numerous additive compounds in their high-performance lithium-ion
batteries, but have not observed any performance enhancement using known,
commercially-available compounds. This indicates a need for novel additives that can
enhance LIB performance by protecting the battery electrodes through controlled SEI
formation.
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3.1.4 Perfluoroalkyl-Substituted Additives for LIBs
Perfluoroalkyl-modified materials are ideal candidates as additives designed to
protect LIB cathodes. First, perfluoroalkyl groups are chemically robust due to the
chemical stability of the C–F bond and their low polarizability.6 This feature allows
perfluoroalkyl groups to withstand the high cell potentials found in lithium-ion batteries.
Second, perfluoroalkyl groups have unique material and self-assembly properties. Due to
their low polarizability, perfluoroalkyl groups are difficult to solvate in most normal
organic solvents. For this reason perfluoroalkyl chains tend to self-assemble into
supramolecular structures, such as micelles, vesicles or bilayers.7 The ability of these
molecules to self-assemble is an attractive feature for protecting of battery electrode
surfaces. Ideally, the perfluoroalkyl-modified additives would be sacrificially oxidized at
the surface of the metal-oxide cathode at high voltages, and become chemically grafted to
the surface. This can initiate the deposition of more perfluoroalkylated compounds onto
the cathode surface, resulting in a self-assembled but chemically reactive thin film. The
oxidized layer of additive serves as a solvophobic passivating layer that can prevent
further oxidation of electrolyte at the cathode surface (Figure 3.2). A similar surface
modification can be envisioned at the graphitic anode, if desired.

88

A

Electroactive Headgroup

Solvophobic Tail

B

Electrode (anode or cathode)

Figure 3.2 Proposed mechanism of cathode protection using oxidatively reactive
additives. (A) Additive design; (B) Proposed mode of action.

With the above design in mind (Figure 3.2), we plan to synthesize a number of
perfluoroalkyl-functionalized additives. The additives will consist of an electroactive
headgroup, which will be oxidized at lower potentials than the carbonate solvent that
comprises the electrolyte solution. The headgroup will either directly react with the
electrode surface or polymerize on the surface to produce a stable coating. The additives
will also feature a perfluoroalkyl group to promote self-assembly into larger structures as
well as provide a solvophobic barrier at the electrode surface.

3.2 (2-Perfluorooctyl)Ethyl Vinyl Sulfone
(2-Perfluorooctyl)ethyl vinyl sulfone 63 was synthesized in two steps.
Photochemical addition of perfluorooctyl iodide to divinyl sulfone was completed using
300 nm irradiation to produce a single PFO chain per molecule of divinyl sulfone. This
intermediate, after workup, was dehalogenated using indium hydride generated in situ8 to
afford the desired (2-perfluorooctyl)ethyl vinyl sulfone 63 in 33% yield over 2 steps
(Figure 3.3).
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Figure 3.3 Synthesis of (2-perfluorooctyl)ethyl vinyl sulfone.

(2-perfluorooctyl)ethyl vinyl sulfone 63 was evaluated as an additive in a LIB at
1–2% w/v in “Gen2” electrolyte, which consists of 1.2 M LiPF6 in 7:3 ethylene
carbonate:ethyl methyl carbonate. 1 wt% of 63 shows significant degradation of cell
cycle performance (Figure 3.4), whereas no detriment or improvement to cell cycle
performance (data not shown) occurred when 2 wt% of 63 was used. This was attributed
to the reduction of the vinyl sulfone on the LIB anode, preventing the intercalation of
lithium ions into the graphitic electrode.

Discharge (mAh/g)
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Figure 3.4 Cycle versus discharge capacity, with and without 1 wt% vinyl sulfone 63.

3.3 The Perfluoroalkyl Ethylene Carbonate Series
Perfluoroalkyl-substituted ethylene carbonates (PFA-ECs) were investigated as
fluorous analogues of ethylene carbonate, the primary solvent present in lithium-ion
batteries. These compounds could easily be prepared from common perfluorinated
starting materials, although the presence of the PFA group was not expected to promote
oxidative degradation on the LIB cathode. Perfluoroalkyl ethylenes were dihydroxylated
using KMnO4 under biphasic conditions.9 These 1,2-diols 64a-d were then treated with
triphosgene to afford PFA-ECs 65a-d in good yields (Figure 3.5).10

91

Figure 3.5 Synthesis of PFA-EC derivatives 65a-d.

PFA-ECs 65a-d were tested as previously described in the “Gen2” electrolyte
mixture in LIB coin cells. Discharge capacity versus cycle number data for 65a, 65b, and
65c are shown in Figures 3.6, 3.7, and 3.8 respectively; Perfluorodecyl-EC 65d was
insufficiently soluble in “Gen2” electrolyte to allow for accurate measurements. The
control experiment with unadulterated “Gen2” electrolyte showed a 14.5% capacity loss
over 25 cycles, whereas the capacity losses were 13.2%, 16.3% and 8.9% for 65a, 65b,
and 65c respectively, at 0.5 wt% additive loading. Similar trends were also noted for
loadings of 1 wt%.
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Figure 3.6 Cycle versus discharge capacity,
with and without perfluorobutyl-EC (PFB-EC) 65a.
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Figure 3.7 Cycle versus discharge capacity,
with and without perfluorohexyl-EC (PFH-EC) 65b.
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Figure 3.8 Cycle versus discharge capacity,
with and without perfluorooctyl-EC (PFO-EC) 65c.

Of the three PFA-EC derivatives tested, only 65c exhibited significant reduction
in capacitive loss in the LIB coin cell system. With this promising lead in hand, cell
discharge capacity was extended to 200 cycles (Figure 3.9). The comparison between the
“Gen2” and 0.5 wt% 65c was striking. The “Gen2” control retains only 27% of its
discharge capacity after 200 cycles, as compared to the cell containing 0.5 wt% 65c,
which retained 66% of its discharge capacity.
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Figure 3.9 Cycle versus discharge capacity over 200 cycles,
with and without 0.5 wt% PFO-EC 65c.

Additionally, 65c exhibited improved performance with respect to impedance in
the LIB coin cell system. Prior to cycling, there is no difference in impedance between
the control cell and the cell that contained 0.5 wt% 65c (data not shown). However when
after 200 cycles, 0.5 wt% 65c produced significantly lower impedance rise relative to the
“Gen2” control cell (Figure 3.10).
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Figure 3.10 AC impedance spectra, with and without PFO-EC (65c), after cell cycling.

3.4 Perfluorooctyl-Substituted Thiophenes
Thiophenes are polymerizable under oxidative conditions, and are candidate
additives for protecting the cathode of lithium-ion batteries. Thiophene structures
polymerize at the cathode to produce a more robust cathode-electrolyte interface, which
extends cycling lifetime and reduces cell impedance increase.11 Methyl 2-carboxy-3aminothiophene was oxidized into diazonium tetrafluoroborate salt 66 using amyl nitrite
and BF3•Et2O, then subjected to Heck coupling with perfluorooctyl ethylene and
Pd(OAc)2 to afford fluorous conjugated thiophene 67 in excellent yield. The ester was
saponified and decarboxylated under Hunsdiecker conditions12 to afford vinyl PFOsubstituted thiophene 68 in good yield. The intermediate Heck product was also reduced
using palladium on carbon under hydrogen to afford the reduced thiophene ester 69.
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Saponification and protodecarboxylation afforded the reduced PFO-functionalized
thiophene 70 (Figure 3.11).

Figure 3.11 Synthesis of perfluorooctyl(vinyl) thiophene (68)
and perfluorooctyl(ethyl) thiophene (70).

Thiophene derivatives 68 and 70 were tested as electrolyte additives in LIB coin
cells as previously described. Compound 68 was shown to have no significant effect on
cycle performance at 0.5 wt% or 2 wt% concentrations versus control with no additive
(Figure 3.12). Additional half-cell experiments were conducted to determine which
electrode was reacting with the additive; in the case, thiophene preferentially reduced at
the anode, rather than oxidized at the cathode (data not shown). We attribute this to the
susceptibility of the vinylene linkage in 68 to electrochemical reduction under
charge/discharge conditions.
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Figure 3.12 Cycle versus discharge capacity,
with and without 3-(PFO-vinylene) thiophene (68).

We then tested PFO-ethylene thiophene 70 as an electroactive additive under
similar conditions. Again, there was no significant improvement in performance at either
0.5 or 1 wt% versus unadulterated electrolyte (Figure 3.13). It is worth noting that neither
68 nor 70 caused any detriment to the battery system, 68 or 70 which may be a useful
factor when modifying other battery properties.
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Figure 3.13 Cycle versus discharge capacity,
with and without 3-(PFO-ethylene) thiophene (70).

3.5 p-(Perfluorooctylphenyl) Diphenylphosphine Oxide
Phosphines and phosphine oxides are also candidates as LIB additives.
Phosphines are more prone to oxidation than the carbonate electrolyte solutions and thus
are sacrificially oxidized at the cathode as opposed to the carbonate electrolyte. A layer
may result preventing further electrolyte decomposition products from depositing on the
cathode

surface.13

Perfluorooctyl

iodide

was

coupled

with

p-

(iodophenyl)diphenylphosphine oxide to PFO-substituted triphenylphosphine oxide 71 in
good yield (Figure 3.14). Compound 71 was tested as an electrolyte additive in a LIB
coin cell as previously described, but did not result in improved cycling performance
(data not shown).
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Figure 3.14 Synthesis of p-(perfluorooctylphenyl) diphenylphosphine oxide 71.

3.6 Boronic Esters of 2-(Perfluoroalkyl)ethylene Glycols
With successful tests with the PFA-EC derivatives in hand, we sought to explore
other structures utilizing the PFA ethylene glycol moiety. Perfluorodecyl ethylene glycol
62d was condensed with benzene boronic acid to afford phenylboronic ester 72 in good
yield (Figure 3.14). Phenylboronic ester 72 was tested in coin cells as previously
described, but solubility in the “Gen2” electrolyte was poor, due to the perfluorodecyl
group present. Shorter perfluoroalkyl derivatives may be synthesized in the future that
would allow the study of their phenyl boronic esters as electrolyte additives.

Figure 3.15 Synthesis of 2-perfluorodecyl ethylene glycol phenyl boronic ester 72.

3.7 Conclusions
A number of novel molecules were synthesized with perfluoroalkyl tails and their
performance as LIB additives were tested. Many molecules tested did not have beneficial
effects on LIB performance, or protect the cathode, and some were preferentially reactive
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at the anode. Perfluorooctyl ethylene carbonate (PFO-EC) 65c was identified early as a
promising additive in LIB performance testing, and a series of PFA-EC derivatives was
prepared to probe the role of perfluoroalkyl chain length. However, performance
evaluation of derivatives with longer or shorter perfluoroalkyl chains showed no benefit.
Investigations of other PFA derivatives with different headgroups were also initiated,
some of which merit further study.

3.8 General Methods and Experimentals
All starting materials and reagents were obtained from commercial sources and
used as received unless otherwise noted. All solvents were freshly distilled prior to use.
1

H NMR spectra were recorded at 300 or 400 MHz; 13C NMR spectra were recorded at

75 or 100 MHz.

19

F NMR spectra were recorded at 282 MHz.

31

P NMR spectra were

recorded at 121 MHz. Chemical shifts were referenced to the solvent used ( 7.27 and
77.00 for CDCl3,

3.31 and 49.15 for CD3OD, and

4.80 in D2O). Mass spectra were

acquired using either a Hewlett-Packard 5989B or a Finnigan 40000 mass spectrometer

(2-Perfluorooctyl)ethyl vinyl sulfone (63). Divinyl sulfone (1 eq, 240 mg, 2.0 mmol)
and perfluorooctyl iodide (1.1 eq, 600 µL, 2.3 mmol) were dissolved in 5 mL of DCM in
a quartz reaction tube. The reaction mixture was irradiated with 300 nm UV light for 6
hours. The reaction mixture was concentrated by rotary evaporation to afford an offwhite solid and was used without further purification in the next step.
InCl3 (6 mg, 20 mol%) and triethylsilane (100 µL, 4 eq) were dissolved in THF
and stirred at rt for 10 minutes. The crude PFO intermediate iodide was added to the THF
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solution, followed by the addition of triethylborane (50 µL, 1M in hexane, 20 mol%).
The reaction mixture was stirred at rt for 4 hours until TLC determined reaction
complete. The reaction was quenched with water and extracted with diethyl ether.
Extracts were dried over sodium sulfate and concentrated by rotary evaporation. The
crude solid was dissolved in refluxing hexane and allowed to crash out at rt to afford pure
(2-Perfluorooctyl)ethyl vinyl sulfone 63 as a white solid (534 mg, 33% over 2 steps). 1H
NMR (300 MHz, CDCl3)

7.01 (dd, J = 16.6, 9.9 Hz, 1H), 6.43 (d, J = 16.6 Hz, 1H),

6.36 (d, J = 9.9 Hz, 1H), 3.52 – 3.40 (m, 2H), 2.81 – 2.60 (m, 2H).

2-(Perfluorooctyl)ethylene glycol (64c). Cetyltrimethylammonium bromide (350 mg,
0.96 mmol) and 1H,1H,2H-perfluorodecene (1.05 mL, 3.95 mmol) were dissolved in
dichloromethane (50 mL). A 6.8% aqueous solution of potassium permanganate (100
mL) was added, and the reaction was stirred vigorously for 3 hours. The biphasic mixture
was filtered through a pad of Celite and separated; the organic phase was washed with
brine, dried over sodium sulfate, and concentrated to dryness. The residue was
redissolved in acetone and passed through a short silica plug, then concentrated to
dryness to afford glycol 64c as a white solid (0.94 g, 50%). 1H NMR (300 MHz, acetoned6):

4.28 (m, 1H), 4.02–3.67 (m, 2H).

13

C NMR (75 MHz, acetone-d6):

122.7-108.3

(8C), 71.49 (1C), 61.09 (1C).

2-(Perfluorobutyl)ethylene glycol (64a). (Perfluorobutyl)ethylene glycol was prepared
in the same manner as above in 70% yield. 1H NMR (300 MHz, acetone-d6)
2H), 4.45 – 4.12 (m, 1H), 4.01 – 3.63 (m, 2H).

5.27 (s,
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2-(Perfluorohexyl)ethylene glycol (64b). (Perfluorohexyl)ethylene glycol was prepared
in the same manner as above in 66% yield. 1H NMR (300 MHz, acetone-d6)

5.96 (s,

1H), 4.95 (s, 1H), 4.31 (m, 1H), 3.96 – 3.71 (m, 2H).

2-(Perfluorodecyl)ethylene glycol (64d). (Perfluorodecyl)ethylene glycol was prepared
in the same manner as above in 46% yield. 1H NMR (300 MHz, acetone-d6) 4.38 – 4.19
(m, 1H), 3.93 – 3.70 (m, 2H).

2-(Perfluorooctyl) ethylene carbonate (65c). Diol 64c (940 mg, 1.96 mmol) was
dissolved in tetrahydrofuran (20 mL) and stirred at 0 °C, then treated sequentially with
triethylamine (600 µL, 4.31 mmol) and triphosgene (210 mg, 0.71 mmol). The reaction
mixture was warmed to rt over 2 hours with stirring, and then neutralized with saturated
aqueous NaHCO3. The product was extracted with diethyl ether, dried over sodium
sulfate and concentrated, then recrystallized from chloroform to afford 2-(Perfluorooctyl)
ethylene carbonate 65c a white solid (785 mg, 79%). 1H NMR (300 MHz, acetone-d6):
5.74 (m, 1H), 5.16 – 4.75 (m, 2H). 13C NMR (101 MHz, acetone-d6)

153.66 (1C),

122.7-108.3 (8C), 72.01 (1C), 64.41 (1C).

2-(Perfluorobutyl)ethylene carbonate (65a). 2-(Perfluorobutyl)ethylene carbonate 65a
was prepared in the same manner as above in 48% yield (560 mg). 1H NMR (300 MHz,
acetone-d6)

5.82-5.65 (m, 1H), 5.00 (dd, J = 9.7, 8.7 Hz, 1H), 4.88 (dd, J = 9.7, 4.7 Hz,

1H). 13C NMR (75 MHz, acetone-d6)
(1C).

153.81 (1C), 122.8-108.1 (4C), 72.06 (1C), 64.53
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2-(Perfluorohexyl)ethylene carbonate (65b). 2-(Perfluorobutyl)ethylene carbonate 65b
was prepared in the same manner as above in 62% yield (630 mg). 1H NMR (400 MHz,
acetone-d6)
1H).

13

5.83 – 5.65 (m, 1H), 4.99 (dd, J = 9.6, 8.8 Hz, 1H), 4.87 (dd, J = 9.6, 4.7,

C NMR (101 MHz, acetone-d6)

153.64 (1C), 122.6-108.4 (6C), 72.01 (1C),

64.40 (1C).

2-(Perfluorodecyl)ethylene carbonate (65d). 2-(Perfluorobutyl)ethylene carbonate 65d
was prepared in the same manner as above in 82% yield (1.26 g). 1H NMR (400 MHz,
acetone-d6)

5.73 (m, 1H), 4.99 (t, J = 9.2 Hz, 1H), 4.87 (dd, J = 9.8, 4.7 Hz, 1H). 13C

NMR (101 MHz, acetone-d6) 153.65 (1C), 122.9-108.3 (10C), 72.00 (1C), 64.40 (1C).

Methyl 1-carboxylate-2-(perfluorooctyl)vinyl thiophene (67). Methyl 3-amino-2carboxythiophene (622 mg, 4.0 mmol, 1 eq) was dissolved in 20 mL THF and cooled to –
40 °C. Amyl nitrite (1.0 mL, 8.0 mmol, 2 eq) and BF3-Et2O (1.5 mL, 12.0 mmol, 3 eq)
were added sequentially. The reaction was allowed to warm to rt. The product was
precipitated out of solution by adding diethyl ether (20 mL) and filtered to obtain
diazonium salt 66 as a white solid in quantitative yield (1022 mg). This solid was used
without further purification.
The diazonium intermediate (242 mg, 0.95 mmol) was suspended in 10 mL
methanol and degassed under a stream of argon. Perfluorooctylethylene (300 µL, 1.1
mmol, 1.1 eq) and Pd(OAc)2 (40 mg, 0.19 mmol, 20 mol%) were added. The reaction
was carefully heated to 50 °C, which generated copious amounts of gas. When
effervescence ceased, the reaction mixture was cooled and concentrated. Then was
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passed through a silica gel plug to afford PFO-substituted thiophene 67 as a white solid in
80% yield (460 mg). 1H NMR (300 MHz, CDCl3)

8.13 (dt, J = 16.3, 2.4 Hz, 1H), 7.50

(dd, J = 5.3, 0.7 Hz, 1H), 7.33 (d, J = 5.3 Hz, 1H), 6.33 – 6.05 (m, 1H), 3.92 (s, 3H).

2-(Perfluorooctyl)vinyl thiophene (68). Methyl 1-carboxylate-2-(perfluorooctyl)vinyl
thiophene 67 (460 mg, 0.79 mmol, 1 eq) was dissolved in 9:1 ethanol:water (10 mL) and
treated with lithium hydroxide (40 mg, 2 eq). The reaction mixture was heated for 4
hours at reflux, then cooled to rt. Extracted with diethyl ether and concentrated to afford
427 mg (95% yield) of the free carboxylic acid, which was used without purification.
Free carboxylic acid prepared above (427 mg, 0.90 mmol, 1 eq) was dissolved in
DMSO and treated with 10% Ag2CO3 (25 mg) and 5% HOAc (3

L). The reaction

mixture was heated at 120 °C for 2.5 hours. The reaction was extracted with diethyl ether,
washed with brine three times, dried over sodium sulfate and concentrated by rotary
evaporation to afford PFO-substituted thiophene 68 as a colorless oil in 89% yield (350
mg). 1H NMR (300 MHz, CDCl3)

7.57 – 7.07 (m, 4H), 6.05 (dt, J = 16.0, 12.2 Hz,

1H).

Methyl 1-carboxylate-2-(perfluorooctyl)ethyl thiophene (69). Methyl 1-carboxylate-2(perfluorooctyl)vinyl thiophene 67 (1860 mg, 3.17 mmol, 1 eq) was dissolved in 1:1
methanol:ethyl acetate (25 mL) and treated with Pd/C (50 mg) under a hydrogen
atmosphere at rt o/n. The reaction mixture was filtered through Celite to remove Pd/C
and concentrated to afford reduced thiophene 69 as a colorless oil in 98% yield (1819
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mg). 1H NMR (300 MHz, CDCl3)

7.47 (d, J = 5.2 Hz, 1H), 6.98 (d, J = 5.1 Hz, 1H),

3.89 (s, 3H), 3.37 – 3.20 (m, 2H), 2.43 (m, 2H).

2-(Perfluorooctyl)ethyl thiophene (70). 2-(perfluorooctyl)ethyl thiophene was prepared
in the same manner as 68. Thiophene 70 was obtained as a pale yellow liquid in 70%
yield over two steps (1.12 grams). 1H NMR (300 MHz, CDCl3)

7.31 (ddd, J = 4.7, 3.0,

1.1 Hz, 1H), 7.03 (dt, J = 2.7, 1.2 Hz, 1H), 6.97 (dd, J = 5.0, 1.3 Hz, 1H), 3.02 – 2.90 (m,
2H), 2.40 (ddt, J = 26.6, 17.9, 8.5 Hz, 2H). 19F NMR (282 MHz, CDCl3)

-82.31 (t, J =

10.1 Hz), -116.34 (m), -122.79 – -123.85 (m), -124.30 (d, J = 19.8 Hz), -124.71 – -125.52
(m), -127.16 – -128.08 (m).

Perfluorooctyl(phenyl)

diphenylphosphine

oxide

(71).

4-(iodophenyl)

diphenylphosphine oxide (808 mg, 2.0 mmol), which was prepared according to literature
procedure14, was then dissolved in DMSO (20 mL). Cu dust (545 mg, 10 mmol, 5 eq) and
perfluorooctyl iodide (900 µL, 3.5 mmol, 1.5 eq) were added. The reaction mixture was
degassed by bubbling argon for 10 minutes, then heated at 90 °C for 12 hours, then the
reaction was cooled and filtered through Celite, then was diluted with 100 mL of diethyl
ether and washed with brine (3x 100 mL) to remove DMSO. The organic extracts were
dried over sodium sulfate, filtered, concentrated by rotary evaporation, then was purified
by column chromatography using 0–10% of ethyl acetate in hexane to afford PFOsubstituted phosphine oxide 71 as a white solid in 51% yield (710 mg). 1H NMR (300
13

MHz, CDCl3)

7.83 (dd, J = 11.4, 7.9 Hz, 2H), 7.76 – 7.40 (m, 12H).

MHz, CDCl3)

138.01, 136.67, 132.27, 132.14, 131.96, 131.83, 130.71, 128.69, 128.52,

C NMR (75

106
126.92, 126.84, 126.76, 120–105 (8C). 19F NMR (282 MHz, CDCl3) -82.50 , -112.86 , 122.87 , -123.23 , -123.55 , -124.39 , -127.81 . 31P NMR (121 MHz, CDCl3) 29.06.

Perfluorodecyl ethylene glycol benzene boronic ester (72). 2-Perfluorodecyl ethylene
glycol 64d (1.11g, 1.83 mmol) was dissolved in trifluorotoluene (20 mL) and treated with
benzene boronic acid (228 mg, 1.88 mmol, 1.03 eq). The reaction mixture was heated at
90 °C for 12 hours. The reaction was concentrated by rotary evoparation and was
subjected to silica gel chromatography using 20–30% ethyl acetate in hexane to afford
boronic ester 72 as a white solid in 85% yield (1.09 g). 1H NMR (300 MHz, CDCl3)
7.90 – 7.72 (m, 2H), 7.60 – 7.47 (m, 1H), 7.47 – 7.35 (m, 2H), 5.07 (m, 1H), 4.67 – 4.48
(m, 2H).
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A new family of polyﬂuoroalkyl-substituted ethylene carbonates is synthesized and tested as additives in
lithium-ion cells containing EC:EMC þ LiPF6-based electrolyte. The inﬂuence of these compounds is
investigated in Li1.2Ni0.15Mn0.55Co0.1O2//graphite cells via a combination of galvanostatic cycling and
electrochemical impedance spectroscopy (EIS) tests. Among the four additives studied in this work (4(triﬂuoromethyl)-1,3-dioxolan-2-one (TFM-EC), 4-(perﬂuorobutyl)-1,3-dioxolan-2-one (PFB-EC), 4-(perﬂuorohexyl)-1,3-dioxolan-2-one (PFH-EC), and 4-(perﬂuorooctyl)-1,3-dioxolan-2-one (PFO-EC)), small
amounts (0.5 wt%) of PFO-EC is found to be most effective in lessening cell performance degradation during
extended cycling. Linear sweep voltammetry (LSV), X-ray photoelectron spectroscopy (XPS) and Raman
spectroscopy are used to further characterize the effects of PFO-EC on the positive and negative electrodes.
LSV data from the electrolyte, and XPS analyses of electrodes harvested after cycling, suggest that PFO-EC is
oxidized on the cathode forming surface ﬁlms that slow electrode/cell impedance rise. Differential capacity
(dQ/dV) plots from graphite//Li cells suggest that PFO-EC is involved in solid electrolyte interphase (SEI)
formation. Raman data from anodes after cycling suggest that structural disordering of graphite is reduced
by the addition of PFO-EC, which may explain the improved cell capacity retention.
! 2013 Elsevier B.V. All rights reserved.
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High-capacity lithium- and manganese-rich metal oxides are
gaining increased attention because of their ability to deliver
high rechargeable capacities; when cycled between 2.0 and 4.7 V
vs. Li, a rechargeable capacity of 270 mAh-g#1 can be routinely
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obtained [1]. Hence lithium-ion cells containing the Li2MnO3stabilized LiMO2 (M ¼ Mn, Ni, Co) positive electrodes, graphite
negative electrodes and EC:EMC (3:7 by wt.) þ 1.2 M LiPF6-based
electrolyte (henceforth referred as Gen2 electrolyte) can be
designed to meet the target cell speciﬁc capacity of 300 Wh kg#1
for transportation applications [2,3]. However, the target battery
cycle life of up to 1000 chargeedischarge cycles at 80% depth of
discharge (DOD) can only be achieved through new electrolyte
formulations because these cells show signiﬁcant performance
degradation on extended cycling [4]. Extensive diagnostic
studies indicate that cell impedance rise mainly arises at the
positive electrode, and cell capacity fade mainly results from
lithium trapping in the solid electrolyte interphase (SEI) at the
negative electrode [4e6]. During electrochemical aging, both
electrodes undergo a cycle of surface ﬁlm formation, decomposition, dissolution, and redeposition; this process results in the
continuous consumption of lithium ions, thereby reducing cell
capacity and often increasing cell impedance [7e9].
Electrolyte additives are known to be an effective and economic approach to improving the stability of electrode surface
ﬁlms [10]. In the past two decades, many organic and inorganic
compounds have been identiﬁed as effective electrolyte additives: examples include vinylene carbonate (VC) [11,12], ethylene
sulﬁte (ES) [13], vinyl ethylene carbonate (VEC) [14,15], and ﬂuoroethylene carbonate (FEC) [16]. In recent years, with the
emergence of many high-voltage cathode materials, the anodic
stability of common electrolytes is recognized as the main
bottleneck limiting the calendar- and cycle-life of high-energy
lithium-ion cells [17]. Therefore, more attention has been
devoted to improving stability of the cathodeeelectrolyte interface [6,18e25]. As part of DOE’s Advanced Battery Research (ABR)
program, we have been examining ways to mitigate performance
degradation of cells containing Li1.2Ni0.15Mn0.55Co0.1O2 (0.5Li2MnO3$0.5LiMn0.375Ni0.375Co0.25O2)-based positive electrodes (LMRNMC) that are cycled at voltages beyond 4.5 V versus Li. Initial
studies indicate that common electrolyte additives such as VC,
VEC, and FEC are not effective at enhancing long-term cycling
performance of these cells, i.e. stable electrode passivation could
not be achieved with traditional SEI-forming additives. This
observation underscores the need for new electrolyte additives
that effectively form stable electrode passivation ﬁlms in highenergy and high-voltage lithium-ion cells.
Polyﬂuoroalkyl (PFA) compounds are well known for their
high chemical stabilities, and exhibit both hydrophobic and lipophobic behaviors. Upon dispersing in organic solvents, solvophobic PFAs tend to aggregate and form micelles in solution
[26]. These types of compounds have been extensively used as
ﬂuorosurfactants, and are especially valuable as additives in stain
repellents [27]. In light of these facts, we envision that
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Scheme 1. Schematic representation illustrating the formation of double-layer
passivation ﬁlms via (i) decomposition of the headgroup on electrode surface forming an inner layer; (ii) self-assembly of tails on these inner layers forming a solvophobic outer layer.

compounds containing PFAs could serve as a new type of electrolyte additive, forming double-layered passivating layers that
reduce both electrode surface degradation and electrolyte
decomposition. In our design, the PFA additive has two components: (i) a reactive headgroup for attachment onto electrode
surfaces via either reductive or oxidative decomposition, so that it
becomes an integral part of the surface layer (inner layer); (ii) a
polyﬂuoroalkyl chain that self-assembles on this inner layer as a
solvophobic layer (outer layer) that is highly stable and impermeable to the electrolyte solvent. A schematic representation of
this idea is shown in Scheme 1.
To explore this novel idea, we synthesized a series of PFAsubstituted ethylene carbonates (PFA-EC) and studied them as electrolyte additives in our lithium-ion cells. Cell performance was
characterized using a combination of galvanostatic cycling and
electrochemical impedance spectroscopy (EIS) techniques, and supplemented by linear sweep voltammetry (LSV), X-ray photoelectron
spectroscopy (XPS) and Raman spectroscopy data. Of the various
PFA-EC compounds studied, we determined that perﬂuorooctylsubstituted ethylene carbonate (PFO-EC) most signiﬁcantly improves the long-term cycling performance of our cells.
2. Experimental
2.1. Materials and synthesis
All chemicals used in the synthesis of polyﬂuoroalkyl compounds
were purchased from commercial suppliers and used without further
puriﬁcation. 4-(triﬂuoromethyl)-1,3-dioxolan-2-one (TFM-EC) was
purchased from Synquest Laboratories, Inc. (United States); all other
polyﬂuoroalkyl-ECs were synthesized by a two-step reaction
sequence (Scheme 2). Newly synthesized compounds were characterized by 1H, 13C, and 19F NMR spectroscopy, using a 300- or 400-MHz
spectrometer. All chemical shift values (d) are reported in ppm,
referenced relative to TMS (1H and 13C) or CFCl3 (19F).

Scheme 2. Synthesis of polyﬂuoroalkyl (PFA)-substituted ethylene carbonates.
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Table 1
Summary of Li1.2Ni0.15Mn0.55Co0.1O2//graphite full cells cycling data using Gen2 electrolytes with or without various PFA-EC derivatives.
Discharge capacity (mAh g(oxide)#1)a

Gen2
TFM-EC
PFB-EC
PFH-EC
PFO-EC

e
0.5 wt%
1 wt%
0.5 wt%
1 wt%
0.5 wt%
1 wt%
0.5 wt%
1 wt%

Initial

After 25 cycles

256.4
266.4
260.5
256.2
266.3
258.3
261.0
261.2
263.9

219.2
235.2
232.3
222.5
229.9
216.2
217.2
238.0
238.4

Capacity fade
(mAh g#1/percentage)

Capacity fade
per cycle (mAh g#1)

37.2/14.5%
31.2/11.7%
28.2/10.8%
33.7/13.2%
36.4/13.7%
42.1/16.3%
43.8/16.8%
23.2/8.9%
25.5/9.7%

1.49
1.25
1.13
1.35
1.46
1.68
1.75
0.93
1.02

a

Cells were cycled between 2.2 and 4.6 V at 30 $ C; the 15 mA g(oxide)#1 current cycle data provide a good measure of “true capacity,” as a low current minimizes ohmic
polarization effects in capacityevoltage proﬁles.

2.2. Electrochemical cycling tests and electrode surface
characterization

w90 wt% graphite, 4 wt% carbons (SuperP), and 6 wt% PVdF; the
coating is 35 mm thick and the graphite loading is 5.6 mg cm#2.
Other details on cell components and chemistry can be found in a
previous article [6].
The electrochemical anodic stability of electrolytes is examined
by linear sweep voltammetry (LSV) using a three-electrode system.
Platinum is used as the working electrode, and lithium metal as the
counter and reference electrodes. LSV data are obtained at room
temperature (23 $ C) using a scan rate of 20 mV s#1 from the open
circuit voltage (OCV) (ca. 3 V) to 5.5 V. The reduction behavior of
electrolytes is investigated in graphite//Li coin cells. The onset potential of the reduction reaction, determined from the differential
capacity curve (dQ/dV vs. V), is deﬁned as the reduction potential.
Electrochemical cycling experiments are conducted in 2032type coin cells, which are galvanostatically cycled at a constant
temperature of 30 $ C. The electrodes are weighed on an analytical
balance (Mettler Toledo, XS105; 0.1 mg resolution) to conﬁrm the
active material loading. Formation cycling of full cells is conducted
using a two-step protocol: three cycles between 2.2 and 4.1 V to
enable complete wetting of the electrochemically active surfaces,
followed by two cycles between 2.2 and 4.6 V to “activate” the oxide
material; a 0.16 mA (wC/15 rate) current is used in both steps.
Extended cycling in the 2.2e4.6 V voltage range is conducted with a
higher current (0.8 mA, wC/3 rate). Low current (0.16 mA) data are
obtained periodically to monitor cell capacity because such cycling
minimizes the effect of cell impedance. AC impedance measurements are conducted periodically with an EG&G 273A potentiostat
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In a typical synthesis, cetyltetramethylammonium bromide
(350 mg, 0.96 mmol) and 1H,1H,2H-perﬂuorodecene (1.05 mL,
3.95 mmol) were dissolved in dichloromethane (50 mL), then
treated with a 6.8% aqueous solution of potassium permanganate
(100 mL). The biphasic reaction mixture was stirred vigorously for
3 h, then ﬁltered through a pad of Celite and separated. The organic
phase was washed with brine, dried over sodium sulfate, and
concentrated. The residue was redissolved in acetone and passed
through a silica gel plug, then concentrated to dryness to obtain
1H,1H,2H-perﬂuorodecane-1,2-diol as a white solid (0.94 g, 50%).
The NMR characterization data for this compound are as follow: 1H
NMR (400 MHz, acetone-d6): d 4.28 (m, 1H), 4.02e3.67 (m, 2H). 13C
NMR (100 MHz, acetone-d6): d 122.7e108.3 (m), 71.49 (t,
J ¼ 22.6 Hz), 61.1 (s).
1H,1H,2H-perﬂuorodecane-1,2-diol (940 mg, 1.96 mmol) was
dissolved in tetrahydrofuran (20 mL) and stirred at 0 $ C, then treated
sequentially with triethylamine (600 mL, 4.31 mmol) and triphosgene (210 mg, 0.71 mmol). The reaction mixture was warmed to
room temperature over 2 h with stirring, then neutralized with
saturated aqueous NaHCO3. The product was extracted with diethyl
ether, dried over sodium sulfate and concentrated, then recrystallized from chloroform to obtain PFO-EC as a white solid (785 mg,
79%). The NMR characterization data for this compound are as
follow: 1H NMR (400 MHz, acetone-d6): d 5.74 (m,1H), 5.16e4.75 (m,
2H). 13C NMR (100 MHz, acetone-d6): d 153.6 (s), 122.7e108.3 (m),
72.0 (dd, J ¼ 22.2, 33.6 Hz), 64.4 (s). 19F NMR (363 MHz, acetone-d6):
d #78.1 (s, 3F), #116.6 to #127.2 (m, 14F).
Perﬂuorobutyl (PFB)- and perﬂuorohexyl (PFH)-substituted ECs
were synthesized in a similar fashion from 1H,1H,2H-perﬂuorohexene and -octene respectively, in 48% and 62% overall yield.
The NMR characterization data for these two compounds are as
follow: PFB-EC: 1H NMR (300 MHz, acetone-d6): d 5.82e5.65 (m,
1H), 5.00 (dd, 1H, J ¼ 8.7, 9.7 Hz), 4.88 (dd, 1H, J ¼ 4.7, 9.7 Hz). 13C
NMR (75 MHz, acetone-d6): d 153.81 (s), 122.8e108.1 (m), 72.1 (dd,
J ¼ 22.3, 33.6 Hz), 64.5 (s). PFH-EC: 1H NMR (400 MHz, acetone-d6)
d 5.83e5.65 (m, 1H), 4.99 (dd, 1H, J ¼ 8.8, 9.6 Hz), 4.87 (dd, 1H,
J ¼ 4.7, 9.6 Hz). 13C NMR (100 MHz, acetone-d6): d 153.64 (s), 122.6e
108.4 (m), 72.0 (dd, J ¼ 22.3, 33.7 Hz), 64.4 (s).
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The baseline electrolyte 1.2 M LiPF6 in EC:EMC (3:7 by weight)
(Gen2) is from Tomiyama Chemical Industry (Japan). The positive
electrode comprises a 15 mm thick Al current collector coated with a
composite of 86 wt% Li1.2Ni0.15Mn0.55Co0.1O2, 6 wt% carbons
(SuperP and SFG-6), and 8 wt% PVdF; the coating is 35 mm thick and
the oxide loading is 6.6 mg cm#2. The negative electrode comprises
a 10 mm thick Cu current collector coated with a composite of
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Fig. 1. Cell discharge capacity vs. cycle number plots for Li1.2Ni0.15Mn0.55Co0.1O2//
graphite full cells using Gen2 electrolytes with or without PFA-EC additives (0.5 wt%).
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and a Solartron SI1260 frequency response analyzer controlled by
ZPLOT measurement software. The cells are charged to 3.75 V and
held for 4 h before data are collected in the potentiostatic mode, at
30 $ C in the 100 kHz to 10 mHz frequency range, with a 10 mV
perturbation around 3.75 V [28].
After the extended cycling, cells are discharged to, and held at,
2 V for 24 h before disassembly in an Ar-atmosphere glove box. The
harvested electrodes are then examined by various electrochemical
and physicochemical characterization tests. X-ray photoelectron
spectroscopy (XPS) spectra on positive electrode samples are obtained with a Kratos Axis Ultra X-ray photoelectron spectrometer
under ultrahigh vacuum (10#9 Torr) conditions and with monochromatic Al Ka (1486.6 eV) radiation as the primary excitation
source. Survey spectra are collected at a constant pass energy of
160 eV from a w1.0 mm2 area of the sample. High-resolution
spectra of the C1s, O1s, F1s, Li1s, P2p, and Mn2p core levels are
collected at a pass energy of 20 eV and an energy step size of
100 meV with the same spot size. The acquired data are from a
depth of w2e5 nm from the electrode surface. Peak ﬁts of all
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spectra are performed using the Shirley background correction and
GaussianeLorentzian curve synthesis. The energy scale is adjusted
based on the graphite peak in the C1s spectrum at 284.5 eV. Raman
spectra on negative electrode samples were obtained on a
Renishaw InVia Raman microscope using a 10-mW HeeNe laser
(632 nm excitation). The power of the laser beam is adjusted to
1 mW at the sample. The acquired data are from a depth of w1 mm
from the electrode surface. The harvested electrodes are thoroughly rinsed in DMC and dried in the glove box prior to Raman
measurements; this rinsing minimizes background ﬂuorescence
from electrolyte residue and electrode surface ﬁlms.
3. Results and discussion
3.1. Cycling performance of Li1.2Ni0.15Mn0.55Co0.1O2//graphite full
cells
During our cycling tests, cell to cell variations are always observed.
These variations arise from various factors that include (i) small differences in active material weight between similar electrodes, (ii)
small differences in the glove box environment when assembling the
cells, (iii) differing amount of impurities in the electrolytes, additives,
etc. However, the overall data trends observed across multiple cells are
consistent. Therefore, only representative data and trends are reported here.
Table 1 summarizes the cycling performance of Li1.2Ni0.15Mn0.55
Co0.1O2//graphite full cells with various PFA-substituted ethylene
carbonates (the corresponding capacity vs. cycle number plots can be
found in the Supporting information). No obvious correlation is
observed between cell cycling performance and PFA chain length.
After 25 cycles, the capacity fade trends are as follows: PFHEC > Gen2 % PFB-EC > TFM-EC > PFO-EC. That is, relative to the
baseline electrolyte, cells with the PFO-EC and PFH-EC additives show
the best and worst capacity retention, respectively. Cell capacity
retention shows a small but consistent correlation with the additive
concentrations. TFM-EC cells with 1 wt% additive perform slightly
better than those with 0.5 wt% additive, but cells with 0.5 wt% PFB-EC,
PFH-EC and PFO-EC perform somewhat better than those with 1 wt%
additive. Additional cells containing 0.5 wt% of each additive were
tested to 50 cycles; the capacity fade data shown in Fig.1 are consistent
with the trend reported above.
AC impedance data of Li1.2Ni0.15Mn0.55Co0.1O2//graphite full
cells, without and with 0.5 wt% of each additive in the baseline
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Fig. 2. AC impedance spectra of Li1.2Ni0.15Mn0.55Co0.1O2//graphite full cells in (a) Gen2
electrolyte, and Gen2 electrolyte with 0.5wt% (b) TFM-EC, (c) PFB-EC, (d) PFH-EC, (e)
PFO-EC cycled between 2.2 and 4.6 V at 30 $ C after formation cycling (black lines) and
after 50 cycles (red lines). (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article.)
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Fig. 3. Capacity vs. cycle number plots for Li1.2Ni0.15Mn0.55Co0.1O2//graphite full cells with
Gen2 electrolyte containing 0, 0.1, 0.5 and 2 wt% PFO-EC. Two low current
(15 mA g(oxide)#1) cycles precede and follow the rapid (75 mA g(oxide)#1) aging cycles.

113

Y. Zhu et al. / Journal of Power Sources 246 (2014) 184e191

4.8

6

4.4

5

4.0

4

Initial, Gen2, PFO-EC
200 cycles, Gen2

3.6

200 cycles, PFO-EC

Current, µA

Voltage, V

188

0.6

2

2.8

1

73% fade

1
0.8

3

3.2

2.4

Gen2
0.5wt% PFO-EC

0.4
0.2
0
3.00

0
3.00

34% fade

3.50

4.00

3.50

4.50

4.00

0

50

100

150

200

250

300

Capacity, mAh g-1
Fig. 4. Capacityevoltage plots for full cells containing the Gen2 electrolyte and
Gen2 þ 0.5 wt% PFO-EC electrolyte. The data were acquired with a 15 mA g(oxide)#1
current in the 2.2e4.6 V voltage window at 30 $ C. The initial cycle data are similar for
cells with and without the additive.
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Of all the additives tested, cells with PFO-EC provided the best
performance, which we attribute to a more solvophobic barrier and
better protection of the electrode surfaces. In fact, PFO-EC is the
least soluble in the Gen2 electrolyte; the maximum additive
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and without PFO-EC, determined by linear sweep voltammetry (LSV) at a Pt working
electrode. The inset contains an expanded view of the data.
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electrolyte, are shown in Fig. 2. The data for various cells are very
similar after the initial formation cycling. After 50 cycles, however,
cell impedances are signiﬁcantly different and show the following
trend: TFM-EC > PFH-EC % PFB-EC > Gen2 > PFO-EC. That is, cells
with 0.5 wt% TFM-EC and 0.5wt% PFO-EC show the highest and
lowest impedances, respectively.
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Fig. 5. AC impedance spectra of Li1.2Ni0.15Mn0.55Co0.1O2//graphite full cells, with and
without 0.5 wt% PFO-EC, after (a) formation cycles, (b) 200 cycles at 30 $ C.
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Fig. 7. Differential capacity plots from ﬁrst cycle lithiation data of graphite//Li cells in
Gen2 electrolyte with and without PFO-EC. (a) The X-axis voltage range is from 2 to
0.3 V, which highlights electrolyte reduction processes; (b) the X-axis voltage range is
from 0.3 to 0 V, which shows the main graphite lithiation peaks.
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loading is ca. 2 wt%, whereas loadings of PFH-EC, PFB-EC and TFMEC could be as high as 5 wt%. The lower solubility of PFO-EC suggests that its decomposition products may also be less soluble in
the electrolyte, which would lend greater stability to the electrode
surface ﬁlms. In contrast, electrode surface ﬁlms arising from PFHEC, PFB-EC and TFM-EC are less stable (or more soluble), and hence
less beneﬁcial to cell performance.
It should be noted that variation in molecular weights of the
PFA-EC additives give rise to large differences in molar ratios for a
given wt.% loading; for example, the molar equivalents of PFO-EC,
PFH-EC, PFB-EC, and TFM-EC are 1.00, 1.25, 1.65, and 3.25, respectively. The improved capacity retention of TFM-EC cells might thus
relate to an effectively higher molarity; previous work has shown
that TFM-EC forms an effective SEI on a graphite anode [29]. Indeed,
when the concentration of TFM-EC is reduced to 0.25 wt% (a closer
molar ratio to 0.5 wt% PFO-EC), a faster cell capacity fade is
observed (data not shown).
A systematic study was further conducted to determine the
concentration of PFO-EC that provide the best performance. Fig. 3
shows that Li1.2Ni0.15Mn0.55Co0.1O2//graphite full cells with 0.5 wt
% PFO-EC provide the best capacity retention. Cells with 2 wt% PFOEC show a faster capacity fade, whereas performance of cells with
0.1 wt% PFO-EC is similar to that of the baseline cell. After 200
cycles, the discharge capacity of cells with 0.5 wt% PFO-EC is
172 mAh-g#1, which is 66% of its initial discharge capacity
(260 mAh-g#1). In contrast, the discharge capacity of the baseline
(Gen2 only) cells is 70 mAh-g#1, which is 27% of its initial discharge
capacity (258 mAh-g#1). The enhanced capacity retention resulting
from the additive is also clearly seen in Fig. 4, which contains capacityevoltage data from the full cells. The PFO-EC additive is also
effective at inhibiting cell impedance rise during long-term cycling.

189

Fig. 5a shows that cells with 0.5 wt% PFO-EC have similar impedances as baseline cells after the initial cycling. However, after 200
cycles between 2.2 and 4.6 V (Fig. 5b), the impedance of the PFO-EC
bearing cell is much smaller than that of the Gen2 baseline cell. Our
previous studies have indicated that cell impedance rise in
Li1.2Ni0.15Mn0.55Co0.1O2//graphite full cells occurs primarily at the
positive electrode [4]. The reduced full cell impedance for the PFOEC-containing cells suggests that the additive forms effective surface ﬁlms at this electrode.
3.2. Oxidationereduction behavior of PFO-EC cells
Fig. 6 shows the oxidation LSV plot of a Pt electrode in Gen2
electrolyte, with and without PFO-EC. For the baseline electrolyte,
accelerated current increase is seen only at voltages greater than
4.8 V, whereas the PFO-EC bearing electrolyte shows an oxidation
current increase starting near w4.3 V. The higher oxidation current
suggests that the PFO-EC has a lower oxidation potential than Gen2
electrolyte and could be sacriﬁcially oxidized on the positive
electrode.
Differential capacity (dQ/dV) plots for the ﬁrst lithiation cycle of
graphite//Li cells were obtained to study electrolyte reduction
behavior, without or with 0.5 wt% PFO-EC in the electrolyte (Fig. 7).
The dQ/dV plots were quite similar regardless of PFO-EC, and
additional reduction peaks at higher voltages (>1 V vs Liþ/Li) were
not observed (Fig. 7a). Increasing the PFO-EC concentration to 2 wt
% yielded similar results (data not shown). The PFO-EC cells showed
a larger peak at w0.75 V vs. Liþ/Li and a smaller peak at w0.65 V vs
Liþ/Li, compared to the Gen2 cells, which suggests that the additive
modiﬁes electrolyte reduction behavior. This may be due in part to
the sacriﬁcial reduction of PFO-EC on the graphite anode surface, at

Fig. 8. XPS spectra from a pristine positive electrode and harvested positive electrodes from Li1.2Ni0.15Mn0.55Co0.1O2//graphite full cells containing Gen2 electrolyte, with and
without 0.5 wt% PFO-EC, after formation cycling and after aging. The aged cells underwent 200 cycles at 30 $ C, between 2.2 and 4.6 V, with 75 mA g#1 current.
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a similar reduction potential as EC [30]; however, the data does not
provide unequivocal proof, as the PFO-EC carbonyl is relatively
more electrophilic and may also be involved in SEI formation
through some chemical reactions. In particular, it is possible that
PFO-EC can preferentially react with various nucleophiles generated from EC reduction (alkoxides, carbonates, etc.), contributing to
SEI formation via anionic polymerizations [31]. The resulting SEI,
composed of PFO-EC reaction products, could be considered as a
“functionalized” passivation ﬁlm with low solvent permeability,
which may improve the SEI layer stability and cell capacity retention. Moreover, this SEI does not affect the overpotential for lithium
ion reduction and intercalation compared to the SEI formed in the
additive-free electrolyte (Fig. 7b).
3.3. XPS spectra from fresh and harvested positive electrodes
XPS spectra from the pristine positive electrode, and from
positive electrodes harvested from formed and aged full cells with
and without 0.5 wt% PFO-EC, are shown in Fig. 8. The harvested
electrodes were lightly rinsed with anhydrous DMC to remove residual electrolyte. Element concentrations (at.%) calculated from
the data are shown in Table 2.
The C1s spectra of the pristine electrode reveals peaks arising
from the poly(vinylidene ﬂuoride) (PVdF) binder (285.8 eV,
290.9 eV) and the conductive carbons (284.5 eV). These peak intensities are reduced in cathodes harvested after formation cycling
and continue to decrease with further cycling/aging, indicative of
surface ﬁlms growth on the electrode surfaces. Similar trends are
observed in the O1s, F1s and Mn2p spectra: upon cycling, intensities are reduced for the F1s peak (687.8 eV) corresponding to
PVdF, and for the O1s peak (529.6 eV) and Mn2p3/2 and Mn2p3/2
peaks (642.1 eV, 654.2 eV) corresponding to the metal oxide. In all
cases, these peak reductions are somewhat greater for the samples
containing PFO-EC, which suggests thicker electrode surface ﬁlms.
However, the thicker ﬁlms do not excessively impede lithium-ion
motion, as the impedance of aged PFO-EC cells is much lower
than that of cells without the additive (Fig. 5b).
The peak centered at 685 eV in the F1s spectra is from LiF, which
is present on both electrodes from the Gen2 and PFO-EC-containing
cells after formation cycling, but is stronger in the latter case. We
attribute the higher LiF content to the oxidation of PFO-EC, which is
consistent with our observations from the LSV study (Fig. 6). This
observation is important because the similar initial cell impedances
of the Gen2 and PFO-EC cells (Fig. 5a) indicate that cell impedance
rise cannot be solely attributed to the presence of LiF. Upon further
cycling, the LiF peak intensities decrease for both samples, which
could simply be due to growth of the overlying layers.
Table 2 and the O1s spectra show that the oxygen content in the
electrode surfaces increases slightly after formation cycling but
more signiﬁcantly after extended cycling: the most obvious
changes are in the 531e535 eV range. These O1s intensity changes,
along with C1s intensity increases in the 286e290 eV range, suggest the presence of various species that may include alkoxides,
carbonyls and carbonates; peaks arising from these compounds

overlap with the PVdF peaks, which makes deﬁnitive identiﬁcation
difﬁcult. Table 2 also shows that the P content in electrode surface
ﬁlms increases upon cycling/aging for both Gen2 and PFO-EC
samples. In addition, the P2p spectra shows an increase in the intensity of peaks centered around 134.6 eV (see Supporting
information), which indicate the presence of PeO bonds that may
arise from LixPOyFz compounds; intensity from these species would
also be seen in the O1s data.
3.4. Raman spectra from fresh and harvested negative electrodes
The graphite anodes were examined by Raman spectroscopy, a
standard tool for characterizing carbonaceous materials [32,33].
Fig. 9 shows representative Raman data from pristine and harvested negative electrodes; in all spectra, three peaks appear between 1000 and 2000 cm-1, assignable as the D, G, and D0 bands
(w1350, w1580, and w1620 cm-1 respectively). The G band is a
commonly accepted signature of graphitic carbon, whereas the D
and D0 bands are associated with defects and disorder within

Table 2
Element concentrations (at.%) calculated from XPS spectra of the fresh positive
electrode and from positive electrode samples harvested from cells that were
formed and aged in the Gen2 and Gen2þ0.5 wt% PFO-EC electrolytes.

Fresh
Formed_Gen2
Aged_Gen2
Formed_PFO-EC
Aged_PFO-EC

C 1s

F 1s

O 1s

Li 1s

Mn 2p

P 2p

58.5
53.7
54.6
47.8
56.1

26.5
22.7
21.8
24.8
20.8

9.7
11.6
15.7
10.4
17.9

3.3
9.3
3.8
14.6
1.7

1.5
1.4
1.6
0.94
0.98

0
0.97
1.9
1.4
2.5

Fig. 9. Raman spectra from graphite electrodes, before and after exposure to Gen2
electrolyte or Gen2þ0.5 wt% PFO-EC (a and b, respectively). Electrodes were harvested
from cells cycled between 2.2 and 4.6 V, either after formation cycles (“formed”) or
after 200 cycles (“aged”). Band intensities are normalized to the G-band.
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graphite; the ratio of the D and G band areas (ID/IG) correlates with
increased carbon disorder.
Fig. 9a shows the Raman spectra for graphite electrodes harvested from cells cycled in Gen2 electrolyte. The ID/IG for the pristine graphite electrode is 0.56, which is higher than that expected
for pure graphite (ID/IG ¼ 0) due to the presence of granular carbons
(ID/IG ¼ 2.47). The D and G peak shapes change noticeably for anode
samples after formation cycling (ID/IG ¼ 0.92) and even more after
another 200 cycles (ID/IG ¼ 1.35), with a substantial increase in the
size of the D peak and a broadening of the G peak. These data
suggest structural disordering at the graphite surface, which exposes new graphitic edges and fragments of graphite planes that
catalyze reductive decomposition of the electrolyte. Continued
structural disordering upon prolonged cycling contributes toward
increased electrolyte reduction and SEI reformation, leading to
gradual transfer of lithium from the cathode to the anode SEI and
eventually degrading cell capacity. Fig. 9b shows Raman spectra for
the fresh graphite electrode and for harvested electrodes from cells
cycled in the PFO-EC electrolyte; the ID/IG is 0.73 after formation
cycling and 0.84 after 200 cycles. These data suggest that the PFOEC additive reduces disordering of the graphite surface, both after
formation cycling and after extended cycling, which results in less
Liþ trapping and improved cell capacity retention.
4. Conclusions
A new family of polyﬂuoroalkyl-substituted ECs is examined
as electrolyte additives in full cells using Li1.2Ni0.15Mn0.55Co0.1O2based cathodes and graphite anodes. Addition of 0.5 wt% 4(perﬂuorooctyl)-1,3-dioxolan-2-one (PFO-EC) to a standardized
electrolyte solution, Gen 2 (1.2 M LiPF6 in a 3:7 mixture of
EC:EMC), is found to improve capacity retention and reduce
impedance rise in full cells cycled between 2.2 and 4.6 V. The LSV
and XPS data suggest that PFO-EC is sacriﬁcially oxidized on the
positive electrode; the dQ/dV plots from the ﬁrst lithiation cycle
of graphite//Li cells also suggest that PFO-EC is involved in SEI
formation.
Improvements in cell performance from the PFO-EC additive can
be attributed to synergistic effects of the performance on both
electrodes. The sacriﬁcial oxidation of PFO-EC at the cathode forms
surface ﬁlms that reduce cell impedance rise; PFO-EC also reacts at
the anode to generate a more stable SEI. The two mechanisms are
synergistic in their actions: the cathode protection not only reduces
electrolyte oxidation and slows down cell impedance rise, but also
reduces the dissolution of transition metal from the oxide, and
ultimately helps to improve SEI stability at the negative electrode.
At the anode, PFO-EC stabilization of the SEI lessens electrolyte
reduction and lithium trapping, which helps to maintain electrolyte
integrity and reduce cell impedance rise. Further mechanistic
studies on additive oxidationereduction reactions are currently
underway, and will be discussed in due course.
The data presented here validates our hypothesis of using polyﬂuoroalkyl-ECs as novel functional electrolyte additives, and
opens up possibilities for developing other PFA-substituted additives that may provide further performance improvements. These
PFA-substituted compounds may also be useful additives in other
lithium-ion cells, including those based on the 5 V spinel-based
positive electrodes.
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